No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d3mg8R_, 1.0000, 0.00, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2, d3mg7R_, 0.9990, 0.18, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3, d3mg6R_, 0.9983, 0.24, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4, d3oevR_, 0.9980, 0.26, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
5, d3mg4R_, 0.9946, 0.44, 1.000, 242, 242, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
6, d3mg0R_, 0.9940, 0.50, 1.000, 242, 242, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
7, d4ltcR_, 0.9939, 0.49, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
8, d3mg0D_, 0.9936, 0.52, 1.000, 242, 242, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
9, d4q1sR_, 0.9935, 0.49, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
10, d4ltcD_, 0.9933, 0.51, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
11, d4j70R_, 0.9931, 0.51, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
12, d4j70D_, 0.9931, 0.52, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
13, d3nzjR_, 0.9931, 0.52, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
14, d3nzjD_, 0.9931, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
15, p3un4R_, 0.9930, 0.53, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
16, d4jsqR_, 0.9929, 0.53, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
17, d4jsqD_, 0.9929, 0.53, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
18, d4hrcD_, 0.9929, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
19, p3un4D_, 0.9929, 0.53, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
20, d3oeuD_, 0.9929, 0.52, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
21, d3nzwR_, 0.9929, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
22, d3nzwD_, 0.9929, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
23, d3hyeR_, 0.9929, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
24, d3hyeD_, 0.9929, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
25, d4jsuR_, 0.9928, 0.53, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
26, d4jsuD_, 0.9928, 0.53, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
27, d4intR_, 0.9928, 0.53, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
28, d4hrdD_, 0.9928, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
29, d4hnpR_, 0.9928, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
30, d4intD_, 0.9927, 0.54, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
31, d4inrR_, 0.9927, 0.54, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
32, d4inrD_, 0.9927, 0.54, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
33, d3gpwR_, 0.9926, 0.54, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
34, d2gplR_, 0.9926, 0.55, 1.000, 242, 242, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
35, d2gplD_, 0.9926, 0.55, 1.000, 242, 242, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
36, d2fakR_, 0.9926, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
37, p4jt0R_, 0.9925, 0.55, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
38, p4jt0D_, 0.9925, 0.55, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
39, p4inuD_, 0.9925, 0.54, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
40, p4fzgR_, 0.9925, 0.54, 1.000, 242, 242, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
41, p4fzgD_, 0.9925, 0.54, 1.000, 242, 242, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
42, d4fzcR_, 0.9925, 0.54, 1.000, 242, 242, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
43, d4fzcD_, 0.9925, 0.54, 1.000, 242, 242, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
44, d3gpwD_, 0.9925, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
45, d3gptR_, 0.9925, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
46, d3gptD_, 0.9925, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
47, d2fakD_, 0.9925, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
48, d2f16R_, 0.9925, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
49, d2f16D_, 0.9925, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
50, p4gk7R_, 0.9924, 0.54, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
51, d3tddR_, 0.9924, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
52, d3tddD_, 0.9924, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
53, p4inuR_, 0.9923, 0.55, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
54, p4gk7D_, 0.9923, 0.55, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
55, d3oevD_, 0.9923, 0.56, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
56, d3nzxR_, 0.9923, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
57, d3nzxD_, 0.9923, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
58, p3e47R_, 0.9923, 0.56, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
59, p3e47D_, 0.9923, 0.56, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
60, d4lqiR_, 0.9922, 0.56, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
61, d4lqiD_, 0.9922, 0.56, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
62, d4hnpD_, 0.9922, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
63, d3shjR_, 0.9922, 0.55, 1.000, 242, 242, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
64, d3shjD_, 0.9922, 0.55, 1.000, 242, 242, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
65, d3dy3R_, 0.9922, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
66, d3mg7D_, 0.9921, 0.57, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
67, d3dy3D_, 0.9921, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
68, d3d29R_, 0.9921, 0.55, 1.000, 242, 242, PROTEASOME INHIBITION BY FELLUTAMIDE B
69, d3d29D_, 0.9921, 0.55, 1.000, 242, 242, PROTEASOME INHIBITION BY FELLUTAMIDE B
70, d2zcyR_, 0.9921, 0.54, 1.000, 242, 242, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
71, d2zcyD_, 0.9921, 0.54, 1.000, 242, 242, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
72, d4q1sD_, 0.9920, 0.55, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
73, d3okjR_, 0.9920, 0.56, 1.000, 242, 242, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
74, d3un8D_, 0.9919, 0.56, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
75, d3okjD_, 0.9919, 0.56, 1.000, 242, 242, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
76, d3un8R_, 0.9918, 0.57, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
77, d3gpjR_, 0.9918, 0.56, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
78, d3dy4R_, 0.9918, 0.56, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
79, d4hrdR_, 0.9917, 0.57, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
80, d3mg8D_, 0.9917, 0.59, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
81, d3gpjD_, 0.9917, 0.56, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
82, d3dy4D_, 0.9917, 0.56, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
83, d3mg6D_, 0.9914, 0.61, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
84, d4hrcR_, 0.9912, 0.60, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
85, d3bdmR_, 0.9912, 0.58, 1.000, 242, 242, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
86, d3bdmD_, 0.9912, 0.58, 1.000, 242, 242, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
87, d1rypS_, 0.9911, 0.59, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
88, d1rypE_, 0.9910, 0.60, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
89, d1g65D_, 0.9904, 0.60, 1.000, 242, 242, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
90, d1g65R_, 0.9902, 0.60, 1.000, 242, 242, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
91, d4eu2S_, 0.9901, 0.62, 1.000, 242, 242, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
92, d1jd2D_, 0.9899, 0.62, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
93, d1jd2Y_, 0.9898, 0.62, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
94, d3mg4D_, 0.9897, 0.65, 1.000, 242, 242, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
95, d4eu2E_, 0.9866, 0.82, 1.000, 242, 242, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
96, p3jcpNA_, 0.9823, 0.80, 1.000, 242, 242, 
97, p3jcpN_, 0.9823, 0.80, 1.000, 242, 242, 
98, p4x6zE_, 0.9811, 1.02, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
99, p4x6zS_, 0.9794, 1.04, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
100, d3wxrE_, 0.9789, 0.58, 1.000, 239, 239, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
101, d3wxrS_, 0.9773, 0.49, 1.000, 238, 238, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
102, p3jcoNA_, 0.9765, 0.92, 1.000, 242, 242, 
103, p3jcoN_, 0.9765, 0.92, 1.000, 242, 242, 
104, d3oeuR_, 0.9742, 0.18, 1.000, 236, 236, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
105, p5mp9e_, 0.9714, 1.18, 1.000, 242, 242, 26S PROTEASOME IN PRESENCE OF ATP (S1)
106, d1z7qE1, 0.9714, 1.09, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
107, p5mp9E_, 0.9713, 1.22, 1.000, 242, 242, 26S PROTEASOME IN PRESENCE OF ATP (S1)
108, d1z7qS1, 0.9713, 1.09, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
109, p1fntE_, 0.9701, 1.10, 0.996, 244, 242, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
110, p1fntS_, 0.9700, 1.11, 0.996, 244, 242, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
111, p5wvkZ_, 0.9699, 1.04, 1.000, 242, 242, 
112, p5nifS_, 0.9691, 0.47, 1.000, 236, 236, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
113, p4zzgS_, 0.9689, 0.48, 1.000, 236, 236, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
114, p5wvkS_, 0.9682, 1.10, 1.000, 242, 242, 
115, p4y8sR_, 0.9672, 0.38, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
116, p4y8sD_, 0.9672, 0.39, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
117, p4ya2R_, 0.9671, 0.39, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
118, p4ya2D_, 0.9671, 0.39, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
119, d4qz7R_, 0.9671, 0.39, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
120, d4qz7D_, 0.9671, 0.40, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
121, d4qlqR_, 0.9671, 0.39, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
122, d4qlqD_, 0.9671, 0.39, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
123, p4y8hR_, 0.9669, 0.40, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
124, p4y8hD_, 0.9669, 0.40, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
125, d4qluR_, 0.9669, 0.39, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
126, d4nnwR_, 0.9669, 0.39, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
127, d4nnwD_, 0.9669, 0.39, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
128, p4y8gR_, 0.9668, 0.40, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
129, p4y8gD_, 0.9668, 0.40, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
130, p4qz0R_, 0.9668, 0.41, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
131, p4qz0D_, 0.9668, 0.41, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
132, d4qluD_, 0.9668, 0.39, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
133, d4qlsR_, 0.9668, 0.40, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
134, d4qlsD_, 0.9668, 0.40, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
135, d5l55R_, 0.9666, 0.41, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
136, d5l55D_, 0.9666, 0.41, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
137, d5l52R_, 0.9666, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
138, d5l52D_, 0.9666, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
139, d5fggR_, 0.9666, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
140, d5fggD_, 0.9666, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
141, d5fg7R_, 0.9666, 0.41, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
142, p5cggR_, 0.9666, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
143, p5cggD_, 0.9666, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
144, d5ahjR_, 0.9666, 0.41, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
145, d5ahjD_, 0.9666, 0.41, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
146, d4qwlR_, 0.9666, 0.42, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
147, d4qwlD_, 0.9666, 0.42, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
148, d4qltR_, 0.9666, 0.42, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
149, d4qltD_, 0.9666, 0.42, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
150, d4no9R_, 0.9666, 0.41, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
151, d4no9D_, 0.9666, 0.41, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
152, d4no8R_, 0.9666, 0.41, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
153, d5l54R_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
154, d5l54D_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
155, d5jhrR_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
156, d5jhrD_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
157, d5d0zR_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
158, d5d0zD_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
159, d5d0vR_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
160, d5d0vD_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
161, d5d0sR_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
162, d5d0sD_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
163, p5cgiR_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
164, p5cgiD_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
165, p4ya7R_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
166, p4ya7D_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
167, p4y8tR_, 0.9665, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
168, p4y8tD_, 0.9665, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
169, p4y8pR_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
170, p4y8pD_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
171, p4y84R_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
172, p4y84D_, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
173, d4qz6R_, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
174, d4qz6D_, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
175, p4qz4R_, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
176, p4qz4D_, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
177, d4qz2R_, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
178, d4qz2D_, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
179, d4qwxR_, 0.9665, 0.43, 1.000, 235, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
180, d4qw6R_, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
181, d4qw6D_, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
182, p4qw5R_, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
183, p4qw5D_, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
184, d4qlvR_, 0.9665, 0.42, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
185, d4qlvD_, 0.9665, 0.42, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
186, d4no8D_, 0.9665, 0.41, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
187, p5cghR_, 0.9664, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
188, p5cghD_, 0.9664, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
189, p4y9zR_, 0.9664, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
190, p4y9zD_, 0.9664, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
191, p4y75R_, 0.9664, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
192, d4qwxD_, 0.9664, 0.43, 1.000, 235, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
193, d4qw7R_, 0.9664, 0.43, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
194, d4qw7D_, 0.9664, 0.43, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
195, d4qvnR_, 0.9664, 0.44, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
196, d4qvnD_, 0.9664, 0.44, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
197, p4qbyR_, 0.9664, 0.43, 1.000, 235, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
198, p4qbyD_, 0.9664, 0.43, 1.000, 235, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
199, d4nnnR_, 0.9664, 0.42, 1.000, 235, 235, YCP IN COMPLEX WITH MG132
200, d4nnnD_, 0.9664, 0.42, 1.000, 235, 235, YCP IN COMPLEX WITH MG132
201, p5mpaE_, 0.9663, 1.29, 1.000, 242, 242, 26S PROTEASOME IN PRESENCE OF ATP (S2)
202, d5l6bR_, 0.9663, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
203, d5l6bD_, 0.9663, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
204, d5fgfR_, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
205, d5fgfD_, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
206, d5cz9R_, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
207, d5cz9D_, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
208, p4ya9R_, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
209, p4ya9D_, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
210, p4y77R_, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
211, p4y77D_, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
212, p4y75D_, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
213, d4qzxR_, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
214, d4qzxD_, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
215, p4qzwR_, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
216, p4qzwD_, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
217, d4qz5R_, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
218, d4qz5D_, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
219, d4qz3R_, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
220, d4qz3D_, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
221, p4qwfR_, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
222, p4qwfD_, 0.9663, 0.44, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
223, d5jhsR_, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
224, d5jhsD_, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
225, d5cz8R_, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
226, d5cz8D_, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
227, d5bxnR_, 0.9662, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
228, d5bxnD_, 0.9662, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
229, p4y8kR_, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
230, p4y8kD_, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
231, p4y70R_, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
232, p4y70D_, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
233, p4qwuR_, 0.9662, 0.45, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
234, p4qwuD_, 0.9662, 0.45, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
235, d4qwrR_, 0.9662, 0.44, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
236, d4qwrD_, 0.9662, 0.44, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
237, d4qw1R_, 0.9662, 0.45, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
238, d4qw1D_, 0.9662, 0.45, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
239, p4no6R_, 0.9662, 0.43, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
240, p4no6D_, 0.9662, 0.43, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
241, d5l6aR_, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
242, d5l6aD_, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
243, d5l5uR_, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
244, d5l5uD_, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
245, d5l5oR_, 0.9661, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
246, d5l5oD_, 0.9661, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
247, d5l5hR_, 0.9661, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
248, d5l5hD_, 0.9661, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
249, d5l5dR_, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
250, d5l5dD_, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
251, d5l5bR_, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
252, d5l5bD_, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
253, d5fgeR_, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
254, d5fgeD_, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
255, d4ya1R_, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
256, p4y8qR_, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
257, p4y8qD_, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
258, p4y8lR_, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
259, p4y8lD_, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
260, p4y8jR_, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
261, p4y8jD_, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
262, p4y7wR_, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
263, p4y7wD_, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
264, p4y74R_, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
265, p4y74D_, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
266, d4qxjR_, 0.9661, 0.44, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
267, d4qxjD_, 0.9661, 0.44, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
268, d4qvpR_, 0.9661, 0.46, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
269, d4qvpD_, 0.9661, 0.46, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
270, d4qv7R_, 0.9661, 0.46, 1.000, 235, 235, YCP BETA5-A50V MUTANT
271, d4qv5R_, 0.9661, 0.45, 1.000, 235, 235, YCP BETA5-M45I MUTANT
272, d4qv5D_, 0.9661, 0.45, 1.000, 235, 235, YCP BETA5-M45I MUTANT
273, d4qv4R_, 0.9661, 0.46, 1.000, 235, 235, YCP BETA5-M45T MUTANT
274, p4qv3R_, 0.9661, 0.45, 1.000, 235, 235, YCP BETA5-M45V MUTANT
275, p4qv3D_, 0.9661, 0.45, 1.000, 235, 235, YCP BETA5-M45V MUTANT
276, p4qv0R_, 0.9661, 0.45, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
277, p4qv0D_, 0.9661, 0.45, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
278, d4no1R_, 0.9661, 0.44, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
279, d4no1D_, 0.9661, 0.44, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
280, p6gopR_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
281, p6gopD_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
282, d5lttR_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
283, d5lttD_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
284, d5l67R_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
285, d5l67D_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
286, d5l66R_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
287, d5l66D_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
288, d5l65R_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
289, d5l65D_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
290, d5l5rR_, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
291, d5l5rD_, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
292, d5l5fR_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
293, d5l5fD_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
294, d5fhsR_, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
295, d5fhsD_, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
296, d5fgiR_, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
297, d5fgiD_, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
298, d5fg7D_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
299, d5d0wR_, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
300, d5d0wD_, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
301, d5czaR_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
302, d5czaD_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
303, d5cz6R_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
304, d5cz6D_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
305, d4ya4R_, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
306, d4ya4D_, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
307, d4ya1D_, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
308, d4y8rR_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
309, d4y8rD_, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
310, p4y82R_, 0.9660, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
311, p4y82D_, 0.9660, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
312, p4y80R_, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
313, p4y80D_, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
314, p4y7yR_, 0.9660, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
315, p4y7yD_, 0.9660, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
316, d4qzzR_, 0.9660, 0.46, 1.000, 235, 235, YCP IN COMPLEX WITH OMURALIDE
317, d4qzzD_, 0.9660, 0.46, 1.000, 235, 235, YCP IN COMPLEX WITH OMURALIDE
318, d4qwiR_, 0.9660, 0.45, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
319, d4qwiD_, 0.9660, 0.45, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
320, p4qvwR_, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
321, d4qvqR_, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
322, d4qvqD_, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
323, d4qvlR_, 0.9660, 0.46, 1.000, 235, 235, YCP IN COMPLEX WITH BORTEZOMIB
324, d4qvlD_, 0.9660, 0.46, 1.000, 235, 235, YCP IN COMPLEX WITH BORTEZOMIB
325, d4qv9R_, 0.9660, 0.45, 1.000, 235, 235, YCP BETA5-C63F MUTANT
326, d4qv9D_, 0.9660, 0.45, 1.000, 235, 235, YCP BETA5-C63F MUTANT
327, d4qv8R_, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-C52F MUTANT
328, d4qv8D_, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-C52F MUTANT
329, d4qv7D_, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-A50V MUTANT
330, d4qv4D_, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-M45T MUTANT
331, d4qv1R_, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-M45A MUTANT
332, d4qv1D_, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-M45A MUTANT
333, d5l6cR_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
334, d5l6cD_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
335, d5l63R_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
336, d5l63D_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
337, d5l61R_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
338, d5l61D_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
339, d5l5xR_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
340, d5l5xD_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
341, d5l5tR_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
342, d5l5tD_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
343, d5l5qR_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
344, d5l5qD_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
345, d5l5jR_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
346, d5l5jD_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
347, d5l5eR_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
348, d5l5eD_, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
349, d5fgaR_, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
350, d5fgaD_, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
351, d5fg9R_, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
352, d5cz7R_, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
353, d5cz7D_, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
354, d5cz5R_, 0.9659, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
355, d5cz5D_, 0.9659, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
356, d5cgfR_, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
357, d5cgfD_, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
358, d5bxlR_, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
359, d5bxlD_, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
360, d4y9yR_, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
361, d4y9yD_, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
362, d4y8mR_, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
363, d4y8mD_, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
364, d4r17R_, 0.9659, 0.45, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
365, d4r17D_, 0.9659, 0.45, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
366, d4r02R_, 0.9659, 0.46, 1.000, 235, 235, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
367, d4r00R_, 0.9659, 0.46, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
368, d4r00D_, 0.9659, 0.47, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
369, p4qz1R_, 0.9659, 0.45, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
370, p4qz1D_, 0.9659, 0.45, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
371, d4qw4R_, 0.9659, 0.45, 1.000, 235, 235, YCP IN COMPLEX WITH CARFILZOMIB
372, d4qvyR_, 0.9659, 0.46, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
373, d4qvyD_, 0.9659, 0.46, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
374, p4qvwD_, 0.9659, 0.46, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
375, d4quyR_, 0.9659, 0.46, 1.000, 235, 235, YCP BETA5-A49S-MUTANT
376, d4quyD_, 0.9659, 0.46, 1.000, 235, 235, YCP BETA5-A49S-MUTANT
377, d5m2bR_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
378, d5m2bD_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
379, d5l68R_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
380, d5l68D_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
381, d5l64R_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
382, d5l64D_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
383, d5l62R_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
384, d5l62D_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
385, d5l5vR_, 0.9658, 0.47, 1.000, 235, 235,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
386, d5l5vD_, 0.9658, 0.47, 1.000, 235, 235,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
387, d5l5sR_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
388, d5l5sD_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
389, d5l5pR_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
390, d5l5pD_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
391, d5l5iR_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
392, d5l5iD_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
393, d5l5aR_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
394, d5l5aD_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
395, d5fgdR_, 0.9658, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
396, d5fgdD_, 0.9658, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
397, d5fg9D_, 0.9658, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
398, d4z1lR_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
399, d4z1lD_, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
400, p4y7xR_, 0.9658, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
401, d4qw4D_, 0.9658, 0.45, 1.000, 235, 235, YCP IN COMPLEX WITH CARFILZOMIB
402, d4qv6R_, 0.9658, 0.47, 1.000, 235, 235, YCP BETA5-A49V MUTANT
403, d4qv6D_, 0.9658, 0.47, 1.000, 235, 235, YCP BETA5-A49V MUTANT
404, d5l5zR_, 0.9657, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
405, d5l5zD_, 0.9657, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
406, d5l5wR_, 0.9657, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
407, d5l5wD_, 0.9657, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
408, d5d0tR_, 0.9657, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
409, d5d0tD_, 0.9657, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
410, p4y8iR_, 0.9657, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
411, p4y8iD_, 0.9657, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
412, p4y81R_, 0.9657, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
413, p4y81D_, 0.9657, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
414, p4y7xD_, 0.9657, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
415, p4y6zR_, 0.9657, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
416, p4y6zD_, 0.9657, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
417, p4quxR_, 0.9657, 0.47, 1.000, 235, 235, YCP BETA5-A49T-MUTANT
418, p4quxD_, 0.9657, 0.47, 1.000, 235, 235, YCP BETA5-A49T-MUTANT
419, d5dkjR_, 0.9656, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
420, d5dkjD_, 0.9656, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
421, p4y8oR_, 0.9656, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
422, p4y8oD_, 0.9656, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
423, p4y78R_, 0.9656, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
424, p4y78D_, 0.9656, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
425, d4qwkR_, 0.9656, 0.46, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
426, d4qwkD_, 0.9656, 0.46, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
427, d4qwjR_, 0.9656, 0.46, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
428, d4qwjD_, 0.9656, 0.46, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
429, d5l5yR_, 0.9655, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
430, d5l5yD_, 0.9655, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
431, p4y8uR_, 0.9655, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
432, p4y8uD_, 0.9655, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
433, p4y6vR_, 0.9655, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
434, p4y6vD_, 0.9655, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
435, p4qwsR_, 0.9655, 0.47, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
436, d4qw0R_, 0.9655, 0.48, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
437, d4qw0D_, 0.9655, 0.48, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
438, p5nifE_, 0.9654, 0.45, 1.000, 236, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
439, d5l69R_, 0.9654, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
440, d5l60R_, 0.9654, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
441, d5l60D_, 0.9654, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
442, d5d0xR_, 0.9654, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
443, d5d0xD_, 0.9654, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
444, d5bouR_, 0.9654, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
445, d5bouD_, 0.9654, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
446, d4rurR_, 0.9654, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
447, d4r18R_, 0.9654, 0.49, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
448, p4qwsD_, 0.9654, 0.47, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
449, d5lajR_, 0.9653, 0.49, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
450, d5lajD_, 0.9653, 0.49, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
451, d5l69D_, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
452, p4y8nR_, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
453, p4y8nD_, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
454, p4y6aR_, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
455, p4y6aD_, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
456, p4y69R_, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
457, p4y69D_, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
458, d4rurD_, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
459, d4r18D_, 0.9653, 0.49, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
460, d4r02D_, 0.9653, 0.47, 1.000, 235, 235, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
461, d4qvmR_, 0.9653, 0.49, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
462, d4qvmD_, 0.9653, 0.49, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
463, d5laiR_, 0.9652, 0.49, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
464, d5laiD_, 0.9652, 0.49, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
465, p4zzgE_, 0.9652, 0.46, 1.000, 236, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
466, p4ya5R_, 0.9652, 0.50, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
467, p4ya5D_, 0.9652, 0.50, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
468, d4qvvR_, 0.9652, 0.50, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
469, d4qvvD_, 0.9652, 0.50, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
470, p5fghR_, 0.9651, 0.50, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
471, p5fghD_, 0.9651, 0.50, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
472, d5dkiR_, 0.9648, 0.51, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
473, d5dkiD_, 0.9648, 0.51, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
474, d5cz4R_, 0.9648, 0.51, 1.000, 235, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
475, d5cz4D_, 0.9648, 0.51, 1.000, 235, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
476, p4ya3R_, 0.9648, 0.51, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
477, p4ya3D_, 0.9648, 0.51, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
478, d4qwgR_, 0.9647, 0.50, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
479, d4qwgD_, 0.9647, 0.50, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
480, d4qw3R_, 0.9646, 0.52, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
481, d4qw3D_, 0.9646, 0.52, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
482, p4ya0R_, 0.9645, 0.52, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
483, p4ya0D_, 0.9645, 0.52, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
484, d4g4sE_, 0.9641, 1.29, 0.992, 249, 239, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
485, d4cr2E_, 0.9630, 1.22, 1.000, 243, 242, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
486, p5mpae_, 0.9627, 1.36, 1.000, 242, 241, 26S PROTEASOME IN PRESENCE OF ATP (S2)
487, d3sdkD_, 0.9598, 0.33, 1.000, 233, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
488, d3sdkR_, 0.9580, 0.15, 1.000, 232, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
489, p5mpcE_, 0.9525, 1.36, 1.000, 242, 242, 
490, p5mpbS_, 0.9476, 1.45, 1.000, 242, 242, 
491, p5wviBA_, 0.9462, 1.51, 1.000, 243, 242, 
492, p4cr4E_, 0.9462, 1.38, 0.971, 243, 241, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
493, d1g0uD_, 0.9453, 0.44, 0.983, 230, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
494, d1g0uR_, 0.9452, 0.44, 0.983, 230, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
495, d3sdiR_, 0.9445, 0.25, 1.000, 229, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
496, d3sdiD_, 0.9395, 0.31, 1.000, 228, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
497, p5mpcS_, 0.9392, 1.57, 1.000, 242, 242, 
498, p5lezR_, 0.9372, 1.26, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
499, p5lezD_, 0.9368, 1.32, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
500, p5leyR_, 0.9365, 1.31, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
501, d5lexR_, 0.9365, 1.30, 0.601, 233, 233, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
502, d5le5R_, 0.9364, 1.33, 0.601, 233, 233, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
503, p5gjqF_, 0.9364, 1.30, 0.601, 234, 233, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
504, p5leyD_, 0.9363, 1.35, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
505, p6avoM_, 0.9362, 1.29, 0.601, 233, 233, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
506, p5lf6R_, 0.9362, 1.30, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
507, d5lf7R_, 0.9361, 1.32, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
508, p5lf6D_, 0.9361, 1.35, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
509, d5lf4R_, 0.9361, 1.31, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
510, d5lf1R_, 0.9361, 1.33, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
511, p5lf0R_, 0.9361, 1.32, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
512, d5lexD_, 0.9361, 1.35, 0.601, 233, 233, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
513, p5gjql_, 0.9361, 1.31, 0.601, 234, 233, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
514, p6avoH_, 0.9360, 1.30, 0.601, 233, 233, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
515, d5lf3R_, 0.9360, 1.31, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
516, p5a5bE_, 0.9359, 1.68, 1.000, 243, 242, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
517, p4cr3E_, 0.9359, 1.68, 1.000, 243, 242, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
518, d5lf4D_, 0.9358, 1.37, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
519, p5lf0D_, 0.9358, 1.36, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
520, p3unbf_, 0.9358, 1.32, 0.601, 233, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
521, d3unbD_, 0.9358, 1.32, 0.601, 233, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
522, d5lf3D_, 0.9356, 1.36, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
523, d5lf1D_, 0.9356, 1.38, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
524, d5lf7D_, 0.9355, 1.37, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
525, d5le5D_, 0.9355, 1.38, 0.601, 233, 233, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
526, p5gjrKA_, 0.9355, 1.33, 0.601, 234, 233, 
527, p5gjrW_, 0.9351, 1.34, 0.601, 234, 233, 
528, p4r67u_, 0.9348, 1.33, 0.601, 234, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
529, d4r67S_, 0.9348, 1.33, 0.601, 234, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
530, p4r67g_, 0.9348, 1.33, 0.601, 234, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
531, d4r67E_, 0.9348, 1.33, 0.601, 234, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
532, d3unbR_, 0.9348, 1.36, 0.601, 233, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
533, p5l4gS_, 0.9342, 1.35, 0.601, 234, 233, 
534, d4r3oS_, 0.9340, 1.33, 0.601, 234, 233, HUMAN CONSTITUTIVE 20S PROTEASOME
535, d4r3oE_, 0.9340, 1.33, 0.601, 234, 233, HUMAN CONSTITUTIVE 20S PROTEASOME
536, p3unbt_, 0.9340, 1.37, 0.601, 233, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
537, d1iruS_, 0.9332, 1.36, 0.601, 234, 233, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
538, d1iruE_, 0.9332, 1.36, 0.601, 234, 233, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
539, p5l4gE_, 0.9325, 1.34, 0.601, 234, 233, 
540, p3uneR_, 0.9307, 1.38, 0.601, 233, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
541, p3uneD_, 0.9301, 1.42, 0.601, 233, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
542, p3unet_, 0.9297, 1.42, 0.601, 233, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
543, d3unfR_, 0.9295, 1.41, 0.601, 233, 233, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
544, d3unfD_, 0.9295, 1.41, 0.601, 233, 233, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
545, p3unhD_, 0.9293, 1.42, 0.601, 233, 233, MOUSE 20S IMMUNOPROTEASOME
546, p3unhR_, 0.9292, 1.42, 0.601, 233, 233, MOUSE 20S IMMUNOPROTEASOME
547, p3unef_, 0.9285, 1.42, 0.601, 233, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
548, p5m32R_, 0.9208, 1.51, 0.547, 233, 232, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
549, p5m32D_, 0.9208, 1.51, 0.547, 233, 232, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
550, d3unfP_, 0.9121, 1.85, 0.343, 248, 236, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
551, p3unfB_, 0.9121, 1.85, 0.343, 248, 236, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
552, p3unhP_, 0.9118, 1.86, 0.343, 248, 236, MOUSE 20S IMMUNOPROTEASOME
553, p3unhB_, 0.9118, 1.86, 0.343, 248, 236, MOUSE 20S IMMUNOPROTEASOME
554, p5gjrIA_, 0.9116, 1.88, 0.343, 250, 236, 
555, d5le5B_, 0.9115, 1.87, 0.343, 248, 236, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
556, d5lf7B_, 0.9114, 1.87, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
557, p5gjrU_, 0.9112, 1.88, 0.343, 250, 236, 
558, p3unbd_, 0.9111, 1.87, 0.343, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
559, d5lf4B_, 0.9110, 1.88, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
560, p5lezB_, 0.9107, 1.88, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
561, p5leyB_, 0.9107, 1.88, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
562, d5lf3B_, 0.9106, 1.88, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
563, d5lf1B_, 0.9106, 1.88, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
564, d5lexB_, 0.9105, 1.88, 0.343, 248, 236, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
565, p3unbB_, 0.9103, 1.89, 0.343, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
566, p5lf0B_, 0.9102, 1.89, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
567, p5lf6B_, 0.9099, 1.89, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
568, d5le5P_, 0.9099, 1.90, 0.343, 247, 236, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
569, d4r3oQ_, 0.9096, 1.91, 0.343, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME
570, d4r3oC_, 0.9096, 1.91, 0.343, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME
571, p4v7oMA_, 0.9093, 1.13, 1.000, 227, 227, 
572, p4v7oE_, 0.9093, 1.13, 1.000, 227, 227, 
573, p4v7oAB_, 0.9093, 1.13, 1.000, 227, 227, 
574, d4r67Q_, 0.9092, 1.91, 0.343, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
575, d4r67C_, 0.9092, 1.91, 0.343, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
576, p4v7oS_, 0.9091, 1.13, 1.000, 227, 227, 
577, p5lezP_, 0.9090, 1.92, 0.343, 247, 236, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
578, d5lf7P_, 0.9086, 1.92, 0.343, 247, 236, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
579, p3unbP_, 0.9086, 1.91, 0.343, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
580, p3uneP_, 0.9085, 1.89, 0.343, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME
581, d5lf4P_, 0.9084, 1.93, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
582, d5lf1P_, 0.9084, 1.93, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
583, p3unbr_, 0.9082, 1.92, 0.343, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
584, p5lf6P_, 0.9081, 1.93, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
585, p5ln3E_, 0.9080, 1.47, 0.595, 232, 232, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
586, p5lf0P_, 0.9080, 1.94, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
587, p5leyP_, 0.9079, 1.94, 0.343, 247, 236, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
588, d5lexP_, 0.9079, 1.93, 0.343, 247, 236, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
589, p3uner_, 0.9079, 1.91, 0.343, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME
590, d5lf3P_, 0.9078, 1.93, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
591, d1iruQ_, 0.9075, 1.91, 0.339, 250, 236, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
592, d1iruC_, 0.9075, 1.91, 0.339, 250, 236, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
593, p3uned_, 0.9068, 1.92, 0.343, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME
594, p3uneB_, 0.9065, 1.93, 0.343, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME
595, p5vfsE_, 0.9059, 1.13, 0.612, 228, 227, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
596, p5vfsDA_, 0.9052, 1.15, 0.612, 228, 227, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
597, d4r02P_, 0.9051, 1.81, 0.358, 244, 232, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
598, d4intP_, 0.9051, 1.81, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
599, d4q1sP_, 0.9050, 1.81, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
600, p5vftK_, 0.9049, 1.18, 0.612, 228, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
601, d4intB_, 0.9049, 1.81, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
602, d4inrP_, 0.9045, 1.82, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
603, p5vfuV_, 0.9044, 1.19, 0.612, 228, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
604, p5t0cW_, 0.9044, 1.17, 0.612, 228, 227, 
605, p5t0cCB_, 0.9044, 1.17, 0.612, 228, 227, 
606, d3wxrQ_, 0.9044, 1.86, 0.358, 244, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
607, d4lqiP_, 0.9043, 1.82, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
608, d4inuP_, 0.9042, 1.82, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
609, d4inrB_, 0.9042, 1.82, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
610, d4hnpP_, 0.9042, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
611, d4lqiB_, 0.9041, 1.82, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
612, d4hrcP_, 0.9041, 1.86, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
613, d4fzcP_, 0.9041, 1.83, 0.358, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
614, d4fzcB_, 0.9040, 1.83, 0.358, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
615, d5lajP_, 0.9039, 1.82, 0.358, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
616, d4jsqP_, 0.9039, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
617, d4jsqB_, 0.9039, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
618, d4j70P_, 0.9039, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
619, d3nzjP_, 0.9039, 1.82, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
620, d1g65P_, 0.9039, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
621, d5lajB_, 0.9038, 1.83, 0.358, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
622, d4nnwP_, 0.9038, 1.83, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
623, d4nnwB_, 0.9038, 1.83, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
624, d4jsuP_, 0.9038, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
625, d4jsuB_, 0.9038, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
626, d4inuB_, 0.9038, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
627, d2gplP_, 0.9038, 1.83, 0.358, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
628, d4no9P_, 0.9037, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
629, d4no9B_, 0.9037, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
630, d4hnpB_, 0.9037, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
631, d3nzjB_, 0.9037, 1.82, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
632, d2gplB_, 0.9037, 1.83, 0.358, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
633, d4r18P_, 0.9036, 1.82, 0.358, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
634, p4r18B_, 0.9036, 1.83, 0.358, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
635, p4gk7P_, 0.9036, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
636, d3tddP_, 0.9036, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
637, d3hyeP_, 0.9036, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
638, d1g65B_, 0.9036, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
639, p4gk7B_, 0.9035, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
640, d3tddB_, 0.9035, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
641, d3nzwP_, 0.9035, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
642, d3hyeB_, 0.9035, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
643, d3dy4P_, 0.9035, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
644, d2fnyP_, 0.9035, 1.83, 0.358, 244, 232,  
645, p5cgiP_, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
646, p4y9zP_, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
647, p4y9zB_, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
648, p4y8sP_, 0.9034, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
649, p4y8sB_, 0.9034, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
650, p4y8jP_, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
651, p4y8jB_, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
652, p4y8iP_, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
653, p4y7yP_, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
654, p4y7yB_, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
655, d4qzxP_, 0.9034, 1.83, 0.358, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
656, d4qzxB_, 0.9034, 1.83, 0.358, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
657, d4qz6P_, 0.9034, 1.83, 0.358, 244, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
658, d4qz6B_, 0.9034, 1.83, 0.358, 244, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
659, d4qz2P_, 0.9034, 1.84, 0.358, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
660, d4qz2B_, 0.9034, 1.84, 0.358, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
661, d4qw6P_, 0.9034, 1.84, 0.358, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
662, d4hrdP_, 0.9034, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
663, d4fzgP_, 0.9034, 1.84, 0.358, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
664, d3nzwB_, 0.9034, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
665, d3dy4B_, 0.9034, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
666, d2fnyB_, 0.9034, 1.83, 0.358, 244, 232,  
667, d5jhrP_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
668, d5fgfP_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
669, d5fgfB_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
670, d5cz8P_, 0.9033, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
671, d5cz8B_, 0.9033, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
672, p5cgiB_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
673, p4y8lP_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
674, p4y8lB_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
675, p4y8iB_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
676, p4y8hP_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
677, p4y8hB_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
678, p4y84P_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
679, p4y84B_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
680, p4y80P_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
681, p4y7wP_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
682, p4y7wB_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
683, p4y70P_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
684, p4y70B_, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
685, d4qz5P_, 0.9033, 1.83, 0.358, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
686, d4qz0P_, 0.9033, 1.84, 0.358, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
687, d4qz0B_, 0.9033, 1.84, 0.358, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
688, d4qxjP_, 0.9033, 1.83, 0.358, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
689, d4qwrP_, 0.9033, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
690, d4qwfP_, 0.9033, 1.84, 0.358, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
691, d4qw7P_, 0.9033, 1.84, 0.358, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
692, d4qw7B_, 0.9033, 1.84, 0.358, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
693, d4qw6B_, 0.9033, 1.84, 0.358, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
694, d4qlsP_, 0.9033, 1.83, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
695, p4qlsB_, 0.9033, 1.83, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
696, d4ltcP_, 0.9033, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
697, d4j70B_, 0.9033, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
698, d4hrcB_, 0.9033, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
699, d4fzgB_, 0.9033, 1.84, 0.358, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
700, d3dy3P_, 0.9033, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
701, d3dy3B_, 0.9033, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
702, d3d29P_, 0.9033, 1.83, 0.358, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
703, d3d29B_, 0.9033, 1.83, 0.358, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
704, d5l52P_, 0.9032, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
705, d5jhsP_, 0.9032, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
706, d5jhrB_, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
707, p4ya9P_, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
708, p4ya9B_, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
709, p4ya7P_, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
710, p4y8uP_, 0.9032, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
711, p4y8kP_, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
712, p4y8gP_, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
713, p4y8gB_, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
714, p4y80B_, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
715, p4y78P_, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
716, p4y78B_, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
717, d4qzwP_, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
718, d4qzwB_, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
719, d4qz5B_, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
720, d4qz4P_, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
721, d4qz4B_, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
722, d4qxjB_, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
723, d4qwrB_, 0.9032, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
724, d4qwfB_, 0.9032, 1.84, 0.358, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
725, d4qw5P_, 0.9032, 1.84, 0.358, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
726, d4qlqP_, 0.9032, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
727, p4qlqB_, 0.9032, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
728, d4nnnP_, 0.9032, 1.83, 0.358, 244, 232, YCP IN COMPLEX WITH MG132
729, d3un8P_, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
730, d3e47P_, 0.9032, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
731, p5vftk_, 0.9031, 1.21, 0.612, 228, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
732, d5l52B_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
733, d5jhsB_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
734, d5d0zP_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
735, d5d0zB_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
736, d5d0vP_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
737, d5d0vB_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
738, d5cz9P_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
739, d5cz9B_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
740, d5cgfP_, 0.9031, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
741, d5cgfB_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
742, d4z1lP_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
743, d4z1lB_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
744, p4ya7B_, 0.9031, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
745, p4y8uB_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
746, p4y8pP_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
747, p4y8pB_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
748, p4y8kB_, 0.9031, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
749, p4y7xP_, 0.9031, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
750, p4y74P_, 0.9031, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
751, d4qz3P_, 0.9031, 1.83, 0.358, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
752, d4qz3B_, 0.9031, 1.84, 0.358, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
753, d4qwxP_, 0.9031, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
754, d4qwxB_, 0.9031, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
755, d4qwjP_, 0.9031, 1.83, 0.358, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
756, d4qwiP_, 0.9031, 1.83, 0.358, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
757, d4qwiB_, 0.9031, 1.83, 0.358, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
758, d4qw5B_, 0.9031, 1.84, 0.358, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
759, d4qw4P_, 0.9031, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH CARFILZOMIB
760, d4nnnB_, 0.9031, 1.83, 0.358, 244, 232, YCP IN COMPLEX WITH MG132
761, p3un4P_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
762, p3un4B_, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
763, d3mg4P_, 0.9031, 1.84, 0.358, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
764, d3e47B_, 0.9031, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
765, d3bdmP_, 0.9031, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
766, d3bdmB_, 0.9031, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
767, d2fakP_, 0.9031, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
768, d5lttP_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
769, d5l5tP_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
770, d5fhsP_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
771, d5fhsB_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
772, d5fgeP_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
773, d5fgdP_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
774, d5fgdB_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
775, d5fgaP_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
776, d5fgaB_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
777, d5dkjP_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
778, d5dkjB_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
779, p4y8qP_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
780, p4y7xB_, 0.9030, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
781, p4y77P_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
782, p4y74B_, 0.9030, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
783, p4y69P_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
784, p4y69B_, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
785, d4qz1P_, 0.9030, 1.84, 0.358, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
786, d4qwlP_, 0.9030, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
787, d4qwlB_, 0.9030, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
788, d4qwjB_, 0.9030, 1.84, 0.358, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
789, d4qw4B_, 0.9030, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH CARFILZOMIB
790, d4eu2Q_, 0.9030, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
791, d3mg0P_, 0.9030, 1.84, 0.358, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
792, d2fakB_, 0.9030, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
793, d5lttB_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
794, d5l5tB_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
795, d5l5eP_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
796, d5l5eB_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
797, d5l55P_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
798, d5l55B_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
799, d5fgiP_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
800, d5fgiB_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
801, d5fggP_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
802, d5fggB_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
803, d5fgeB_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
804, d5d0tP_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
805, d5d0tB_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
806, d5d0sP_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
807, d5cz7P_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
808, d5cz5P_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
809, d5cz5B_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
810, p5cggP_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
811, d4y9yP_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
812, p4y8tP_, 0.9029, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
813, p4y8tB_, 0.9029, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
814, p4y8qB_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
815, p4y82P_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
816, p4y82B_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
817, p4y77B_, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
818, d4r00P_, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
819, d4r00B_, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
820, d4qz7P_, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
821, d4qz7B_, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
822, d4qz1B_, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
823, d4qwuP_, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
824, d4qwuB_, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
825, d4qwkP_, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
826, d4qwkB_, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
827, d4qw0P_, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
828, d4qvqP_, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
829, d4qvpP_, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
830, d3shjP_, 0.9029, 1.84, 0.358, 244, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
831, d3gpwP_, 0.9029, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
832, d5l68P_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
833, d5l68B_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
834, d5l65P_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
835, d5l60P_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
836, d5l60B_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
837, d5l5sP_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
838, d5l5sB_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
839, d5l5oP_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
840, d5l5jP_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
841, d5l5jB_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
842, d5l5iP_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
843, d5l5iB_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
844, d5fg9P_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
845, d5fg9B_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
846, d5fg7P_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
847, d5d0xP_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
848, d5d0xB_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
849, d5d0sB_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
850, d5cz7B_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
851, p5cggB_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
852, d5bxlP_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
853, p4ya5P_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
854, p4ya5B_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
855, p4ya3P_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
856, d4ya1P_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
857, p4ya0P_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
858, p4ya0B_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
859, d4y9yB_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
860, p4y8oP_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
861, p4y8oB_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
862, p4y6zP_, 0.9028, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
863, p4y6vP_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
864, p4y6aP_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
865, p4x6zQ_, 0.9028, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
866, d4rurP_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
867, d4qw1P_, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
868, d4qw0B_, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
869, d4qvwP_, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
870, d4qvwB_, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
871, d4qvvP_, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
872, d4qvvB_, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
873, d4qvqB_, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
874, d4qvpB_, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
875, d4qv8P_, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT
876, d4qv7P_, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT
877, d4qv3P_, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-M45V MUTANT
878, d4quxP_, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A49T-MUTANT
879, d4quxB_, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A49T-MUTANT
880, d4jt0P_, 0.9028, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
881, d4jt0B_, 0.9028, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
882, d3shjB_, 0.9028, 1.84, 0.358, 244, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
883, d3gpwB_, 0.9028, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
884, d2zcyP_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
885, d2zcyB_, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
886, d2f16P_, 0.9028, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
887, d5l65B_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
888, d5l5xP_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
889, d5l5xB_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
890, d5l5vP_, 0.9027, 1.84, 0.358, 244, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
891, d5l5vB_, 0.9027, 1.84, 0.358, 244, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
892, d5l5qP_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
893, d5l5oB_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
894, d5l54P_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
895, d5l54B_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
896, d5fg7B_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
897, d5dkiP_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
898, d5dkiB_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
899, d5bxlB_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
900, d5bouP_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
901, d5bouB_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
902, p4ya3B_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
903, p4ya2P_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
904, p4ya2B_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
905, d4ya1B_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
906, p4y8nP_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
907, p4y8nB_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
908, d4y8mP_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
909, p4y81P_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
910, p4y81B_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
911, p4y75P_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
912, p4y75B_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
913, p4y6zB_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
914, p4y6vB_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
915, p4y6aB_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
916, d4rurB_, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
917, d4qwsP_, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
918, d4qwsB_, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
919, d4qw1B_, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
920, d4qvyP_, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
921, d4qvyB_, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
922, d4qv8B_, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT
923, d4qv7B_, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT
924, d4qv3B_, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-M45V MUTANT
925, d4qv0P_, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT
926, d4qv0B_, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT
927, d3nzxP_, 0.9027, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
928, d3nzxB_, 0.9027, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
929, d2f16B_, 0.9027, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
930, d1rypQ_, 0.9027, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
931, d5l6bP_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
932, d5l6bB_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
933, d5l67P_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
934, d5l5zP_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
935, d5l5yP_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
936, d5l5qB_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
937, d5l5hP_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
938, d5l5hB_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
939, d5l5fP_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
940, d5l5fB_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
941, p5fghP_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
942, d5czaP_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
943, d5czaB_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
944, d5cz6P_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
945, d5cz6B_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
946, d5cz4P_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
947, d5cz4B_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
948, p5cghP_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
949, d4y8rP_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
950, d4y8mB_, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
951, d4r17P_, 0.9026, 1.84, 0.358, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
952, d4qzzP_, 0.9026, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH OMURALIDE
953, d4qzzB_, 0.9026, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH OMURALIDE
954, d4qvnP_, 0.9026, 1.85, 0.358, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
955, d4qvnB_, 0.9026, 1.85, 0.358, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
956, d4qvmP_, 0.9026, 1.84, 0.358, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
957, d4qvmB_, 0.9026, 1.84, 0.358, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
958, d4qvlP_, 0.9026, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH BORTEZOMIB
959, d4qluP_, 0.9026, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
960, d4qltP_, 0.9026, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
961, p4qltB_, 0.9026, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
962, d4no6P_, 0.9026, 1.83, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
963, d4no6B_, 0.9026, 1.83, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
964, d5laiP_, 0.9025, 1.84, 0.358, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
965, d5l6cP_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
966, d5l6cB_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
967, d5l67B_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
968, d5l64P_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
969, d5l63P_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
970, d5l62P_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
971, d5l62B_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
972, d5l5zB_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
973, d5l5yB_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
974, d5l5pP_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
975, d5l5pB_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
976, p5fghB_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
977, d5d0wP_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
978, p5cghB_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
979, d5ahjP_, 0.9025, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
980, d4ya4P_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
981, d4ya4B_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
982, d4y8rB_, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
983, d4r17B_, 0.9025, 1.84, 0.358, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
984, d4qvlB_, 0.9025, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH BORTEZOMIB
985, d4qv9P_, 0.9025, 1.84, 0.358, 244, 232, YCP BETA5-C63F MUTANT
986, d4quyP_, 0.9025, 1.84, 0.358, 244, 232, YCP BETA5-A49S-MUTANT
987, d4quyB_, 0.9025, 1.84, 0.358, 244, 232, YCP BETA5-A49S-MUTANT
988, p4qluB_, 0.9025, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
989, d3okjP_, 0.9025, 1.84, 0.358, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
990, d3okjB_, 0.9025, 1.84, 0.358, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
991, p6gopP_, 0.9024, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
992, p6gopB_, 0.9024, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
993, d5laiB_, 0.9024, 1.84, 0.358, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
994, d5l66P_, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
995, d5l66B_, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
996, d5l64B_, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
997, d5l63B_, 0.9024, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
998, d5l61P_, 0.9024, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
999, d5l5uP_, 0.9024, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1000, d5l5uB_, 0.9024, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1001, d5l5dP_, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1002, d5l5dB_, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1003, d5l5aP_, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1004, d5l5aB_, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1005, d5d0wB_, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1006, d5ahjB_, 0.9024, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1007, d4qv9B_, 0.9024, 1.84, 0.358, 244, 232, YCP BETA5-C63F MUTANT
1008, d4qv5P_, 0.9024, 1.84, 0.358, 244, 232, YCP BETA5-M45I MUTANT
1009, d4qv4P_, 0.9024, 1.84, 0.358, 244, 232, YCP BETA5-M45T MUTANT
1010, d4qv4B_, 0.9024, 1.84, 0.358, 244, 232, YCP BETA5-M45T MUTANT
1011, d3un8B_, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1012, d3gptP_, 0.9024, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1013, d5l69P_, 0.9023, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1014, d5l69B_, 0.9023, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1015, d5l61B_, 0.9023, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1016, d5l5wP_, 0.9023, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1017, d5l5wB_, 0.9023, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1018, d4qw3P_, 0.9023, 1.85, 0.358, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1019, d4qv5B_, 0.9023, 1.84, 0.358, 244, 232, YCP BETA5-M45I MUTANT
1020, d4qv1P_, 0.9023, 1.84, 0.358, 244, 232, YCP BETA5-M45A MUTANT
1021, d4qv1B_, 0.9023, 1.84, 0.358, 244, 232, YCP BETA5-M45A MUTANT
1022, d3gptB_, 0.9023, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1023, p5mpbE_, 0.9022, 1.26, 1.000, 228, 228, 
1024, d5m2bP_, 0.9022, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1025, d5m2bB_, 0.9022, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1026, d4qwgP_, 0.9022, 1.84, 0.358, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1027, d4qwgB_, 0.9022, 1.84, 0.358, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1028, d4qw3B_, 0.9022, 1.85, 0.358, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1029, d4hrdB_, 0.9022, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1030, d5l6aP_, 0.9021, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1031, d5l5bP_, 0.9021, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1032, d5bxnP_, 0.9021, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1033, d5bxnB_, 0.9021, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1034, d5l6aB_, 0.9020, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1035, d5l5bB_, 0.9020, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1036, d4ltcB_, 0.9020, 1.86, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1037, d5l5rP_, 0.9019, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1038, d5l5rB_, 0.9019, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1039, p4zzgC_, 0.9019, 1.86, 0.358, 241, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1040, d4r02B_, 0.9019, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1041, d4qv6P_, 0.9019, 1.85, 0.358, 244, 232, YCP BETA5-A49V MUTANT
1042, p4q1sB_, 0.9019, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1043, p5nifC_, 0.9018, 1.86, 0.358, 241, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1044, d4qv6B_, 0.9018, 1.85, 0.358, 244, 232, YCP BETA5-A49V MUTANT
1045, d4qlvP_, 0.9018, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1046, d3gpjP_, 0.9018, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1047, p4qlvB_, 0.9017, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1048, d3gpjB_, 0.9017, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1049, d4no1P_, 0.9016, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1050, p5nifQ_, 0.9015, 1.87, 0.358, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1051, p4zzgQ_, 0.9015, 1.86, 0.358, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1052, p4qbyP_, 0.9015, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1053, d4no8P_, 0.9015, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1054, d4no8B_, 0.9015, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1055, d4no1B_, 0.9015, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1056, p5vfuJA_, 0.9014, 1.26, 0.612, 228, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1057, p4qbyB_, 0.9014, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1058, d3wxrC_, 0.9014, 1.86, 0.349, 242, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1059, d3mg0B_, 0.9014, 1.86, 0.358, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1060, p4x6zC_, 0.9012, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1061, p5vfok_, 0.9011, 1.15, 0.611, 228, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1062, d1rypC_, 0.9011, 1.86, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1063, d4eu2C_, 0.9006, 1.86, 0.358, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1064, d1jd2W_, 0.9005, 1.87, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1065, d3mg4B_, 0.9004, 1.86, 0.358, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1066, d1jd2B_, 0.9003, 1.87, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1067, p5vfpCA_, 0.8999, 1.17, 0.611, 228, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1068, p5vfrk_, 0.8998, 1.17, 0.606, 228, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1069, p5mp9c_, 0.8995, 1.85, 0.358, 244, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1070, p5vfqDA_, 0.8994, 1.18, 0.606, 228, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1071, p5mp9C_, 0.8986, 1.86, 0.358, 244, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1072, d1z7qQ1, 0.8985, 1.82, 0.358, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1073, d1z7qC1, 0.8985, 1.82, 0.358, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1074, p3jcpLA_, 0.8980, 1.90, 0.358, 244, 232, 
1075, p3jcpL_, 0.8980, 1.90, 0.358, 244, 232, 
1076, p5mpac_, 0.8978, 1.87, 0.358, 244, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1077, p5mpaC_, 0.8975, 1.89, 0.358, 244, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1078, p5vfrI_, 0.8974, 1.94, 0.339, 248, 236, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1079, p5vfqC_, 0.8971, 1.95, 0.339, 248, 236, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1080, p5vfoI_, 0.8971, 1.96, 0.339, 248, 236, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1081, d4g4sC_, 0.8970, 1.76, 0.357, 237, 230, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1082, d1g0uO_, 0.8969, 1.44, 0.330, 246, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1083, d1g0uA_, 0.8968, 1.44, 0.330, 246, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1084, p1fntC_, 0.8968, 1.84, 0.358, 241, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1085, d1jd2V_, 0.8967, 1.43, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1086, p1fntQ_, 0.8966, 1.84, 0.358, 241, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1087, p5vfrK_, 0.8963, 1.24, 0.602, 228, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1088, p5t0gK_, 0.8962, 1.31, 0.612, 228, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1089, d3sdiO_, 0.8961, 1.44, 0.330, 246, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1090, p5vfpC_, 0.8959, 1.96, 0.339, 248, 236, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1091, d3mg7O_, 0.8959, 1.45, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1092, d3mg8O_, 0.8956, 1.45, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1093, d1jd2A_, 0.8956, 1.45, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1094, p5vfqE_, 0.8955, 1.25, 0.602, 228, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1095, d3oeuO_, 0.8955, 1.45, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1096, d1rypP_, 0.8955, 1.45, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1097, d4intO_, 0.8954, 1.45, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1098, d3mg4O_, 0.8954, 1.45, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1099, d3sdkO_, 0.8953, 1.46, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1100, p5vfpE_, 0.8951, 1.26, 0.606, 228, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1101, d4inuO_, 0.8950, 1.45, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1102, d4intA_, 0.8950, 1.45, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1103, d4inrO_, 0.8950, 1.45, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1104, d1rypB_, 0.8950, 1.46, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1105, d4hnpO_, 0.8949, 1.46, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1106, d3oevO_, 0.8949, 1.46, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1107, d3e47O_, 0.8949, 1.46, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1108, d2fnyO_, 0.8949, 1.46, 0.330, 250, 227,  
1109, d1g65O_, 0.8949, 1.46, 0.330, 250, 227, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1110, p5vfoK_, 0.8948, 1.26, 0.606, 228, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1111, d4qv5O_, 0.8948, 1.46, 0.330, 250, 227, YCP BETA5-M45I MUTANT
1112, d4qv5A_, 0.8948, 1.47, 0.330, 250, 227, YCP BETA5-M45I MUTANT
1113, d4jsqO_, 0.8948, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1114, d4jsqA_, 0.8948, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1115, d3wxrP_, 0.8948, 1.47, 0.330, 249, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1116, d3mg6O_, 0.8948, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1117, d3e47A_, 0.8948, 1.46, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1118, d2fnyA_, 0.8948, 1.46, 0.330, 250, 227,  
1119, d4inuA_, 0.8947, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1120, d4inrA_, 0.8947, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1121, d3mg0O_, 0.8947, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1122, d2gplO_, 0.8947, 1.46, 0.330, 250, 227, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1123, d4fzcO_, 0.8946, 1.46, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1124, d3un8O_, 0.8946, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1125, p3un4O_, 0.8946, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1126, d2gplA_, 0.8946, 1.46, 0.330, 250, 227, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1127, d4fzcA_, 0.8945, 1.46, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1128, d1g65A_, 0.8945, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1129, d5ahjO_, 0.8944, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1130, d5ahjA_, 0.8944, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1131, d4qv3O_, 0.8944, 1.47, 0.330, 250, 227, YCP BETA5-M45V MUTANT
1132, d3sdiA_, 0.8944, 1.47, 0.330, 246, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1133, d3mg7A_, 0.8944, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1134, d3mg6A_, 0.8944, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1135, d1z7qP1, 0.8944, 1.59, 0.328, 249, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1136, d1z7qB1, 0.8944, 1.59, 0.328, 249, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1137, d1j2qB_, 0.8944, 2.03, 0.408, 237, 233, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1138, d5l5rO_, 0.8943, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1139, d5l5rA_, 0.8943, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1140, d5l5bO_, 0.8943, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1141, d5fggO_, 0.8943, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1142, d4qv3A_, 0.8943, 1.47, 0.330, 250, 227, YCP BETA5-M45V MUTANT
1143, d4no1O_, 0.8943, 1.47, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1144, d4ltcO_, 0.8943, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1145, d4jsuO_, 0.8943, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1146, d4jsuA_, 0.8943, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1147, d4hrcO_, 0.8943, 1.47, 0.330, 249, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1148, d4fzgO_, 0.8943, 1.46, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1149, d2fakO_, 0.8943, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1150, d2f16O_, 0.8943, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1151, d5l5bA_, 0.8942, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1152, d5l55O_, 0.8942, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1153, d5fggA_, 0.8942, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1154, d4qv4O_, 0.8942, 1.47, 0.330, 250, 227, YCP BETA5-M45T MUTANT
1155, d4qv4A_, 0.8942, 1.47, 0.330, 250, 227, YCP BETA5-M45T MUTANT
1156, d4no1A_, 0.8942, 1.47, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1157, d4jt0O_, 0.8942, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1158, d4jt0A_, 0.8942, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1159, d4fzgA_, 0.8942, 1.46, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1160, d3un8A_, 0.8942, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1161, d3sdkA_, 0.8942, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1162, d3mg8A_, 0.8942, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1163, d3mg4A_, 0.8942, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1164, d2fakA_, 0.8942, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1165, d2f16A_, 0.8942, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1166, p5mpbQ_, 0.8941, 1.93, 0.358, 244, 232, 
1167, d5l6aO_, 0.8941, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1168, d5l6aA_, 0.8941, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1169, d5l55A_, 0.8941, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1170, p5cggO_, 0.8941, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1171, d4qv1O_, 0.8941, 1.48, 0.330, 250, 227, YCP BETA5-M45A MUTANT
1172, d4g4sB_, 0.8941, 1.47, 0.330, 246, 227, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1173, d3okjO_, 0.8941, 1.47, 0.330, 250, 227, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1174, d3oevA_, 0.8941, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1175, d3oeuA_, 0.8941, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1176, d3mg7P_, 0.8941, 1.70, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1177, d5d0wO_, 0.8940, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1178, d5d0wA_, 0.8940, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1179, p4ya9O_, 0.8940, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1180, d4qv1A_, 0.8940, 1.48, 0.330, 250, 227, YCP BETA5-M45A MUTANT
1181, d4nnnO_, 0.8940, 1.47, 0.330, 250, 227, YCP IN COMPLEX WITH MG132
1182, d4nnnA_, 0.8940, 1.47, 0.330, 250, 227, YCP IN COMPLEX WITH MG132
1183, d3wxrB_, 0.8940, 1.48, 0.330, 249, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1184, d3shjO_, 0.8940, 1.48, 0.330, 250, 227, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1185, d3okjA_, 0.8940, 1.47, 0.330, 250, 227, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1186, d1j2qF_, 0.8940, 2.04, 0.408, 237, 233, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1187, d1j2qD_, 0.8940, 2.04, 0.408, 237, 233, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1188, d5l5uO_, 0.8939, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1189, d5l5uA_, 0.8939, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1190, d5l5dO_, 0.8939, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1191, d5jhrO_, 0.8939, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1192, p4zzgB_, 0.8939, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1193, d4r02O_, 0.8939, 1.47, 0.330, 250, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1194, d4qz7O_, 0.8939, 1.48, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1195, d4qz4O_, 0.8939, 1.47, 0.330, 250, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1196, d4qz4A_, 0.8939, 1.47, 0.330, 250, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1197, d4qvnO_, 0.8939, 1.48, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1198, d4qv9O_, 0.8939, 1.48, 0.330, 250, 227, YCP BETA5-C63F MUTANT
1199, d4qv9A_, 0.8939, 1.48, 0.330, 250, 227, YCP BETA5-C63F MUTANT
1200, d4qv0O_, 0.8939, 1.48, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1201, d4qv0A_, 0.8939, 1.48, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1202, d4quyO_, 0.8939, 1.48, 0.330, 250, 227, YCP BETA5-A49S-MUTANT
1203, d4no8O_, 0.8939, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1204, d4no8A_, 0.8939, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1205, d4no6O_, 0.8939, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1206, d4no6A_, 0.8939, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1207, d3tddO_, 0.8939, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1208, d3shjA_, 0.8939, 1.48, 0.330, 250, 227, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1209, d1j2qG_, 0.8939, 2.04, 0.408, 237, 233, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1210, p6gopO_, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1211, d5l5hO_, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1212, d5l5dA_, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1213, d5jhrA_, 0.8938, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1214, d5bxnO_, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1215, d5bxnA_, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1216, p4ya7O_, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1217, d4ya4O_, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1218, d4ya4A_, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1219, p4y8sO_, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1220, p4y8pO_, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1221, p4y75O_, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1222, d4qz7A_, 0.8938, 1.48, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1223, d4qz0O_, 0.8938, 1.48, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1224, d4qz0A_, 0.8938, 1.48, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1225, d4qvnA_, 0.8938, 1.48, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1226, d4qv7O_, 0.8938, 1.48, 0.330, 250, 227, YCP BETA5-A50V MUTANT
1227, d4qv7A_, 0.8938, 1.48, 0.330, 250, 227, YCP BETA5-A50V MUTANT
1228, d4quyA_, 0.8938, 1.48, 0.330, 250, 227, YCP BETA5-A49S-MUTANT
1229, d4qluO_, 0.8938, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1230, d4qluA_, 0.8938, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1231, d4no9O_, 0.8938, 1.47, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1232, d4nnwO_, 0.8938, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1233, d4nnwA_, 0.8938, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1234, d3tddA_, 0.8938, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1235, d3oevP_, 0.8938, 1.70, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1236, d3nzxO_, 0.8938, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1237, p3jcoLA_, 0.8938, 1.95, 0.358, 244, 232, 
1238, p3jcoL_, 0.8938, 1.95, 0.358, 244, 232, 
1239, d3hyeO_, 0.8938, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1240, d3gptO_, 0.8938, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1241, d2zcyO_, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1242, d1j2qE_, 0.8938, 2.04, 0.408, 237, 233, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1243, d1j2qA_, 0.8938, 2.04, 0.408, 237, 233, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1244, d5l63O_, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1245, d5l5hA_, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1246, d5czaO_, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1247, d5czaA_, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1248, p5cghO_, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1249, d5bxlO_, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1250, d5bxlA_, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1251, d4qv8O_, 0.8937, 1.48, 0.330, 250, 227, YCP BETA5-C52F MUTANT
1252, d4qv8A_, 0.8937, 1.48, 0.330, 250, 227, YCP BETA5-C52F MUTANT
1253, d4qlsO_, 0.8937, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1254, d4qlsA_, 0.8937, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1255, d4no9A_, 0.8937, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1256, d4ltcA_, 0.8937, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1257, d4hnpA_, 0.8937, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1258, p4gk7O_, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1259, d3oeuP_, 0.8937, 1.70, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1260, d3nzxA_, 0.8937, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1261, d3nzwO_, 0.8937, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1262, d3hyeA_, 0.8937, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1263, d3dy3O_, 0.8937, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1264, d3dy3A_, 0.8937, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1265, d2zcyA_, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1266, p5nifB_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1267, d5m2bO_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1268, d5l6bO_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1269, d5l6bA_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1270, d5l63A_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1271, d5l61O_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1272, d5l5wO_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1273, d5l5wA_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1274, d5l5oO_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1275, d5l5oA_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1276, d5l52O_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1277, d5l52A_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1278, p4ya2O_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1279, d4ya1O_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1280, d4ya1A_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1281, p4y8kO_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1282, p4y8gO_, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1283, d4qz6O_, 0.8936, 1.48, 0.330, 250, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1284, d4qz6A_, 0.8936, 1.48, 0.330, 250, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1285, d4qwxO_, 0.8936, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1286, d4qwxA_, 0.8936, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1287, d4qwuO_, 0.8936, 1.48, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1288, d4qwlO_, 0.8936, 1.48, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1289, d4qwlA_, 0.8936, 1.48, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1290, d4qv6O_, 0.8936, 1.48, 0.330, 250, 227, YCP BETA5-A49V MUTANT
1291, d4qv6A_, 0.8936, 1.48, 0.330, 250, 227, YCP BETA5-A49V MUTANT
1292, d3nzwA_, 0.8936, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1293, d3gptA_, 0.8936, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1294, d1j2qC_, 0.8936, 2.04, 0.408, 237, 233, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1295, d5m2bA_, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1296, d5l61A_, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1297, d5d0vO_, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1298, d5d0vA_, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1299, d5d0sO_, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1300, d5d0sA_, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1301, p4zzgP_, 0.8935, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1302, p4y9zO_, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1303, p4y8tO_, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1304, d4y8rO_, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1305, d4y8rA_, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1306, p4y8hO_, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1307, p4y77O_, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1308, d4qzzO_, 0.8935, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH OMURALIDE
1309, d4qzzA_, 0.8935, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH OMURALIDE
1310, d4qwuA_, 0.8935, 1.48, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1311, d4qw6O_, 0.8935, 1.48, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1312, d4qw6A_, 0.8935, 1.48, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1313, d4lqiO_, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1314, d4lqiA_, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1315, d3sdiP_, 0.8935, 1.69, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1316, d3mg6P_, 0.8935, 1.71, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1317, d3gpwO_, 0.8935, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1318, p5t0hK_, 0.8934, 1.35, 0.612, 228, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1319, p5nifP_, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1320, d5l65O_, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1321, d5l65A_, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1322, d5l64O_, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1323, d5l62O_, 0.8934, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1324, d5l5tO_, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1325, d5l5tA_, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1326, d5l5sO_, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1327, d5l5sA_, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1328, d5l5pO_, 0.8934, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1329, d5l5pA_, 0.8934, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1330, d5l5jO_, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1331, d4y9yO_, 0.8934, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1332, d4y9yA_, 0.8934, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1333, p4x6zP_, 0.8934, 1.49, 0.330, 249, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1334, d4hrdO_, 0.8934, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1335, d3nzjO_, 0.8934, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1336, d3mg0A_, 0.8934, 1.48, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1337, d3gpwA_, 0.8934, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1338, d3gpjO_, 0.8934, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1339, d3gpjA_, 0.8934, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1340, d3bdmO_, 0.8934, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1341, d5l6cO_, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1342, d5l6cA_, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1343, d5l67O_, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1344, d5l67A_, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1345, d5l66O_, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1346, d5l66A_, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1347, d5l64A_, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1348, d5l62A_, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1349, d5l5qO_, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1350, d5l5qA_, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1351, d5l5jA_, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1352, d5l5aO_, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1353, d5l5aA_, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1354, d5d0zO_, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1355, d5d0zA_, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1356, d5cz9O_, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1357, d5cz9A_, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1358, d5cz6O_, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1359, d5cz6A_, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1360, d4qz3O_, 0.8933, 1.48, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1361, d4qz3A_, 0.8933, 1.48, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1362, d4qwfO_, 0.8933, 1.48, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1363, d4qwfA_, 0.8933, 1.48, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1364, d4qw7O_, 0.8933, 1.49, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1365, d4qw5O_, 0.8933, 1.49, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1366, d4qvlO_, 0.8933, 1.49, 0.330, 250, 227, YCP IN COMPLEX WITH BORTEZOMIB
1367, d4qvlA_, 0.8933, 1.49, 0.330, 250, 227, YCP IN COMPLEX WITH BORTEZOMIB
1368, d4qltO_, 0.8933, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1369, d4qltA_, 0.8933, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1370, d4q1sO_, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1371, d3nzjA_, 0.8933, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1372, d3mg8P_, 0.8933, 1.70, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1373, d3dy4O_, 0.8933, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1374, d3d29O_, 0.8933, 1.48, 0.330, 250, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1375, d3bdmA_, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1376, d5lttO_, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1377, d5lttA_, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1378, d5l69O_, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1379, d5l69A_, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1380, d5l68O_, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1381, d5l68A_, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1382, d5l5xO_, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1383, d5l5xA_, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1384, d5l5iO_, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1385, d5fgaO_, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1386, d5fgaA_, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1387, p5cgiO_, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1388, d4r18O_, 0.8932, 1.48, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1389, d4r18A_, 0.8932, 1.48, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1390, d4r00O_, 0.8932, 1.49, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1391, d4qz2O_, 0.8932, 1.49, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1392, d4qz2A_, 0.8932, 1.49, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1393, d4qw7A_, 0.8932, 1.49, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1394, d4qw5A_, 0.8932, 1.49, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1395, d4qw1O_, 0.8932, 1.49, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1396, d4qw1A_, 0.8932, 1.49, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1397, d4qlqO_, 0.8932, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1398, d4qlqA_, 0.8932, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1399, p4qbyO_, 0.8932, 1.49, 0.330, 250, 227, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1400, d3dy4A_, 0.8932, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1401, d3d29A_, 0.8932, 1.48, 0.330, 250, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1402, d5l5iA_, 0.8931, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1403, d5jhsO_, 0.8931, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1404, d5fg7O_, 0.8931, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1405, d5fg7A_, 0.8931, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1406, p4y74O_, 0.8931, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1407, d4r00A_, 0.8931, 1.49, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1408, d4qzwO_, 0.8931, 1.49, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1409, d4qzwA_, 0.8931, 1.49, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1410, d5l5zO_, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1411, d5l5zA_, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1412, d5l5vO_, 0.8930, 1.49, 0.330, 250, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1413, d5l5vA_, 0.8930, 1.49, 0.330, 250, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1414, d5l5fO_, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1415, d5l5fA_, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1416, d5jhsA_, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1417, d5fgfO_, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1418, d5fgfA_, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1419, d4y8mO_, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1420, d4y8mA_, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1421, d4r17O_, 0.8930, 1.49, 0.330, 249, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1422, d4r17A_, 0.8930, 1.49, 0.330, 249, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1423, d4qz5O_, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1424, d4qz5A_, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1425, d4qvyO_, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1426, d4qvyA_, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1427, d4qvwO_, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1428, d4qvwA_, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1429, d4quxO_, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49T-MUTANT
1430, d4quxA_, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49T-MUTANT
1431, d5l5yO_, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1432, d5l5yA_, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1433, d5l54O_, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1434, d5l54A_, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1435, d5fg9O_, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1436, d5fg9A_, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1437, d5cgfO_, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1438, d5cgfA_, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1439, p4y84O_, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1440, p4y70O_, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1441, d4qwrO_, 0.8929, 1.49, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1442, d4qvpO_, 0.8929, 1.49, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1443, d4qvpA_, 0.8929, 1.49, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1444, d5lajO_, 0.8928, 1.49, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1445, d5lajA_, 0.8928, 1.49, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1446, d5l60O_, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1447, d5l60A_, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1448, d5l5eO_, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1449, d5l5eA_, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1450, d5fgeO_, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1451, d5fgeA_, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1452, d5cz7O_, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1453, d5cz7A_, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1454, p4y82O_, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1455, d4qwrA_, 0.8928, 1.49, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1456, d3sdkP_, 0.8928, 1.71, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1457, d5bouO_, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1458, d5bouA_, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1459, p4y8lO_, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1460, p4y8jO_, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1461, p4y7wO_, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1462, d4qw4O_, 0.8927, 1.49, 0.330, 250, 227, YCP IN COMPLEX WITH CARFILZOMIB
1463, d4qw4A_, 0.8927, 1.49, 0.330, 250, 227, YCP IN COMPLEX WITH CARFILZOMIB
1464, d4qvqO_, 0.8927, 1.49, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1465, d4qvqA_, 0.8927, 1.49, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1466, d4q1sA_, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1467, d4hrdA_, 0.8927, 1.49, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1468, d5fgiO_, 0.8926, 1.50, 0.330, 249, 227, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1469, d5cz8O_, 0.8926, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1470, d4z1lO_, 0.8926, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1471, d4z1lA_, 0.8926, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1472, d5fhsO_, 0.8925, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1473, d5fhsA_, 0.8925, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1474, d5fgiA_, 0.8925, 1.50, 0.330, 249, 227, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1475, d5dkjO_, 0.8925, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1476, d5dkjA_, 0.8925, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1477, d5cz8A_, 0.8925, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1478, p4y8qO_, 0.8925, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1479, p4y80O_, 0.8925, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1480, p4y7xO_, 0.8925, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1481, p4y6zO_, 0.8925, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1482, p4y6vO_, 0.8925, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1483, d4rurO_, 0.8925, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1484, d4r02A_, 0.8925, 1.50, 0.330, 250, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1485, d4qz1O_, 0.8925, 1.50, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1486, d4qlvO_, 0.8925, 1.49, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1487, p4y8uO_, 0.8924, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1488, p4y81O_, 0.8924, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1489, p4y6aO_, 0.8924, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1490, d4rurA_, 0.8924, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1491, d4qzxO_, 0.8924, 1.50, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1492, d4qzxA_, 0.8924, 1.50, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1493, d4qz1A_, 0.8924, 1.50, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1494, d4qlvA_, 0.8924, 1.49, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1495, d4hrcA_, 0.8924, 1.49, 0.330, 249, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1496, d5fgdO_, 0.8923, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1497, d5fgdA_, 0.8923, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1498, p4y8oO_, 0.8923, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1499, p4y8iO_, 0.8923, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1500, p4y7yO_, 0.8923, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1501, p4y69O_, 0.8923, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1502, d4qxjO_, 0.8923, 1.50, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1503, d4qwiO_, 0.8923, 1.50, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1504, d4j70O_, 0.8923, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1505, d5d0tO_, 0.8922, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1506, d5cz5O_, 0.8922, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1507, p4y8nO_, 0.8922, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1508, d4qxjA_, 0.8922, 1.50, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1509, d4qwiA_, 0.8922, 1.50, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1510, d4j70A_, 0.8922, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1511, d1g0uP_, 0.8922, 1.71, 0.360, 235, 228, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1512, d5d0tA_, 0.8921, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1513, d5cz5A_, 0.8921, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1514, d4qw0O_, 0.8921, 1.50, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1515, d4qw0A_, 0.8921, 1.50, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1516, p5vfsC_, 0.8920, 2.11, 0.335, 250, 236, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1517, d4qwkO_, 0.8920, 1.50, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1518, d4qwkA_, 0.8920, 1.50, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1519, d4qvmO_, 0.8920, 1.50, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1520, d4qvmA_, 0.8920, 1.50, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1521, d4eu2P_, 0.8920, 1.45, 0.327, 249, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1522, d5d0xO_, 0.8919, 1.51, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1523, d5d0xA_, 0.8919, 1.51, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1524, p4ya5O_, 0.8919, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1525, p4y78O_, 0.8919, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1526, d5laiO_, 0.8918, 1.51, 0.330, 250, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1527, d5laiA_, 0.8918, 1.51, 0.330, 250, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1528, p5fghO_, 0.8917, 1.51, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1529, p5mp9B_, 0.8915, 1.49, 0.330, 250, 227, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1530, d4qwjO_, 0.8915, 1.51, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1531, d4qwjA_, 0.8915, 1.51, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1532, d4qwsO_, 0.8914, 1.51, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1533, d4qwsA_, 0.8914, 1.51, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1534, d5dkiO_, 0.8913, 1.52, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1535, d5dkiA_, 0.8913, 1.52, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1536, d4qvvO_, 0.8912, 1.52, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1537, d5cz4O_, 0.8911, 1.52, 0.330, 250, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1538, d5cz4A_, 0.8911, 1.52, 0.330, 250, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1539, d4qwgO_, 0.8911, 1.52, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1540, d4qwgA_, 0.8911, 1.52, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1541, d4qvvA_, 0.8911, 1.52, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1542, d1g0uB_, 0.8911, 1.72, 0.360, 235, 228, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1543, p4ya3O_, 0.8910, 1.52, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1544, d4qw3O_, 0.8910, 1.52, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1545, d4qw3A_, 0.8910, 1.52, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1546, d3mg8B_, 0.8910, 1.73, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1547, p3jcpKA_, 0.8910, 1.52, 0.330, 250, 227, 
1548, p3jcpK_, 0.8910, 1.52, 0.330, 250, 227, 
1549, p4ya0O_, 0.8908, 1.52, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1550, d3mg6B_, 0.8906, 1.73, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1551, p3unbe_, 0.8905, 1.97, 0.343, 239, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1552, p1fntP_, 0.8905, 1.66, 0.328, 247, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1553, p1fntB_, 0.8905, 1.66, 0.328, 247, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1554, d3sdkB_, 0.8901, 1.73, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1555, d3oevB_, 0.8900, 1.74, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1556, p5t0cU_, 0.8899, 2.11, 0.335, 250, 236, 
1557, p5t0cAB_, 0.8899, 2.11, 0.335, 250, 236, 
1558, p5gjrX_, 0.8899, 1.78, 0.313, 238, 230, 
1559, d3sdiB_, 0.8899, 1.73, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1560, p5gjqm_, 0.8898, 1.82, 0.313, 238, 230, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1561, d3oeuB_, 0.8897, 1.73, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1562, d3mg7B_, 0.8897, 1.74, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1563, p3unhQ_, 0.8896, 1.99, 0.348, 238, 233, MOUSE 20S IMMUNOPROTEASOME
1564, p3unhC_, 0.8896, 1.99, 0.348, 238, 233, MOUSE 20S IMMUNOPROTEASOME
1565, p5gjqG_, 0.8895, 1.79, 0.313, 238, 230, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1566, p5mp9b_, 0.8893, 1.54, 0.330, 250, 227, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1567, d5lf3O_, 0.8893, 1.45, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1568, p5lf0O_, 0.8893, 1.45, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1569, d3unfQ_, 0.8893, 1.99, 0.348, 238, 233, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1570, d3unfC_, 0.8893, 1.99, 0.348, 238, 233, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1571, d1z7qD1, 0.8893, 1.99, 0.342, 241, 234, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1572, p6epfC_, 0.8892, 2.09, 0.336, 249, 235, GROUND STATE 26S PROTEASOME (GS1)
1573, p5lezO_, 0.8892, 1.45, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1574, d1z7qR1, 0.8892, 1.99, 0.342, 241, 234, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1575, p5leyO_, 0.8891, 1.45, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1576, p3uneq_, 0.8891, 1.55, 0.310, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
1577, d5lexO_, 0.8890, 1.46, 0.311, 230, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1578, p5gjrLA_, 0.8890, 1.83, 0.313, 238, 230, 
1579, p5mpbC_, 0.8889, 1.98, 0.358, 244, 232, 
1580, d5lf1O_, 0.8889, 1.46, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1581, d4q1sC_, 0.8889, 2.00, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1582, d5lf7O_, 0.8888, 1.46, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1583, p5lezA_, 0.8888, 1.46, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1584, d4eu2B_, 0.8888, 1.50, 0.327, 249, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1585, p3unbC_, 0.8888, 2.00, 0.343, 239, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1586, p5vfuT_, 0.8887, 2.13, 0.335, 250, 236, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1587, p5vftI_, 0.8887, 2.13, 0.335, 250, 236, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1588, p5lf6O_, 0.8887, 1.46, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1589, p5gjqD_, 0.8887, 1.87, 0.339, 240, 230, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1590, p5lf0A_, 0.8886, 1.46, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1591, p3unbQ_, 0.8886, 2.00, 0.339, 239, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1592, d3sdiC_, 0.8886, 2.00, 0.335, 238, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1593, p5vfqB_, 0.8885, 1.65, 0.307, 230, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1594, d5lf4O_, 0.8885, 1.46, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1595, d5lexA_, 0.8885, 1.46, 0.311, 230, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1596, p3uneO_, 0.8885, 1.57, 0.310, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
1597, p5mpab_, 0.8884, 1.54, 0.330, 250, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1598, p3uneQ_, 0.8884, 1.99, 0.343, 239, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1599, d5le5O_, 0.8883, 1.47, 0.311, 230, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1600, p4x6zB_, 0.8883, 1.51, 0.327, 248, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1601, p5l4gT_, 0.8882, 1.80, 0.313, 238, 230, 
1602, d5lf3A_, 0.8881, 1.47, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1603, d4r3oP_, 0.8881, 1.59, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
1604, d4r3oB_, 0.8881, 1.59, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
1605, d3oeuC_, 0.8881, 2.04, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1606, p6avoP_, 0.8880, 1.48, 0.311, 230, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1607, p6avob_, 0.8880, 1.48, 0.311, 230, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1608, p5lf6A_, 0.8880, 1.47, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1609, d5lf1A_, 0.8880, 1.47, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1610, p5leyA_, 0.8880, 1.47, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1611, p3unbs_, 0.8880, 2.01, 0.339, 239, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1612, d3sdkC_, 0.8880, 2.04, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1613, d5lf4A_, 0.8879, 1.47, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1614, p1fntD_, 0.8879, 1.98, 0.342, 239, 234, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1615, p5wvkY_, 0.8878, 2.00, 0.339, 241, 233, 
1616, d1g0uC_, 0.8878, 2.01, 0.335, 238, 233, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1617, p1fntR_, 0.8878, 1.99, 0.342, 239, 234, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1618, d5lf7A_, 0.8877, 1.47, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1619, d5le5A_, 0.8877, 1.47, 0.311, 230, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1620, p4r67s_, 0.8877, 1.90, 0.339, 240, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1621, d4r67r_, 0.8877, 1.59, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1622, d4r67P_, 0.8877, 1.59, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1623, p5l4gF_, 0.8876, 1.83, 0.313, 238, 230, 
1624, d4r67d_, 0.8876, 1.60, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1625, d4r67B_, 0.8875, 1.60, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1626, p3uneA_, 0.8875, 1.57, 0.310, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
1627, p5m32P_, 0.8874, 2.13, 0.338, 244, 234, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1628, p3unec_, 0.8874, 1.57, 0.310, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
1629, d3dy4C_, 0.8873, 2.01, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1630, d2zcyC_, 0.8873, 2.02, 0.335, 241, 233, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1631, d2zcyQ_, 0.8872, 2.02, 0.335, 241, 233, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1632, d1iruP_, 0.8872, 1.62, 0.310, 233, 226, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1633, p5wvkW_, 0.8871, 1.54, 0.330, 250, 227, 
1634, d4eu2D_, 0.8871, 2.02, 0.335, 241, 233, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1635, p3uneC_, 0.8871, 1.99, 0.348, 239, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1636, d3dy4Q_, 0.8871, 2.02, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1637, p5vfoH_, 0.8870, 1.69, 0.307, 230, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1638, p5l4gP_, 0.8870, 1.56, 0.310, 233, 226, 
1639, p6avoZ_, 0.8869, 1.88, 0.339, 240, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1640, p6avoO_, 0.8869, 1.88, 0.339, 240, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1641, d3un8C_, 0.8869, 2.03, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1642, d3mg8C_, 0.8869, 2.06, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1643, d3mg6C_, 0.8869, 2.05, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1644, p4zzgD_, 0.8868, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1645, d3un8Q_, 0.8868, 2.03, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1646, p3jcoKA_, 0.8868, 1.58, 0.330, 250, 227, 
1647, p3jcoK_, 0.8868, 1.58, 0.330, 250, 227, 
1648, d3dy3C_, 0.8868, 2.02, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1649, d1rypD_, 0.8868, 2.02, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1650, d3dy3Q_, 0.8867, 2.02, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1651, d5lf7C_, 0.8866, 1.93, 0.346, 236, 231, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1652, d4inrC_, 0.8866, 2.03, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1653, d4hnpC_, 0.8866, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1654, d1j2pF_, 0.8866, 2.18, 0.402, 243, 234, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1655, d1g0uQ_, 0.8866, 2.02, 0.335, 238, 233, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1656, p5nifD_, 0.8865, 2.05, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1657, p5vfrH_, 0.8864, 1.69, 0.307, 230, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1658, d5le5C_, 0.8864, 1.93, 0.351, 236, 231, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1659, d3bdmC_, 0.8864, 2.02, 0.335, 241, 233, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1660, d1j2pG_, 0.8864, 2.18, 0.402, 243, 234, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1661, d1j2pE_, 0.8864, 2.18, 0.402, 243, 234, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1662, d1j2pC_, 0.8864, 2.18, 0.402, 243, 234, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1663, d1j2pA_, 0.8864, 2.18, 0.402, 243, 234, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1664, d5lf3C_, 0.8863, 1.94, 0.346, 236, 231, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1665, d4r67T_, 0.8863, 1.98, 0.312, 238, 231, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1666, d4inuC_, 0.8863, 2.03, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1667, d3gpjC_, 0.8863, 2.02, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1668, d3bdmQ_, 0.8863, 2.02, 0.335, 241, 233, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1669, d1j2pD_, 0.8863, 2.19, 0.402, 243, 234, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1670, d1j2pB_, 0.8863, 2.18, 0.402, 243, 234, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1671, d1iruT_, 0.8863, 1.98, 0.312, 238, 231, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1672, p5gjqC_, 0.8862, 1.62, 0.310, 233, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1673, d4inrQ_, 0.8862, 2.03, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1674, d4hrcC_, 0.8862, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1675, d3gpjQ_, 0.8862, 2.02, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1676, d1rypR_, 0.8862, 2.02, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1677, d5lf4C_, 0.8861, 1.94, 0.346, 236, 231, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1678, p5l4gB_, 0.8861, 1.68, 0.310, 233, 226, 
1679, d4r3oF_, 0.8861, 1.82, 0.313, 238, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
1680, d4q1sQ_, 0.8861, 2.03, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1681, d4intC_, 0.8861, 2.03, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1682, d3unbS_, 0.8861, 1.85, 0.313, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1683, d4jsqQ_, 0.8860, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1684, d4jsqC_, 0.8860, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1685, d3unbq_, 0.8860, 1.44, 0.312, 231, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1686, d1g65C_, 0.8860, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1687, p5wvkP_, 0.8859, 1.57, 0.330, 250, 227, 
1688, p5vfpB_, 0.8859, 1.69, 0.307, 230, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1689, p5l4gC_, 0.8859, 1.89, 0.339, 240, 230, 
1690, d4lqiC_, 0.8859, 2.03, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1691, d4jsuQ_, 0.8859, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1692, d4jsuC_, 0.8859, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1693, d4inuQ_, 0.8859, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1694, d4intQ_, 0.8859, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1695, p3un4Q_, 0.8859, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1696, p3un4C_, 0.8859, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1697, d3nzwC_, 0.8859, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1698, d3gptC_, 0.8859, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1699, p5t0gI_, 0.8858, 2.12, 0.335, 250, 236, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1700, p5lf0C_, 0.8858, 1.94, 0.351, 236, 231, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1701, p5lezC_, 0.8858, 1.94, 0.351, 236, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1702, p5leyC_, 0.8858, 1.94, 0.346, 236, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1703, p4zzgR_, 0.8858, 2.06, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1704, d4lqiQ_, 0.8858, 2.03, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1705, p4gk7C_, 0.8858, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1706, d4fzcC_, 0.8858, 2.04, 0.335, 241, 233, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1707, d3shjQ_, 0.8858, 2.03, 0.335, 241, 233, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1708, d3shjC_, 0.8858, 2.03, 0.335, 241, 233, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1709, d3nzwQ_, 0.8858, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1710, d3mg7C_, 0.8858, 2.08, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1711, d3hyeC_, 0.8858, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1712, d3gptQ_, 0.8858, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1713, p4r67h_, 0.8857, 1.85, 0.313, 238, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1714, p4gk7Q_, 0.8857, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1715, d4fzcQ_, 0.8857, 2.04, 0.335, 241, 233, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1716, d4eu2R_, 0.8857, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1717, p3unbu_, 0.8857, 1.86, 0.313, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1718, d3nzjC_, 0.8857, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1719, d3gpwC_, 0.8857, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1720, d5lf1C_, 0.8856, 1.95, 0.346, 236, 231, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1721, d4r67F_, 0.8856, 1.86, 0.313, 238, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1722, d3tddC_, 0.8856, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1723, d3nzxC_, 0.8856, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1724, d3nzjQ_, 0.8856, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1725, d3hyeQ_, 0.8856, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1726, d3gpwQ_, 0.8856, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1727, d4jt0Q_, 0.8855, 2.05, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1728, d4jt0C_, 0.8855, 2.05, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1729, d4j70C_, 0.8855, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1730, p3unes_, 0.8855, 2.01, 0.343, 239, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1731, d3unbc_, 0.8855, 1.45, 0.312, 231, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1732, d3unbA_, 0.8855, 1.45, 0.312, 231, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1733, d3tddQ_, 0.8855, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1734, d3nzxQ_, 0.8855, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1735, p5nifR_, 0.8854, 2.06, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1736, d4r3oT_, 0.8854, 1.86, 0.313, 238, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
1737, d4hrdC_, 0.8854, 2.05, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1738, p3unhS_, 0.8854, 1.85, 0.313, 238, 230, MOUSE 20S IMMUNOPROTEASOME
1739, p3unhE_, 0.8854, 1.85, 0.313, 238, 230, MOUSE 20S IMMUNOPROTEASOME
1740, d3okjC_, 0.8854, 2.04, 0.335, 241, 233, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1741, d3oevC_, 0.8854, 2.08, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1742, d3mg0C_, 0.8854, 2.05, 0.335, 241, 233, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1743, d3e47C_, 0.8854, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1744, d2fnyC_, 0.8854, 2.03, 0.335, 241, 233,  
1745, p5mpcC_, 0.8853, 2.02, 0.353, 244, 232, 
1746, p5gjqj_, 0.8853, 1.92, 0.339, 240, 230, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1747, p4x6zD_, 0.8853, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1748, d4hnpQ_, 0.8853, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1749, d3unbO_, 0.8853, 1.45, 0.312, 231, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1750, d3okjQ_, 0.8853, 2.04, 0.335, 241, 233, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1751, d3e47Q_, 0.8853, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1752, d2fnyQ_, 0.8853, 2.04, 0.335, 241, 233,  
1753, d5lexC_, 0.8852, 1.95, 0.351, 236, 231, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1754, d4ltcC_, 0.8852, 2.05, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1755, d4j70Q_, 0.8852, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1756, p4cr4C_, 0.8852, 2.08, 0.352, 245, 233, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1757, p5lf6C_, 0.8851, 1.95, 0.351, 236, 231, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1758, p5l4gQ_, 0.8851, 1.90, 0.339, 240, 230, 
1759, d3wxrD_, 0.8851, 2.08, 0.335, 241, 233, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1760, d3unfS_, 0.8851, 1.86, 0.313, 238, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1761, d3unfE_, 0.8851, 1.86, 0.313, 238, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1762, p3unee_, 0.8851, 2.02, 0.348, 239, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1763, d3mg0Q_, 0.8851, 2.05, 0.335, 241, 233, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1764, d2fakC_, 0.8851, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1765, d2f16C_, 0.8851, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1766, d4fzgC_, 0.8850, 2.04, 0.335, 241, 233, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1767, p3uneS_, 0.8850, 1.87, 0.313, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
1768, d2f16Q_, 0.8850, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1769, d4fzgQ_, 0.8849, 2.04, 0.335, 241, 233, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1770, d2fakQ_, 0.8849, 2.05, 0.335, 241, 233, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1771, d1g65Q_, 0.8848, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1772, p5t0jI_, 0.8847, 2.08, 0.331, 250, 236, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1773, p5gjrHA_, 0.8847, 1.45, 0.312, 231, 224, 
1774, p5gjrT_, 0.8845, 1.45, 0.312, 231, 224, 
1775, d4ltcQ_, 0.8845, 2.06, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1776, d3sdiQ_, 0.8845, 2.05, 0.335, 238, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1777, p5lf0S_, 0.8844, 1.68, 0.316, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1778, d3mg4C_, 0.8843, 2.06, 0.335, 241, 233, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1779, d1iruR_, 0.8843, 2.03, 0.343, 243, 233, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1780, d1iruD_, 0.8843, 2.03, 0.343, 243, 233, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1781, p5t0iI_, 0.8842, 2.13, 0.339, 250, 236, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1782, p3uneu_, 0.8842, 1.91, 0.313, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
1783, p3uneE_, 0.8842, 1.90, 0.313, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
1784, d2gplC_, 0.8842, 2.05, 0.335, 241, 233, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1785, d1iruB_, 0.8842, 1.69, 0.310, 233, 226, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1786, d2gplQ_, 0.8841, 2.05, 0.335, 241, 233, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1787, p6gopQ_, 0.8840, 2.01, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1788, p6gopC_, 0.8840, 2.01, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1789, d4hrcQ_, 0.8840, 2.06, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1790, d1jd2C_, 0.8840, 2.05, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1791, p5vfrl_, 0.8839, 1.90, 0.317, 238, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1792, p4x6zR_, 0.8839, 2.08, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1793, d1iruF_, 0.8839, 1.90, 0.313, 238, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1794, p5vfol_, 0.8838, 1.92, 0.317, 238, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1795, p5m32O_, 0.8838, 1.51, 0.311, 230, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1796, p5m32A_, 0.8838, 1.51, 0.311, 230, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1797, d5lexS_, 0.8838, 1.69, 0.316, 235, 228, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1798, p4r67e_, 0.8838, 1.90, 0.341, 239, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1799, p3unbg_, 0.8838, 1.90, 0.313, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1800, p5vfoL_, 0.8837, 1.88, 0.313, 238, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1801, d4qv9Q_, 0.8837, 2.02, 0.341, 240, 232, YCP BETA5-C63F MUTANT
1802, d4qv9C_, 0.8837, 2.02, 0.341, 240, 232, YCP BETA5-C63F MUTANT
1803, p5mpcQ_, 0.8836, 1.93, 0.349, 244, 232, 
1804, d5lf4S_, 0.8836, 1.70, 0.316, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1805, d5d0tQ_, 0.8836, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1806, d5d0tC_, 0.8836, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1807, d4qv0Q_, 0.8836, 2.02, 0.341, 240, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1808, d4qv0C_, 0.8836, 2.02, 0.341, 240, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1809, p6epfE_, 0.8835, 1.96, 0.592, 233, 233, GROUND STATE 26S PROTEASOME (GS1)
1810, p5lf6S_, 0.8835, 1.70, 0.316, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1811, d4qv7Q_, 0.8835, 2.02, 0.341, 240, 232, YCP BETA5-A50V MUTANT
1812, d4qv7C_, 0.8835, 2.02, 0.341, 240, 232, YCP BETA5-A50V MUTANT
1813, d4qv3C_, 0.8835, 2.02, 0.341, 240, 232, YCP BETA5-M45V MUTANT
1814, p3uneg_, 0.8835, 1.89, 0.313, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
1815, d1jd2X_, 0.8835, 2.05, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1816, d5lf7S_, 0.8834, 1.69, 0.311, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1817, d4r00C_, 0.8834, 2.02, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1818, d4qzzQ_, 0.8834, 2.02, 0.341, 240, 232, YCP IN COMPLEX WITH OMURALIDE
1819, d4qzzC_, 0.8834, 2.02, 0.341, 240, 232, YCP IN COMPLEX WITH OMURALIDE
1820, d4qw1Q_, 0.8834, 2.02, 0.341, 240, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1821, d4qw1C_, 0.8834, 2.02, 0.341, 240, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1822, d4qvpC_, 0.8834, 2.02, 0.341, 240, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1823, d4qv6Q_, 0.8834, 2.02, 0.341, 240, 232, YCP BETA5-A49V MUTANT
1824, d4qv6C_, 0.8834, 2.02, 0.341, 240, 232, YCP BETA5-A49V MUTANT
1825, d4qv3Q_, 0.8834, 2.02, 0.341, 240, 232, YCP BETA5-M45V MUTANT
1826, d4hrdQ_, 0.8834, 2.07, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1827, d3unbE_, 0.8834, 1.91, 0.313, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1828, d5dkjQ_, 0.8833, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1829, d5dkjC_, 0.8833, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1830, d5cgfC_, 0.8833, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1831, d4r00Q_, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1832, d4qwuQ_, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1833, d4qwuC_, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1834, d4qwlC_, 0.8833, 2.03, 0.341, 240, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1835, d4qvvQ_, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1836, d4qvvC_, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1837, d4qvpQ_, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1838, d4qv8Q_, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-C52F MUTANT
1839, d4qv8C_, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-C52F MUTANT
1840, d4cr2C_, 0.8833, 2.13, 0.352, 245, 233, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1841, d5lf3S_, 0.8832, 1.70, 0.316, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1842, d5lf1S_, 0.8832, 1.70, 0.316, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1843, p5lezS_, 0.8832, 1.70, 0.316, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1844, p5leyS_, 0.8832, 1.70, 0.316, 235, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1845, d5fgaQ_, 0.8832, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1846, d5fgaC_, 0.8832, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1847, d5fg7C_, 0.8832, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1848, d5cgfQ_, 0.8832, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1849, d4qz6C_, 0.8832, 2.03, 0.341, 240, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1850, d4qz5Q_, 0.8832, 2.02, 0.341, 240, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1851, d4qz5C_, 0.8832, 2.02, 0.341, 240, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1852, d4qwlQ_, 0.8832, 2.03, 0.341, 240, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1853, p5vfrL_, 0.8831, 1.90, 0.317, 238, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1854, p5vfqEA_, 0.8831, 1.91, 0.317, 238, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1855, d5l54C_, 0.8831, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1856, d5fg7Q_, 0.8831, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1857, d5d0xC_, 0.8831, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1858, d5cz8Q_, 0.8831, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1859, d5cz8C_, 0.8831, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1860, d4z1lQ_, 0.8831, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1861, d4z1lC_, 0.8831, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1862, p4ya2Q_, 0.8831, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1863, p4ya2C_, 0.8831, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1864, d4qz6Q_, 0.8831, 2.03, 0.341, 240, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1865, d4qz3Q_, 0.8831, 2.03, 0.341, 240, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1866, d4qz3C_, 0.8831, 2.03, 0.341, 240, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1867, d4qv4C_, 0.8831, 2.02, 0.341, 240, 232, YCP BETA5-M45T MUTANT
1868, d4qv1Q_, 0.8831, 2.02, 0.341, 240, 232, YCP BETA5-M45A MUTANT
1869, d4qv1C_, 0.8831, 2.02, 0.341, 240, 232, YCP BETA5-M45A MUTANT
1870, d4quyQ_, 0.8831, 2.02, 0.341, 240, 232, YCP BETA5-A49S-MUTANT
1871, d4quyC_, 0.8831, 2.02, 0.341, 240, 232, YCP BETA5-A49S-MUTANT
1872, d5l54Q_, 0.8830, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1873, d5d0xQ_, 0.8830, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1874, d5d0wQ_, 0.8830, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1875, d5d0wC_, 0.8830, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1876, d5d0sQ_, 0.8830, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1877, d5d0sC_, 0.8830, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1878, p4y8sQ_, 0.8830, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1879, p4y8sC_, 0.8830, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1880, d4y8rQ_, 0.8830, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1881, d4y8rC_, 0.8830, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1882, d4qwjC_, 0.8830, 2.03, 0.341, 240, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1883, d4qvqQ_, 0.8830, 2.03, 0.341, 240, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1884, d4qvqC_, 0.8830, 2.03, 0.341, 240, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1885, d4qvlQ_, 0.8830, 2.02, 0.341, 240, 232, YCP IN COMPLEX WITH BORTEZOMIB
1886, d4qvlC_, 0.8830, 2.02, 0.341, 240, 232, YCP IN COMPLEX WITH BORTEZOMIB
1887, d4qv5Q_, 0.8830, 2.03, 0.341, 240, 232, YCP BETA5-M45I MUTANT
1888, d4qv5C_, 0.8830, 2.03, 0.341, 240, 232, YCP BETA5-M45I MUTANT
1889, d4qv4Q_, 0.8830, 2.03, 0.341, 240, 232, YCP BETA5-M45T MUTANT
1890, d5lajC_, 0.8829, 2.02, 0.341, 240, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1891, d5dkiQ_, 0.8829, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1892, d5dkiC_, 0.8829, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1893, d5d0zQ_, 0.8829, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1894, d5d0zC_, 0.8829, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1895, d5czaQ_, 0.8829, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1896, d5czaC_, 0.8829, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1897, d5bxnC_, 0.8829, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1898, d4y9yQ_, 0.8829, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1899, d4y9yC_, 0.8829, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1900, d4qzwQ_, 0.8829, 2.03, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1901, d4qzwC_, 0.8829, 2.03, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1902, d4qz7Q_, 0.8829, 2.03, 0.341, 240, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1903, d4qz7C_, 0.8829, 2.02, 0.341, 240, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1904, d4qwjQ_, 0.8829, 2.03, 0.341, 240, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1905, d4qw7C_, 0.8829, 2.03, 0.341, 240, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1906, d4qw0Q_, 0.8829, 2.02, 0.341, 240, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1907, d4qw0C_, 0.8829, 2.02, 0.341, 240, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1908, d4qltC_, 0.8829, 2.02, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1909, p3uneG_, 0.8829, 2.00, 0.263, 244, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
1910, d3mg8Q_, 0.8829, 2.11, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1911, d1iruO_, 0.8829, 2.02, 0.263, 244, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1912, d5lajQ_, 0.8828, 2.02, 0.341, 240, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1913, d5l55C_, 0.8828, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1914, d5l52Q_, 0.8828, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1915, d5l52C_, 0.8828, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1916, d5jhsQ_, 0.8828, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1917, d5jhsC_, 0.8828, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1918, d5fggQ_, 0.8828, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1919, d5fggC_, 0.8828, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1920, d5fg9Q_, 0.8828, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1921, d5fg9C_, 0.8828, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1922, d5bxnQ_, 0.8828, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1923, p4y7yC_, 0.8828, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1924, d4r02C_, 0.8828, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1925, d4qw7Q_, 0.8828, 2.03, 0.341, 240, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1926, d4qw6C_, 0.8828, 2.03, 0.341, 240, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1927, d4qvyC_, 0.8828, 2.02, 0.341, 240, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1928, d4qvwQ_, 0.8828, 2.02, 0.341, 240, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1929, d4qvwC_, 0.8828, 2.02, 0.341, 240, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1930, d4qltQ_, 0.8828, 2.02, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1931, d1iruA_, 0.8828, 2.02, 0.263, 244, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1932, p5vfpDA_, 0.8827, 1.92, 0.317, 238, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1933, d5l55Q_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1934, d5fhsQ_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1935, d5fhsC_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1936, d5cz5Q_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1937, d5cz5C_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1938, p5cggQ_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1939, p5cggC_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1940, d4ya4Q_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1941, d4ya4C_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1942, p4y9zQ_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1943, p4y9zC_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1944, p4y8lC_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1945, p4y8jQ_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1946, p4y8jC_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1947, p4y7yQ_, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1948, d4qwiQ_, 0.8827, 2.03, 0.341, 240, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1949, d4qwiC_, 0.8827, 2.03, 0.341, 240, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1950, d4qw6Q_, 0.8827, 2.03, 0.341, 240, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1951, d4qw5Q_, 0.8827, 2.03, 0.341, 240, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1952, d4qw5C_, 0.8827, 2.03, 0.341, 240, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1953, d4qvyQ_, 0.8827, 2.02, 0.341, 240, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1954, d4qvnC_, 0.8827, 2.03, 0.341, 240, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1955, d5le5S_, 0.8826, 1.75, 0.316, 237, 228, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1956, p5fghQ_, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1957, p5fghC_, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1958, d5cz9Q_, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1959, d5cz9C_, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1960, p5cgiQ_, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1961, p5cgiC_, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1962, d5bxlQ_, 0.8826, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1963, d5bxlC_, 0.8826, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1964, p4ya7C_, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1965, d4ya1Q_, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1966, d4ya1C_, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1967, p4y8uQ_, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1968, p4y8uC_, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1969, p4y8lQ_, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1970, p4y7wC_, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1971, p4y70C_, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1972, d4qzxQ_, 0.8826, 2.03, 0.341, 240, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1973, d4qzxC_, 0.8826, 2.03, 0.341, 240, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1974, d4qwkQ_, 0.8826, 2.03, 0.341, 240, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1975, d4qwkC_, 0.8826, 2.03, 0.341, 240, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1976, d4qvnQ_, 0.8826, 2.03, 0.341, 240, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1977, d4nnnQ_, 0.8826, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH MG132
1978, d4nnnC_, 0.8826, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH MG132
1979, d5jhrC_, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1980, d5fgiQ_, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1981, d5fgiC_, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1982, d5d0vC_, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1983, d5cz7Q_, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1984, p4ya7Q_, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1985, p4y8iC_, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1986, p4y7wQ_, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1987, p4y70Q_, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1988, d4qz4C_, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1989, d4qz2C_, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1990, d4qxjQ_, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1991, d4qxjC_, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1992, d4qwrQ_, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1993, d4qwrC_, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1994, d4qw4C_, 0.8825, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH CARFILZOMIB
1995, d4quxQ_, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-A49T-MUTANT
1996, d4quxC_, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-A49T-MUTANT
1997, d4no8C_, 0.8825, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1998, d4no1Q_, 0.8825, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1999, d4no1C_, 0.8825, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2000, p6avoL_, 0.8824, 1.65, 0.317, 234, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2001, p6avoG_, 0.8824, 1.65, 0.317, 234, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2002, d5jhrQ_, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2003, p5gjqi_, 0.8824, 1.48, 0.312, 231, 224, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2004, d5d0vQ_, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2005, d5cz7C_, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2006, d5cz6Q_, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2007, d5cz6C_, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2008, d5ahjC_, 0.8824, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2009, d4y8mQ_, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2010, d4y8mC_, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2011, p4y8iQ_, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2012, d4qz4Q_, 0.8824, 2.03, 0.341, 240, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2013, d4qz2Q_, 0.8824, 2.03, 0.341, 240, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2014, d4qz0C_, 0.8824, 2.04, 0.341, 240, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2015, d4qwfQ_, 0.8824, 2.03, 0.341, 240, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2016, d4qwfC_, 0.8824, 2.03, 0.341, 240, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2017, d4qw4Q_, 0.8824, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH CARFILZOMIB
2018, d4qvmQ_, 0.8824, 2.03, 0.341, 240, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2019, d4qvmC_, 0.8824, 2.03, 0.341, 240, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2020, d4no8Q_, 0.8824, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2021, p5vfuW_, 0.8823, 1.93, 0.313, 238, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2022, p5vfsF_, 0.8823, 1.82, 0.319, 238, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2023, d5fgdC_, 0.8823, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2024, d5ahjQ_, 0.8823, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2025, p4y8qQ_, 0.8823, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2026, p4y8qC_, 0.8823, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2027, p4y8hQ_, 0.8823, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2028, p4y8hC_, 0.8823, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2029, p4y80Q_, 0.8823, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2030, p4y80C_, 0.8823, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2031, p4y78Q_, 0.8823, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2032, p4y78C_, 0.8823, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2033, d4r18Q_, 0.8823, 2.03, 0.341, 240, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2034, d4r18C_, 0.8823, 2.03, 0.341, 240, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2035, d4qz0Q_, 0.8823, 2.04, 0.341, 240, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2036, d4qlsQ_, 0.8823, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2037, d4qlsC_, 0.8823, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2038, d5fgfQ_, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2039, d5fgfC_, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2040, d5fgeQ_, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2041, d5fgeC_, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2042, d5fgdQ_, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2043, p5cghQ_, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2044, p5cghC_, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2045, p4ya9C_, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2046, p4ya3Q_, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2047, p4ya3C_, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2048, p4ya0Q_, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2049, p4ya0C_, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2050, p4y8pQ_, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2051, p4y8pC_, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2052, p4y69Q_, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2053, p4y69C_, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2054, d4qlqQ_, 0.8822, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2055, d4qlqC_, 0.8822, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2056, d4no6Q_, 0.8822, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2057, d4no6C_, 0.8822, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2058, p5vfsAA_, 0.8821, 1.64, 0.310, 232, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2059, p5mpaB_, 0.8821, 1.64, 0.330, 250, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2060, p4ya9Q_, 0.8821, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2061, p4ya5C_, 0.8821, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2062, p4y84Q_, 0.8821, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2063, p4y77Q_, 0.8821, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2064, p4y77C_, 0.8821, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2065, d4qwxQ_, 0.8821, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2066, d4qwxC_, 0.8821, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2067, d4qw3C_, 0.8821, 2.03, 0.341, 240, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2068, d3mg6Q_, 0.8821, 2.12, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2069, d3mg4Q_, 0.8821, 2.09, 0.335, 241, 233, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2070, p5vfqAA_, 0.8820, 1.63, 0.310, 232, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2071, p5vfpF_, 0.8820, 1.92, 0.317, 238, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2072, d5cz4Q_, 0.8820, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2073, d5cz4C_, 0.8820, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2074, p4ya5Q_, 0.8820, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2075, p4y8gQ_, 0.8820, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2076, p4y8gC_, 0.8820, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2077, p4y84C_, 0.8820, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2078, p4y82C_, 0.8820, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2079, d4r3oO_, 0.8820, 2.02, 0.263, 244, 232, HUMAN CONSTITUTIVE 20S PROTEASOME
2080, d4qw3Q_, 0.8820, 2.03, 0.341, 240, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2081, p5vftL_, 0.8819, 1.80, 0.319, 238, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2082, p4y8nQ_, 0.8819, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2083, p4y8nC_, 0.8819, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2084, p4y82Q_, 0.8819, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2085, p4y7xQ_, 0.8819, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2086, p4y7xC_, 0.8819, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2087, p4y75Q_, 0.8819, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2088, p4y75C_, 0.8819, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2089, p4y74Q_, 0.8819, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2090, p4y74C_, 0.8819, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2091, p4y6vQ_, 0.8819, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2092, p4y6vC_, 0.8819, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2093, p4y6aQ_, 0.8819, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2094, p4y6aC_, 0.8819, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2095, d4qwsC_, 0.8819, 2.04, 0.341, 240, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2096, d3sdkQ_, 0.8819, 2.11, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2097, d3oevQ_, 0.8819, 2.12, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2098, p5vfuGA_, 0.8818, 1.79, 0.308, 232, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2099, p5vfth_, 0.8818, 1.79, 0.308, 232, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2100, p5mp9D_, 0.8818, 2.01, 0.341, 240, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2101, d4rurQ_, 0.8818, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2102, d4rurC_, 0.8818, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2103, d4qwsQ_, 0.8818, 2.04, 0.341, 240, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2104, p4qbyQ_, 0.8818, 2.04, 0.345, 240, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2105, p4qbyC_, 0.8818, 2.04, 0.345, 240, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2106, p3unhO_, 0.8818, 1.45, 0.314, 230, 223, MOUSE 20S IMMUNOPROTEASOME
2107, p3unhA_, 0.8818, 1.45, 0.314, 230, 223, MOUSE 20S IMMUNOPROTEASOME
2108, p5vfqF_, 0.8817, 1.93, 0.317, 238, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2109, d5bouQ_, 0.8817, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2110, d5bouC_, 0.8817, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2111, p4y8tQ_, 0.8817, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2112, p4y8tC_, 0.8817, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2113, p4y8oQ_, 0.8817, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2114, p4y8oC_, 0.8817, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2115, p4y8kQ_, 0.8817, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2116, p4y8kC_, 0.8817, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2117, d4no9Q_, 0.8817, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2118, d4no9C_, 0.8817, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2119, d3unfO_, 0.8817, 1.46, 0.314, 230, 223, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2120, d3unfA_, 0.8817, 1.46, 0.314, 230, 223, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2121, p4y81Q_, 0.8816, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2122, p4y81C_, 0.8816, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2123, d4r3oA_, 0.8816, 2.03, 0.263, 244, 232, HUMAN CONSTITUTIVE 20S PROTEASOME
2124, d4qlvC_, 0.8816, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2125, d4qz1Q_, 0.8815, 2.04, 0.341, 240, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2126, d4qz1C_, 0.8815, 2.04, 0.341, 240, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2127, d4qlvQ_, 0.8815, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2128, p3uneU_, 0.8815, 2.02, 0.263, 244, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2129, p5vfsB_, 0.8814, 1.65, 0.310, 232, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2130, p4y6zQ_, 0.8814, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2131, p4y6zC_, 0.8814, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2132, p4r67q_, 0.8814, 2.03, 0.263, 244, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2133, d4r67O_, 0.8814, 2.03, 0.263, 244, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2134, p4r67c_, 0.8814, 2.03, 0.263, 244, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2135, d4r67A_, 0.8814, 2.03, 0.263, 244, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2136, p5vfoh_, 0.8813, 1.64, 0.310, 232, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2137, p5mp9d_, 0.8813, 2.03, 0.341, 240, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2138, d4r17Q_, 0.8813, 2.04, 0.341, 240, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2139, d4r17C_, 0.8813, 2.04, 0.341, 240, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2140, p5vfsEA_, 0.8812, 1.81, 0.319, 238, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2141, p5vfrh_, 0.8812, 1.64, 0.310, 232, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2142, d5l5wQ_, 0.8812, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2143, d5l5wC_, 0.8812, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2144, p3unew_, 0.8812, 2.03, 0.259, 244, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2145, p5vfpZ_, 0.8811, 1.65, 0.310, 232, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2146, p5gjqX_, 0.8811, 2.43, 0.342, 243, 234, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2147, d4qluQ_, 0.8811, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2148, d4qluC_, 0.8811, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2149, d4nnwQ_, 0.8811, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2150, d4nnwC_, 0.8811, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2151, d5laiQ_, 0.8810, 2.04, 0.341, 240, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2152, d5laiC_, 0.8810, 2.04, 0.341, 240, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2153, d5l5zQ_, 0.8810, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2154, d5l5zC_, 0.8810, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2155, d5l5xQ_, 0.8810, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2156, d5l5xC_, 0.8810, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2157, d5l5uQ_, 0.8810, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2158, d5l5uC_, 0.8810, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2159, p5a0qQ_, 0.8810, 1.84, 0.346, 237, 228, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2160, p5a0qC_, 0.8810, 1.84, 0.346, 237, 228, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2161, p6epdC_, 0.8809, 2.15, 0.343, 249, 236, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
2162, d5lttQ_, 0.8809, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2163, d5lttC_, 0.8809, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2164, d5l64Q_, 0.8809, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2165, d5l64C_, 0.8809, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2166, d5l60Q_, 0.8809, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2167, d5l60C_, 0.8809, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2168, d4qwgQ_, 0.8809, 2.05, 0.341, 240, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2169, d4qwgC_, 0.8809, 2.05, 0.341, 240, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2170, d5l62Q_, 0.8808, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2171, d5l62C_, 0.8808, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2172, d5l5fQ_, 0.8808, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2173, d5l5fC_, 0.8808, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2174, d5l5eQ_, 0.8808, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2175, d5l5eC_, 0.8808, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2176, d3unbG_, 0.8808, 1.98, 0.260, 243, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2177, d5l65Q_, 0.8807, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2178, d5l65C_, 0.8807, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2179, d5l61Q_, 0.8807, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2180, d5l61C_, 0.8807, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2181, d5l5yQ_, 0.8807, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2182, d5l5yC_, 0.8807, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2183, d5l5bQ_, 0.8807, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2184, p5gjqn_, 0.8807, 2.41, 0.342, 243, 234, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2185, d4r02Q_, 0.8807, 2.05, 0.341, 240, 232, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2186, d5l6bQ_, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2187, d5l63Q_, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2188, d5l63C_, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2189, d5l5sQ_, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2190, d5l5sC_, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2191, d5l5bC_, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2192, d5l5aQ_, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2193, d5l5aC_, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2194, p3unei_, 0.8806, 2.04, 0.263, 244, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2195, d5l6bC_, 0.8805, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2196, d5l67Q_, 0.8805, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2197, d5l67C_, 0.8805, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2198, d5l66Q_, 0.8805, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2199, d5l66C_, 0.8805, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2200, d5l5vQ_, 0.8805, 2.06, 0.341, 240, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2201, d5l5vC_, 0.8805, 2.05, 0.341, 240, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2202, d5l5rQ_, 0.8805, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2203, d5l5rC_, 0.8805, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2204, d5l5hQ_, 0.8805, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2205, p5vfuKA_, 0.8804, 1.83, 0.314, 238, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2206, p5vftl_, 0.8804, 1.83, 0.314, 238, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2207, p5lf0E_, 0.8804, 1.60, 0.314, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2208, d5l6cQ_, 0.8804, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2209, d5l6cC_, 0.8804, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2210, d5l5qQ_, 0.8804, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2211, d5l5qC_, 0.8804, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2212, d5l5pQ_, 0.8804, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2213, d5l5pC_, 0.8804, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2214, d5l5iC_, 0.8804, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2215, d5l5hC_, 0.8804, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2216, p3unbi_, 0.8804, 1.99, 0.260, 243, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2217, p5vfuS_, 0.8803, 1.64, 0.310, 232, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2218, p5vftH_, 0.8803, 1.64, 0.310, 232, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2219, p5t0cX_, 0.8803, 1.94, 0.313, 238, 230, 
2220, p5t0cDB_, 0.8803, 1.94, 0.313, 238, 230, 
2221, d5lf4E_, 0.8803, 1.60, 0.314, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2222, d5l6aQ_, 0.8803, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2223, d5l6aC_, 0.8803, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2224, d5l5tQ_, 0.8803, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2225, d5l5tC_, 0.8803, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2226, d5l5iQ_, 0.8803, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2227, p5l4gG_, 0.8803, 2.35, 0.346, 242, 234, 
2228, d3mg7Q_, 0.8803, 2.14, 0.339, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2229, d5l5oQ_, 0.8802, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2230, d5l5oC_, 0.8802, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2231, p3jcpMA_, 0.8802, 2.11, 0.335, 241, 233, 
2232, p3jcpM_, 0.8802, 2.11, 0.335, 241, 233, 
2233, p5lf6E_, 0.8801, 1.60, 0.314, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2234, d5l5jQ_, 0.8801, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2235, d5l5jC_, 0.8801, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2236, d5l5dQ_, 0.8801, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2237, d5l5dC_, 0.8801, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2238, d3oeuQ_, 0.8801, 2.15, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2239, p5t0hI_, 0.8800, 2.19, 0.339, 250, 236, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2240, d5m2bQ_, 0.8800, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2241, d5m2bC_, 0.8800, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2242, d5lf7E_, 0.8800, 1.60, 0.314, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2243, d5l68Q_, 0.8800, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2244, p6avoQ_, 0.8799, 2.36, 0.343, 239, 233, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2245, p6avoJ_, 0.8799, 2.36, 0.343, 239, 233, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2246, d5lf1E_, 0.8799, 1.61, 0.314, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2247, p5leyE_, 0.8799, 1.61, 0.314, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2248, d5lexE_, 0.8799, 1.60, 0.314, 233, 226, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2249, d5l68C_, 0.8799, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2250, p5gjrMA_, 0.8798, 2.38, 0.342, 243, 234, 
2251, d5lf3E_, 0.8797, 1.61, 0.314, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2252, d5le5E_, 0.8797, 1.61, 0.314, 233, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2253, d5l69Q_, 0.8797, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2254, d5l69C_, 0.8797, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2255, p5t0cZA_, 0.8796, 1.66, 0.310, 232, 226, 
2256, p5t0cT_, 0.8796, 1.66, 0.310, 232, 226, 
2257, p5gjrY_, 0.8796, 2.38, 0.342, 243, 234, 
2258, p3unbw_, 0.8793, 2.01, 0.260, 243, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2259, p5mpad_, 0.8792, 2.05, 0.341, 240, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2260, d3unbU_, 0.8792, 2.01, 0.260, 243, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2261, p5lezE_, 0.8791, 1.61, 0.314, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2262, p5l4gU_, 0.8789, 2.39, 0.346, 241, 234, 
2263, d3wxrR_, 0.8784, 2.17, 0.335, 241, 233, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2264, p5t0gL_, 0.8783, 1.94, 0.313, 238, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2265, d4r3oG_, 0.8782, 2.42, 0.346, 245, 234, HUMAN CONSTITUTIVE 20S PROTEASOME
2266, d4r3oU_, 0.8780, 2.42, 0.346, 245, 234, HUMAN CONSTITUTIVE 20S PROTEASOME
2267, d3unfU_, 0.8780, 2.02, 0.264, 243, 231, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2268, d3unfG_, 0.8780, 2.02, 0.264, 243, 231, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2269, p3unbv_, 0.8780, 2.37, 0.348, 244, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2270, d3unbT_, 0.8780, 2.37, 0.348, 244, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2271, p4cr4B_, 0.8778, 1.90, 0.329, 250, 228, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2272, d3sdiT_, 0.8777, 2.30, 0.332, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2273, p5t0gH_, 0.8776, 1.71, 0.310, 233, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2274, d5l63T_, 0.8775, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2275, d5l63F_, 0.8775, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2276, d4r02F_, 0.8775, 2.30, 0.328, 243, 232, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2277, d5l6aT_, 0.8774, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2278, d5l6aF_, 0.8774, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2279, d5l64T_, 0.8774, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2280, d5l64F_, 0.8774, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2281, d5l61T_, 0.8774, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2282, d5l61F_, 0.8774, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2283, d4r18T_, 0.8774, 2.31, 0.332, 243, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2284, d4r18F_, 0.8774, 2.31, 0.332, 243, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2285, d5m2bT_, 0.8773, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2286, d5m2bF_, 0.8773, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2287, d5l62T_, 0.8773, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2288, d5l62F_, 0.8773, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2289, d5l5wT_, 0.8773, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2290, d5l5wF_, 0.8773, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2291, d5l5oT_, 0.8773, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2292, d5l5oF_, 0.8773, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2293, d5l5dT_, 0.8773, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2294, d5l5dF_, 0.8773, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2295, p3jcoMA_, 0.8773, 2.15, 0.335, 241, 233, 
2296, p3jcoM_, 0.8773, 2.15, 0.335, 241, 233, 
2297, d5l6cT_, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2298, d5l6cF_, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2299, d5l66T_, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2300, d5l66F_, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2301, d5l5tT_, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2302, d5l5tF_, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2303, d5l5rT_, 0.8772, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2304, d5l5rF_, 0.8772, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2305, d5l5pT_, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2306, d5l5pF_, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2307, d5l5hT_, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2308, d5l5hF_, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2309, d5fggT_, 0.8772, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2310, d5fggF_, 0.8772, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2311, d5ahjT_, 0.8772, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2312, d4qvnT_, 0.8772, 2.31, 0.332, 243, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2313, d4qvnF_, 0.8772, 2.32, 0.332, 243, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2314, d5l6bT_, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2315, d5l6bF_, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2316, d5l69T_, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2317, d5l67T_, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2318, d5l67F_, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2319, d5l65T_, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2320, d5l65F_, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2321, d5l60T_, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2322, d5l5yT_, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2323, d5l5yF_, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2324, d5l5uT_, 0.8771, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2325, d5l5uF_, 0.8771, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2326, d5l5qT_, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2327, d5l5qF_, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2328, d5l5jT_, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2329, d5l5jF_, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2330, d5ahjF_, 0.8771, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2331, d5lajT_, 0.8770, 2.31, 0.332, 243, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2332, d5lajF_, 0.8770, 2.31, 0.332, 243, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2333, d5l69F_, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2334, d5l68T_, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2335, d5l60F_, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2336, d5l5zT_, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2337, d5l5zF_, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2338, d5l5xT_, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2339, d5l5vT_, 0.8770, 2.31, 0.332, 243, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2340, d5l5vF_, 0.8770, 2.31, 0.332, 243, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2341, d5l5sT_, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2342, d5l5sF_, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2343, d5l5iT_, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2344, d5l5iF_, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2345, d5l5bT_, 0.8770, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2346, d5l5bF_, 0.8770, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2347, p5cghT_, 0.8770, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2348, p5cghF_, 0.8770, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2349, d4r02T_, 0.8770, 2.32, 0.328, 243, 232, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2350, d4eu2G_, 0.8770, 2.29, 0.332, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2351, d5l68F_, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2352, d5l5xF_, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2353, d5l5fT_, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2354, d5l5fF_, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2355, d5cz9T_, 0.8769, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2356, d5cz9F_, 0.8769, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2357, p5cggT_, 0.8769, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2358, p5cggF_, 0.8769, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2359, d5bxnT_, 0.8769, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2360, d5bxnF_, 0.8769, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2361, p4zzgU_, 0.8769, 2.28, 0.328, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2362, d3unbF_, 0.8769, 2.40, 0.348, 244, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2363, p5mp9g_, 0.8768, 2.29, 0.332, 243, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2364, d5lttT_, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2365, d5l5eT_, 0.8768, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2366, d5l5eF_, 0.8768, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2367, d5fgiT_, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2368, d5fgeT_, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2369, d5d0vT_, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2370, d5d0sT_, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2371, d5d0sF_, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2372, p4zzgG_, 0.8768, 2.25, 0.323, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2373, p4ya9T_, 0.8768, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2374, p4ya9F_, 0.8768, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2375, p4y8kT_, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2376, p4y8gT_, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2377, p4y8gF_, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2378, d4r67U_, 0.8768, 2.37, 0.343, 245, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2379, d4r67G_, 0.8768, 2.37, 0.343, 245, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2380, d4qz7T_, 0.8768, 2.32, 0.332, 243, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2381, d4qz7F_, 0.8768, 2.32, 0.332, 243, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2382, d4qz0T_, 0.8768, 2.32, 0.332, 243, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2383, d4qwfT_, 0.8768, 2.32, 0.332, 243, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2384, d4qwfF_, 0.8768, 2.32, 0.332, 243, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2385, d4qw6T_, 0.8768, 2.32, 0.332, 243, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2386, d4qw6F_, 0.8768, 2.32, 0.332, 243, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2387, d4qw5T_, 0.8768, 2.32, 0.332, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2388, d4qvwT_, 0.8768, 2.31, 0.332, 243, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2389, d4qvwF_, 0.8768, 2.31, 0.332, 243, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2390, p3uneF_, 0.8768, 2.27, 0.349, 244, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2391, p5mpcP_, 0.8767, 1.85, 0.332, 250, 229, 
2392, d5lttF_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2393, d5l5aT_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2394, d5l5aF_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2395, d5fgiF_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2396, d5fgeF_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2397, d5d0zT_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2398, d5d0zF_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2399, d5d0vF_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2400, d5cz7T_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2401, d5cz7F_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2402, d5bxlT_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2403, d5bxlF_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2404, d4ya4T_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2405, d4ya4F_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2406, p4y8tT_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2407, p4y8tF_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2408, p4y8pT_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2409, p4y8pF_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2410, p4y8kF_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2411, p4y75T_, 0.8767, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2412, p4y75F_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2413, p4y6aT_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2414, p4y6aF_, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2415, p4r67w_, 0.8767, 2.37, 0.343, 245, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2416, p4r67i_, 0.8767, 2.37, 0.343, 245, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2417, d4qzzT_, 0.8767, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH OMURALIDE
2418, d4qzzF_, 0.8767, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH OMURALIDE
2419, d4qz0F_, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2420, d4qwlT_, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2421, d4qwlF_, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2422, d4qw7T_, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2423, d4qw7F_, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2424, d4qw5F_, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2425, d4qw1T_, 0.8767, 2.31, 0.332, 243, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2426, d4qw1F_, 0.8767, 2.31, 0.332, 243, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2427, d4qvyT_, 0.8767, 2.31, 0.332, 243, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2428, d4qvyF_, 0.8767, 2.31, 0.332, 243, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2429, d4qvqT_, 0.8767, 2.31, 0.332, 243, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2430, d4qvqF_, 0.8767, 2.31, 0.332, 243, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2431, d4qvpT_, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2432, d4qvpF_, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2433, d4qlsT_, 0.8767, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2434, d4qlsF_, 0.8767, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2435, d4hnpF_, 0.8767, 2.29, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2436, d3sdiF_, 0.8767, 2.28, 0.332, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2437, p5nifU_, 0.8766, 2.29, 0.328, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2438, p5lezT_, 0.8766, 2.45, 0.342, 240, 234, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2439, d5lexT_, 0.8766, 2.40, 0.339, 240, 233, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2440, d5l55T_, 0.8766, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2441, d5l55F_, 0.8766, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2442, d5jhsT_, 0.8766, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2443, d5jhsF_, 0.8766, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2444, d5cz6F_, 0.8766, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2445, d5bouT_, 0.8766, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2446, d5bouF_, 0.8766, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2447, d4qz6T_, 0.8766, 2.32, 0.332, 243, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2448, d4qz6F_, 0.8766, 2.32, 0.332, 243, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2449, d4qz4T_, 0.8766, 2.31, 0.332, 243, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2450, d4qz4F_, 0.8766, 2.31, 0.332, 243, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2451, d4qwxT_, 0.8766, 2.31, 0.332, 243, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2452, d4qwxF_, 0.8766, 2.31, 0.332, 243, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2453, d4qvlT_, 0.8766, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH BORTEZOMIB
2454, d4qvlF_, 0.8766, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH BORTEZOMIB
2455, d4qv5T_, 0.8766, 2.33, 0.332, 243, 232, YCP BETA5-M45I MUTANT
2456, d4qv5F_, 0.8766, 2.33, 0.332, 243, 232, YCP BETA5-M45I MUTANT
2457, d4qv4T_, 0.8766, 2.32, 0.332, 243, 232, YCP BETA5-M45T MUTANT
2458, d4qv4F_, 0.8766, 2.32, 0.332, 243, 232, YCP BETA5-M45T MUTANT
2459, d4qv1T_, 0.8766, 2.32, 0.332, 243, 232, YCP BETA5-M45A MUTANT
2460, d4qv1F_, 0.8766, 2.32, 0.332, 243, 232, YCP BETA5-M45A MUTANT
2461, d4qv0F_, 0.8766, 2.32, 0.332, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2462, d4quxF_, 0.8766, 2.32, 0.332, 243, 232, YCP BETA5-A49T-MUTANT
2463, p5nifG_, 0.8765, 2.25, 0.323, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2464, d5jhrT_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2465, d5jhrF_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2466, d5fgfT_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2467, d5fgfF_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2468, d5fgdT_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2469, d5fgdF_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2470, d5d0wT_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2471, d5d0wF_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2472, d5czaT_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2473, d5czaF_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2474, d5cz6T_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2475, d4ya1T_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2476, d4ya1F_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2477, p4y8uT_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2478, p4y8uF_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2479, p4y8hT_, 0.8765, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2480, p4y8hF_, 0.8765, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2481, p4y77T_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2482, p4y77F_, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2483, d4qw4T_, 0.8765, 2.31, 0.332, 243, 232, YCP IN COMPLEX WITH CARFILZOMIB
2484, d4qv8T_, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT
2485, d4qv8F_, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT
2486, d4qv7T_, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-A50V MUTANT
2487, d4qv7F_, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-A50V MUTANT
2488, d4qv6F_, 0.8765, 2.27, 0.328, 243, 232, YCP BETA5-A49V MUTANT
2489, d4qv0T_, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2490, d4quyT_, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-A49S-MUTANT
2491, d4quyF_, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-A49S-MUTANT
2492, d4quxT_, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-A49T-MUTANT
2493, d5fgaF_, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2494, d4y9yT_, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2495, d4y9yF_, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2496, p4y8sT_, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2497, p4y8sF_, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2498, d4y8mT_, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2499, d4y8mF_, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2500, p4y84T_, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2501, p4y84F_, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2502, p4y6vF_, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2503, p4y69T_, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2504, p4y69F_, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2505, d4rurT_, 0.8764, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2506, d4rurF_, 0.8764, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2507, d4qz2T_, 0.8764, 2.32, 0.332, 243, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2508, d4qz2F_, 0.8764, 2.32, 0.332, 243, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2509, d4qwuT_, 0.8764, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2510, d4qwuF_, 0.8764, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2511, d4qw4F_, 0.8764, 2.31, 0.332, 243, 232, YCP IN COMPLEX WITH CARFILZOMIB
2512, d4qvmT_, 0.8764, 2.31, 0.332, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2513, d4qvmF_, 0.8764, 2.31, 0.332, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2514, d4qv6T_, 0.8764, 2.27, 0.328, 243, 232, YCP BETA5-A49V MUTANT
2515, d4qlvT_, 0.8764, 2.30, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2516, d4qlvF_, 0.8764, 2.30, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2517, p3unev_, 0.8764, 2.28, 0.349, 244, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2518, p3unbh_, 0.8764, 2.25, 0.349, 244, 232, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2519, d5l52T_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2520, d5l52F_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2521, d5fgaT_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2522, d5fg9T_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2523, d5fg9F_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2524, d5fg7T_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2525, d5fg7F_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2526, p4ya7T_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2527, p4ya7F_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2528, p4ya2T_, 0.8763, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2529, p4y8nT_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2530, p4y8nF_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2531, p4y82T_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2532, p4y81T_, 0.8763, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2533, p4y81F_, 0.8763, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2534, p4y7xT_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2535, p4y7xF_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2536, p4y6vT_, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2537, d4r00T_, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2538, d4qzwT_, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2539, d4qzwF_, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2540, d4qz3T_, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2541, d4qz3F_, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2542, d4qwrT_, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2543, d4qwrF_, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2544, d4qwkT_, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2545, d4qwkF_, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2546, d4qw0T_, 0.8763, 2.31, 0.332, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2547, d4qw0F_, 0.8763, 2.31, 0.332, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2548, d4nnwT_, 0.8763, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2549, d4nnwF_, 0.8763, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2550, d4hrcF_, 0.8763, 2.24, 0.328, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2551, p6gopT_, 0.8762, 2.28, 0.328, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2552, p6gopF_, 0.8762, 2.28, 0.328, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2553, p6gopA_, 0.8762, 1.44, 0.333, 230, 222, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2554, p5mpaD_, 0.8762, 2.08, 0.336, 240, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2555, d5le5T_, 0.8762, 2.50, 0.342, 240, 234, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2556, d5fhsT_, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2557, d5fhsF_, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2558, d5dkjT_, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2559, d5d0tT_, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2560, d5d0tF_, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2561, p5cgiT_, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2562, p5cgiF_, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2563, p4ya5T_, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2564, p4ya5F_, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2565, p4ya2F_, 0.8762, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2566, d4y8rT_, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2567, d4y8rF_, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2568, p4y82F_, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2569, p4y6zT_, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2570, p4y6zF_, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2571, d4r17T_, 0.8762, 2.32, 0.332, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2572, d4r17F_, 0.8762, 2.32, 0.332, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2573, d4r00F_, 0.8762, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2574, d4qz1T_, 0.8762, 2.32, 0.332, 243, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2575, d4qz1F_, 0.8762, 2.32, 0.332, 243, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2576, d4qwiT_, 0.8762, 2.32, 0.332, 243, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2577, d4qwiF_, 0.8762, 2.32, 0.332, 243, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2578, d4qv9F_, 0.8762, 2.33, 0.332, 243, 232, YCP BETA5-C63F MUTANT
2579, d4qv3T_, 0.8762, 2.33, 0.332, 243, 232, YCP BETA5-M45V MUTANT
2580, d4qv3F_, 0.8762, 2.33, 0.332, 243, 232, YCP BETA5-M45V MUTANT
2581, d4no9T_, 0.8762, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2582, d4no9F_, 0.8762, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2583, d4hrdF_, 0.8762, 2.29, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2584, p5fghT_, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2585, p5fghF_, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2586, d5dkjF_, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2587, d5d0xT_, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2588, d5cz5T_, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2589, d5cz5F_, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2590, d5cgfT_, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2591, d5cgfF_, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2592, p4y8qT_, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2593, p4y8qF_, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2594, p4y8oT_, 0.8761, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2595, p4y74T_, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2596, p4y74F_, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2597, d4qwsT_, 0.8761, 2.32, 0.332, 243, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2598, d4qwsF_, 0.8761, 2.32, 0.332, 243, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2599, d4qv9T_, 0.8761, 2.33, 0.332, 243, 232, YCP BETA5-C63F MUTANT
2600, d4q1sF_, 0.8761, 2.31, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2601, p3unhF_, 0.8761, 2.29, 0.349, 244, 232, MOUSE 20S IMMUNOPROTEASOME
2602, p5mp9G_, 0.8760, 2.26, 0.332, 243, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2603, d5d0xF_, 0.8760, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2604, p4y9zT_, 0.8760, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2605, p4y9zF_, 0.8760, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2606, p4y8oF_, 0.8760, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2607, p4y8lT_, 0.8760, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2608, p4y8lF_, 0.8760, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2609, p4x6zU_, 0.8760, 2.26, 0.328, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2610, d4qz5T_, 0.8760, 2.32, 0.332, 243, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2611, d4qz5F_, 0.8760, 2.32, 0.332, 243, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2612, d4qltT_, 0.8760, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2613, d4no1T_, 0.8760, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2614, d4no1F_, 0.8760, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2615, d4nnnT_, 0.8760, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH MG132
2616, p3unhT_, 0.8760, 2.29, 0.349, 244, 232, MOUSE 20S IMMUNOPROTEASOME
2617, p5vfsD_, 0.8759, 2.15, 0.339, 239, 233, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2618, d5laiT_, 0.8759, 2.32, 0.332, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2619, d5laiF_, 0.8759, 2.32, 0.332, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2620, d5cz8T_, 0.8759, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2621, d5cz8F_, 0.8759, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2622, d4z1lT_, 0.8759, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2623, d4z1lF_, 0.8759, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2624, p4y8iT_, 0.8759, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2625, p4y8iF_, 0.8759, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2626, d4qwgT_, 0.8759, 2.31, 0.332, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2627, d4qwgF_, 0.8759, 2.32, 0.332, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2628, d4qw3T_, 0.8759, 2.31, 0.332, 243, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2629, d4qw3F_, 0.8759, 2.31, 0.332, 243, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2630, d4qluT_, 0.8759, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2631, d4qluF_, 0.8759, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2632, d4qltF_, 0.8759, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2633, d4nnnF_, 0.8759, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH MG132
2634, p5lf0F_, 0.8758, 2.51, 0.342, 239, 234, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2635, d5l54T_, 0.8758, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2636, d5l54F_, 0.8758, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2637, p4y80T_, 0.8758, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2638, p4y80F_, 0.8758, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2639, p4x6zG_, 0.8758, 2.30, 0.328, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2640, d4qzxT_, 0.8758, 2.32, 0.332, 243, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2641, d4qzxF_, 0.8758, 2.32, 0.332, 243, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2642, d4qxjT_, 0.8758, 2.32, 0.332, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2643, d4qxjF_, 0.8758, 2.32, 0.332, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2644, d4qlqT_, 0.8758, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2645, d4qlqF_, 0.8758, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2646, d4hnpT_, 0.8758, 2.32, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2647, d3un8F_, 0.8758, 2.32, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2648, d5lexF_, 0.8757, 2.28, 0.341, 239, 232, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2649, p4y8jT_, 0.8757, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2650, p4y8jF_, 0.8757, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2651, d4qvvT_, 0.8757, 2.32, 0.332, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2652, d4qvvF_, 0.8757, 2.32, 0.332, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2653, d4no8T_, 0.8757, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2654, d4no8F_, 0.8757, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2655, d4no6T_, 0.8757, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2656, d4no6F_, 0.8757, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2657, d3un8T_, 0.8757, 2.32, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2658, d5cz4T_, 0.8756, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2659, d5cz4F_, 0.8756, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2660, p4ya3T_, 0.8756, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2661, p4ya3F_, 0.8756, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2662, p4y7wT_, 0.8756, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2663, p4y7wF_, 0.8756, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2664, p4y70T_, 0.8756, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2665, p4y70F_, 0.8756, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2666, d4qwjT_, 0.8756, 2.32, 0.332, 243, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2667, d4qwjF_, 0.8756, 2.32, 0.332, 243, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2668, d4ltcT_, 0.8756, 2.32, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2669, d4hrcT_, 0.8756, 2.32, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2670, d5lf3F_, 0.8755, 2.46, 0.342, 239, 234, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2671, d5lf1T_, 0.8755, 2.47, 0.346, 240, 234, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2672, p4y78T_, 0.8755, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2673, d4ltcF_, 0.8755, 2.32, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2674, p3uneh_, 0.8755, 2.30, 0.349, 244, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2675, d3nzjT_, 0.8755, 2.32, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2676, p5lezF_, 0.8754, 2.29, 0.341, 239, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2677, p4ya0T_, 0.8754, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2678, p4ya0F_, 0.8754, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2679, p4y7yT_, 0.8754, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2680, p4y7yF_, 0.8754, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2681, p4y78F_, 0.8754, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2682, p4qbyT_, 0.8754, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2683, p4qbyF_, 0.8754, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2684, d3nzjF_, 0.8754, 2.32, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2685, d3mg4F_, 0.8754, 2.32, 0.332, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2686, d5dkiT_, 0.8753, 2.27, 0.328, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2687, d4j70F_, 0.8753, 2.32, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2688, d5lf7T_, 0.8752, 2.48, 0.346, 240, 234, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2689, d5dkiF_, 0.8752, 2.27, 0.328, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2690, d4q1sT_, 0.8752, 2.34, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2691, d4intT_, 0.8752, 2.32, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2692, d4inrT_, 0.8752, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2693, d4inrF_, 0.8752, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2694, d4hrdT_, 0.8752, 2.32, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2695, d3mg4T_, 0.8752, 2.33, 0.332, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2696, d3mg0T_, 0.8752, 2.33, 0.332, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2697, d5lf4T_, 0.8751, 2.52, 0.342, 240, 234, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2698, d4j70T_, 0.8751, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2699, d4intF_, 0.8751, 2.32, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2700, d3gptT_, 0.8751, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2701, d3gptF_, 0.8751, 2.32, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2702, d1jd21_, 0.8751, 2.32, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2703, d5lf7F_, 0.8750, 2.40, 0.343, 239, 233, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2704, p4v7oQ_, 0.8750, 1.83, 0.342, 232, 225, 
2705, d3unfT_, 0.8750, 2.16, 0.351, 244, 231, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2706, d3unfF_, 0.8750, 2.16, 0.351, 244, 231, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2707, p3uneT_, 0.8750, 2.32, 0.349, 244, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2708, d3nzwT_, 0.8750, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2709, d3nzwF_, 0.8750, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2710, d3l5qT_, 0.8750, 1.83, 0.342, 232, 225,  
2711, d1jd2F_, 0.8750, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2712, p4v7oKA_, 0.8749, 1.84, 0.342, 232, 225, 
2713, p4v7oC_, 0.8749, 1.84, 0.342, 232, 225, 
2714, d4lqiF_, 0.8749, 2.34, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2715, d4inuT_, 0.8749, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2716, d4inuF_, 0.8749, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2717, d3l5qH_, 0.8749, 1.84, 0.342, 232, 225,  
2718, d3hyeT_, 0.8749, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2719, d3hyeF_, 0.8749, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2720, d1vsyQ_, 0.8749, 1.84, 0.342, 232, 225,  
2721, d1vsyC_, 0.8749, 1.84, 0.342, 232, 225,  
2722, p5lf6T_, 0.8748, 2.48, 0.346, 240, 234, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2723, p5lf0T_, 0.8748, 2.49, 0.346, 240, 234, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2724, p5leyT_, 0.8748, 2.48, 0.346, 240, 234, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2725, d4lqiT_, 0.8748, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2726, d4jsqT_, 0.8748, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2727, d4jsqF_, 0.8748, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2728, d4fzgT_, 0.8748, 2.32, 0.332, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2729, d4fzgF_, 0.8748, 2.32, 0.332, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2730, d4cr2B_, 0.8748, 1.88, 0.329, 250, 228, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2731, d5lf1F_, 0.8747, 2.41, 0.343, 239, 233, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2732, p5leyF_, 0.8747, 2.41, 0.343, 239, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2733, d5le5F_, 0.8747, 2.40, 0.343, 239, 233, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2734, d3tddT_, 0.8747, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2735, d3tddF_, 0.8747, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2736, d2fnyT_, 0.8747, 2.33, 0.332, 244, 232,  
2737, d2fnyF_, 0.8747, 2.33, 0.332, 244, 232,  
2738, d5lf3T_, 0.8746, 2.48, 0.346, 240, 234, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2739, d3e47T_, 0.8746, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2740, d3e47F_, 0.8746, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2741, d3d29T_, 0.8746, 2.33, 0.332, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
2742, d3d29F_, 0.8746, 2.33, 0.332, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
2743, d2fakT_, 0.8746, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2744, p6epcC_, 0.8745, 2.31, 0.339, 249, 236, GROUND STATE 26S PROTEASOME (GS2)
2745, p5wvkR_, 0.8745, 2.21, 0.339, 241, 233, 
2746, d3gpwT_, 0.8745, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2747, d3gpwF_, 0.8745, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2748, d2fakF_, 0.8745, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2749, d1rypG_, 0.8745, 2.32, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2750, d4jt0T_, 0.8744, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2751, d4jt0F_, 0.8744, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2752, d4jsuT_, 0.8744, 2.34, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2753, d4jsuF_, 0.8744, 2.34, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2754, d3nzxT_, 0.8744, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2755, d3nzxF_, 0.8744, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2756, d3dy3T_, 0.8744, 2.34, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2757, d3dy3F_, 0.8744, 2.34, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2758, p5lf6F_, 0.8743, 2.41, 0.343, 239, 233, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2759, d5lf4F_, 0.8743, 2.41, 0.343, 239, 233, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2760, d4eu2U_, 0.8743, 2.35, 0.332, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2761, d3mg0F_, 0.8743, 2.34, 0.332, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2762, d2gplT_, 0.8743, 2.33, 0.332, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2763, d2gplF_, 0.8743, 2.33, 0.332, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2764, d1z7qG1, 0.8743, 2.29, 0.332, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2765, d1rypU_, 0.8743, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2766, d1g0uF_, 0.8743, 2.32, 0.332, 242, 232, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2767, d5lf1Q_, 0.8742, 2.15, 0.345, 238, 232, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2768, p4gk7T_, 0.8742, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2769, p4gk7F_, 0.8742, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2770, d3okjT_, 0.8742, 2.33, 0.332, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2771, d3okjF_, 0.8742, 2.33, 0.332, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2772, d3mg4U_, 0.8742, 2.09, 0.241, 243, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2773, d1z7qU1, 0.8742, 2.29, 0.332, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2774, p5mpcB_, 0.8741, 1.85, 0.332, 250, 229, 
2775, p5lf6Q_, 0.8740, 2.15, 0.345, 238, 232, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2776, p3un4T_, 0.8740, 2.34, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2777, p3un4F_, 0.8740, 2.34, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2778, d1g0uT_, 0.8740, 2.32, 0.332, 242, 232, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2779, p4v7oG_, 0.8739, 2.37, 0.328, 244, 232, 
2780, d3shjT_, 0.8739, 2.34, 0.332, 244, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2781, d3shjF_, 0.8739, 2.34, 0.332, 244, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2782, d3mg7U_, 0.8739, 2.10, 0.237, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2783, d3l5qL_, 0.8739, 2.37, 0.328, 244, 232,  
2784, d3gpjT_, 0.8739, 2.35, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2785, d2f16T_, 0.8739, 2.34, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2786, d2f16F_, 0.8739, 2.34, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2787, p5wviDA_, 0.8738, 1.93, 0.325, 250, 228, 
2788, p4v7oU_, 0.8738, 2.37, 0.328, 244, 232, 
2789, d3l5qX_, 0.8738, 2.37, 0.328, 244, 232,  
2790, d3gpjF_, 0.8738, 2.35, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2791, d3dy4T_, 0.8738, 2.35, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2792, d3bdmT_, 0.8738, 2.35, 0.332, 244, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2793, d3bdmF_, 0.8738, 2.35, 0.332, 244, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2794, d5lf4Q_, 0.8737, 2.16, 0.345, 238, 232, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2795, p4v7oOA_, 0.8737, 2.37, 0.328, 244, 232, 
2796, p4v7oCB_, 0.8737, 2.37, 0.328, 244, 232, 
2797, d4fzcF_, 0.8737, 2.34, 0.332, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2798, d3sdkU_, 0.8737, 2.10, 0.241, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2799, d3dy4F_, 0.8737, 2.35, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2800, d2zcyT_, 0.8737, 2.35, 0.332, 244, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2801, d1vsyU_, 0.8737, 2.37, 0.328, 244, 232,  
2802, d1vsyG_, 0.8737, 2.37, 0.328, 244, 232,  
2803, p5vfuU_, 0.8736, 2.16, 0.343, 239, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2804, p5vftJ_, 0.8736, 2.16, 0.343, 239, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2805, d4fzcT_, 0.8736, 2.34, 0.332, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2806, d2zcyF_, 0.8736, 2.35, 0.332, 244, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2807, d3un8U_, 0.8735, 2.11, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2808, d1iruU_, 0.8735, 2.45, 0.346, 245, 234, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2809, d1iruG_, 0.8735, 2.45, 0.346, 245, 234, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2810, p5wviOA_, 0.8734, 1.94, 0.329, 250, 228, 
2811, d1g65T_, 0.8734, 2.32, 0.332, 244, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2812, p5wvkBA_, 0.8732, 2.24, 0.328, 244, 232, 
2813, d5lf7Q_, 0.8732, 2.16, 0.345, 238, 232, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2814, p5leyQ_, 0.8732, 2.17, 0.345, 239, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2815, d3mg6U_, 0.8732, 2.10, 0.241, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2816, d1g65F_, 0.8732, 2.32, 0.332, 244, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2817, d5lf3Q_, 0.8731, 2.16, 0.345, 238, 232, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2818, d3mg8U_, 0.8731, 2.10, 0.237, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2819, d3mg7G_, 0.8731, 2.12, 0.241, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2820, p5mpbB_, 0.8730, 1.99, 0.329, 250, 228, 
2821, p5lf0Q_, 0.8730, 2.17, 0.345, 238, 232, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2822, p5mpag_, 0.8729, 2.36, 0.336, 243, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2823, d3wxrO_, 0.8729, 2.10, 0.241, 243, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2824, d3oeuU_, 0.8729, 2.11, 0.237, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2825, p6epcE_, 0.8728, 2.18, 0.592, 233, 233, GROUND STATE 26S PROTEASOME (GS2)
2826, p5vfsCA_, 0.8725, 2.18, 0.343, 239, 233, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2827, d4q1sU_, 0.8725, 2.12, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2828, d4hnpU_, 0.8724, 2.11, 0.237, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2829, d4g4sG_, 0.8724, 2.18, 0.335, 246, 230, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2830, d3oevU_, 0.8724, 2.12, 0.241, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2831, d1rypO_, 0.8724, 2.13, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2832, p5cggA_, 0.8723, 1.44, 0.335, 229, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2833, d4ltcU_, 0.8723, 2.12, 0.237, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2834, p4ya9A_, 0.8722, 1.44, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2835, p4y8sA_, 0.8722, 1.44, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2836, p4y75A_, 0.8721, 1.45, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2837, d4j70U_, 0.8721, 2.13, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2838, d3un8G_, 0.8721, 2.13, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2839, d3sdkG_, 0.8721, 2.13, 0.241, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2840, p5m32E_, 0.8720, 1.84, 0.322, 234, 227, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2841, p5cghA_, 0.8720, 1.45, 0.335, 229, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2842, p4ya7A_, 0.8720, 1.45, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2843, p4y8gA_, 0.8720, 1.45, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2844, d3mg6G_, 0.8720, 2.13, 0.241, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2845, p5dsvF_, 0.8719, 2.55, 0.346, 244, 234, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2846, p4ya2A_, 0.8719, 1.45, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2847, p4y8tA_, 0.8719, 1.45, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2848, d3oeuG_, 0.8719, 2.13, 0.241, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2849, p5dsvN_, 0.8718, 2.56, 0.346, 244, 234, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2850, p5dsvL_, 0.8718, 2.56, 0.346, 245, 234, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2851, p4y8hA_, 0.8718, 1.45, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2852, d4jsqU_, 0.8718, 2.13, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2853, d4hrcU_, 0.8718, 2.11, 0.237, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2854, d3h4pD_, 0.8718, 2.29, 0.430, 232, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2855, p4y9zA_, 0.8717, 1.45, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2856, p4y77A_, 0.8717, 1.45, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2857, d4jsqG_, 0.8717, 2.13, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2858, d4inrU_, 0.8717, 2.13, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2859, d3oevG_, 0.8717, 2.13, 0.241, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2860, d1rypA_, 0.8717, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2861, p5dsvB_, 0.8716, 2.56, 0.346, 245, 234, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2862, d4j70G_, 0.8716, 2.14, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2863, d4intU_, 0.8716, 2.13, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2864, d3tddU_, 0.8716, 2.14, 0.241, 243, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2865, p4qbyA_, 0.8715, 1.45, 0.335, 229, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2866, d3tddG_, 0.8715, 2.14, 0.241, 243, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2867, d3mg8G_, 0.8715, 2.13, 0.241, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2868, d3mg0U_, 0.8715, 2.13, 0.237, 243, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2869, p5mpbP_, 0.8714, 1.79, 0.330, 250, 227, 
2870, p5dsvA_, 0.8714, 2.56, 0.346, 244, 234, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2871, p5cgiA_, 0.8714, 1.45, 0.335, 229, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2872, d4jsuU_, 0.8714, 2.14, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2873, d4jsuG_, 0.8714, 2.14, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2874, p5dsvD_, 0.8713, 2.57, 0.346, 244, 234, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2875, p3un4U_, 0.8713, 2.13, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2876, d3shjU_, 0.8713, 2.14, 0.241, 243, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2877, d1jd22_, 0.8713, 2.14, 0.237, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2878, p4y84A_, 0.8712, 1.46, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2879, p4v7oO_, 0.8712, 2.14, 0.241, 243, 232, 
2880, p4v7oIA_, 0.8712, 2.14, 0.241, 243, 232, 
2881, p4v7oA_, 0.8712, 2.14, 0.241, 243, 232, 
2882, d4jt0U_, 0.8712, 2.14, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2883, d4jt0G_, 0.8712, 2.14, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2884, d4hrdU_, 0.8712, 2.13, 0.237, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2885, p3un4G_, 0.8712, 2.13, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2886, d3shjG_, 0.8712, 2.14, 0.241, 243, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2887, d3nzxU_, 0.8712, 2.14, 0.237, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2888, d3nzjU_, 0.8712, 2.14, 0.241, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2889, d3mg4G_, 0.8712, 2.14, 0.241, 243, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2890, d3l5qC_, 0.8712, 2.14, 0.241, 243, 232,  
2891, d3l5qA_, 0.8712, 2.14, 0.241, 243, 232,  
2892, d1vsyA_, 0.8712, 2.14, 0.241, 243, 232,  
2893, p1fntU_, 0.8712, 2.34, 0.332, 240, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2894, p1fntG_, 0.8712, 2.34, 0.332, 240, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2895, p5dsvE_, 0.8711, 2.57, 0.346, 245, 234, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2896, p4y70A_, 0.8711, 1.46, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2897, p4v7oWA_, 0.8711, 2.14, 0.241, 243, 232, 
2898, d4lqiU_, 0.8711, 2.14, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2899, d4inrG_, 0.8711, 2.14, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2900, p3h4pL_, 0.8711, 2.29, 0.430, 232, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2901, d1vsyO_, 0.8711, 2.14, 0.241, 243, 232,  
2902, d1g65U_, 0.8711, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2903, p5a5bD_, 0.8710, 2.12, 0.332, 242, 232, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2904, p4y8lA_, 0.8710, 1.46, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2905, p4y8jA_, 0.8710, 1.46, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2906, p4cr3D_, 0.8710, 2.12, 0.332, 242, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2907, d3wxrA_, 0.8710, 2.14, 0.241, 243, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2908, d3sdiU_, 0.8710, 2.14, 0.250, 240, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2909, d3nzxG_, 0.8710, 2.14, 0.237, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2910, d3nzjG_, 0.8710, 2.14, 0.241, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2911, d3gpwU_, 0.8710, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2912, p4y7wA_, 0.8709, 1.46, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2913, d4lqiG_, 0.8709, 2.14, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2914, d3gpwG_, 0.8709, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2915, d2fakU_, 0.8709, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2916, p4y6vA_, 0.8708, 1.46, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2917, d4inuU_, 0.8708, 2.14, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2918, p3jcpPA_, 0.8708, 2.31, 0.323, 244, 232, 
2919, p3jcpP_, 0.8708, 2.30, 0.323, 244, 232, 
2920, d3hyeU_, 0.8708, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2921, d3gpjG_, 0.8708, 2.16, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2922, d3e47U_, 0.8708, 2.13, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2923, d2fakG_, 0.8708, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2924, p5m32Q_, 0.8707, 2.10, 0.343, 235, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2925, p4y8uA_, 0.8707, 1.46, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2926, p4y8oA_, 0.8707, 1.47, 0.335, 229, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2927, p4y8iA_, 0.8707, 1.47, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2928, d4ltcG_, 0.8707, 2.14, 0.237, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2929, d4fzcU_, 0.8707, 2.14, 0.237, 243, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2930, d3okjU_, 0.8707, 2.14, 0.237, 243, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2931, d3hyeG_, 0.8707, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2932, d3gptU_, 0.8707, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2933, d3gpjU_, 0.8707, 2.16, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2934, d2fnyU_, 0.8707, 2.14, 0.241, 243, 232,  
2935, p4y8nA_, 0.8706, 1.47, 0.335, 229, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2936, p4y7yA_, 0.8706, 1.47, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2937, p4y69A_, 0.8706, 1.47, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2938, d4fzcG_, 0.8706, 2.14, 0.237, 243, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2939, d3nzwU_, 0.8706, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2940, d3gptG_, 0.8706, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2941, d3e47G_, 0.8706, 2.14, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2942, d3bdmU_, 0.8706, 2.16, 0.241, 243, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2943, d3bdmG_, 0.8706, 2.16, 0.241, 243, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2944, p5t0iH_, 0.8705, 1.83, 0.310, 233, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2945, d4fzgU_, 0.8705, 2.14, 0.237, 243, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2946, d3okjG_, 0.8705, 2.15, 0.237, 243, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2947, d3nzwG_, 0.8705, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2948, d2fnyG_, 0.8705, 2.14, 0.241, 243, 232,  
2949, p5dsvG_, 0.8704, 2.58, 0.346, 242, 234, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2950, d4inuG_, 0.8704, 2.15, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2951, d4intG_, 0.8704, 2.14, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2952, d4fzgG_, 0.8704, 2.14, 0.237, 243, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2953, p3h4pH_, 0.8704, 2.18, 0.432, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2954, d2gplU_, 0.8704, 2.15, 0.241, 243, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2955, d2f16U_, 0.8704, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2956, p5dsvK_, 0.8703, 2.50, 0.343, 244, 233, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2957, p4ya5A_, 0.8703, 1.47, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2958, d3h4pA_, 0.8703, 2.04, 0.430, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2959, d2gplG_, 0.8703, 2.15, 0.241, 243, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2960, d2f16G_, 0.8703, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2961, p5t0hL_, 0.8702, 2.03, 0.317, 238, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2962, p5m32C_, 0.8702, 2.08, 0.349, 234, 229, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2963, p3jcpJA_, 0.8702, 2.16, 0.237, 243, 232, 
2964, p3jcpJ_, 0.8702, 2.16, 0.237, 243, 232, 
2965, d1g0uU_, 0.8702, 2.16, 0.250, 240, 232, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2966, p5t0jL_, 0.8701, 2.04, 0.313, 238, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2967, p5fghA_, 0.8701, 1.48, 0.335, 229, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2968, p5dsvI_, 0.8701, 2.50, 0.343, 244, 233, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2969, d4q1sG_, 0.8700, 2.16, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2970, p4gk7U_, 0.8699, 2.15, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2971, p4gk7G_, 0.8697, 2.15, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2972, d3h4pE_, 0.8697, 2.06, 0.430, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2973, d1g65G_, 0.8697, 2.17, 0.241, 243, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2974, p4x6zA_, 0.8696, 2.16, 0.237, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2975, d3dy3U_, 0.8696, 2.18, 0.241, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2976, d3dy3G_, 0.8696, 2.18, 0.241, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2977, d1g0uG_, 0.8696, 2.17, 0.250, 240, 232, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2978, p3h4pN_, 0.8695, 2.06, 0.430, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2979, p3h4pJ_, 0.8695, 2.19, 0.432, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2980, d3h4pC_, 0.8695, 2.06, 0.430, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2981, p4ya3A_, 0.8694, 1.48, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2982, d3h4pF_, 0.8694, 2.19, 0.432, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2983, d3dy4U_, 0.8694, 2.17, 0.241, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2984, d3dy4G_, 0.8694, 2.17, 0.241, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2985, d2zcyU_, 0.8694, 2.17, 0.241, 243, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2986, d2zcyG_, 0.8694, 2.17, 0.241, 243, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2987, d5fggU_, 0.8692, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2988, p4ya0A_, 0.8692, 1.49, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2989, d4qv9U_, 0.8692, 2.11, 0.238, 241, 231, YCP BETA5-C63F MUTANT
2990, d4qv9G_, 0.8692, 2.11, 0.238, 241, 231, YCP BETA5-C63F MUTANT
2991, p3h4pI_, 0.8692, 2.08, 0.430, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2992, p5wviCA_, 0.8691, 2.21, 0.352, 245, 233, 
2993, p5t0cV_, 0.8691, 2.18, 0.343, 239, 233, 
2994, p5t0cBB_, 0.8691, 2.18, 0.343, 239, 233, 
2995, d5fggG_, 0.8691, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2996, d5l5bU_, 0.8690, 2.12, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2997, d5l5bG_, 0.8690, 2.12, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2998, d5ahjU_, 0.8690, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2999, d4hrdG_, 0.8690, 2.16, 0.237, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3000, d4hnpG_, 0.8690, 2.16, 0.237, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3001, p3un4A_, 0.8690, 1.43, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3002, d5ahjG_, 0.8689, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3003, d4qv3U_, 0.8689, 2.12, 0.242, 241, 231, YCP BETA5-M45V MUTANT
3004, d4qv3G_, 0.8689, 2.12, 0.242, 241, 231, YCP BETA5-M45V MUTANT
3005, d4no8U_, 0.8689, 2.12, 0.238, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3006, d4no8G_, 0.8689, 2.12, 0.238, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3007, d3sdiG_, 0.8689, 2.18, 0.250, 240, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3008, d5l55U_, 0.8688, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3009, d5d0wU_, 0.8688, 2.12, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3010, d5d0wG_, 0.8688, 2.12, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3011, p4y8hU_, 0.8688, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3012, p4y8hG_, 0.8688, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3013, d4no1U_, 0.8688, 2.12, 0.238, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3014, p5nifA_, 0.8687, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3015, d5l55G_, 0.8687, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3016, d5czaU_, 0.8687, 2.12, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3017, d5czaG_, 0.8687, 2.12, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3018, p5cggU_, 0.8687, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3019, p5cggG_, 0.8687, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3020, d4ya4U_, 0.8687, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3021, d4ya4G_, 0.8687, 2.12, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3022, d4no9U_, 0.8687, 2.11, 0.238, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3023, d4no9G_, 0.8687, 2.11, 0.238, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3024, d4no1G_, 0.8687, 2.12, 0.238, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3025, d1jd2G_, 0.8687, 2.18, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3026, d4nnnU_, 0.8686, 2.12, 0.238, 241, 231, YCP IN COMPLEX WITH MG132
3027, p3h4pK_, 0.8686, 2.20, 0.432, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3028, d3d29U2, 0.8686, 2.19, 0.237, 241, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
3029, d3d29G2, 0.8686, 2.19, 0.237, 241, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
3030, p5mpaG_, 0.8685, 2.30, 0.333, 243, 231, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3031, d5jhrU_, 0.8685, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3032, d5d0sU_, 0.8685, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3033, p4zzgA_, 0.8685, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3034, d4qwlU_, 0.8685, 2.12, 0.238, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3035, d4nnnG_, 0.8685, 2.12, 0.238, 241, 231, YCP IN COMPLEX WITH MG132
3036, d4hrcG_, 0.8685, 2.17, 0.237, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3037, d5l5rU_, 0.8684, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3038, d5jhrG_, 0.8684, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3039, d5fg7U_, 0.8684, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3040, d5fg7G_, 0.8684, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3041, d5d0sG_, 0.8684, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3042, d4ya1U_, 0.8684, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3043, d4ya1G_, 0.8684, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3044, d4y8rU_, 0.8684, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3045, d4y8rG_, 0.8684, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3046, d4qwlG_, 0.8684, 2.12, 0.238, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3047, p5vfom_, 0.8683, 2.47, 0.330, 240, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3048, d5l5rG_, 0.8683, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3049, d5cgfU_, 0.8683, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3050, d4qv7U_, 0.8683, 2.13, 0.242, 241, 231, YCP BETA5-A50V MUTANT
3051, d4qv7G_, 0.8683, 2.13, 0.242, 241, 231, YCP BETA5-A50V MUTANT
3052, d4quyU_, 0.8683, 2.13, 0.242, 241, 231, YCP BETA5-A49S-MUTANT
3053, d4quyG_, 0.8683, 2.13, 0.242, 241, 231, YCP BETA5-A49S-MUTANT
3054, d3mg0G_, 0.8683, 2.18, 0.241, 243, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3055, d5l52U_, 0.8682, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3056, d5l52G_, 0.8682, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3057, d5cgfG_, 0.8682, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3058, p4y8pA_, 0.8682, 1.45, 0.336, 228, 220, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3059, d4qv5U_, 0.8682, 2.13, 0.242, 241, 231, YCP BETA5-M45I MUTANT
3060, d4qv5G_, 0.8682, 2.13, 0.242, 241, 231, YCP BETA5-M45I MUTANT
3061, p4gk7A_, 0.8682, 1.44, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3062, p3h4pM_, 0.8682, 2.09, 0.430, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3063, d3h4pB_, 0.8682, 2.09, 0.430, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3064, p5wvkV_, 0.8681, 2.15, 0.237, 243, 232, 
3065, p5vfsBA_, 0.8681, 2.13, 0.330, 240, 230, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3066, d5fgfU_, 0.8681, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3067, d5fgaU_, 0.8681, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3068, d5bxlG_, 0.8681, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3069, p4ya2U_, 0.8681, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3070, p4ya2G_, 0.8681, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3071, p4y8tU_, 0.8681, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3072, p4y8tG_, 0.8681, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3073, d5l5uU_, 0.8680, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3074, d5l5uG_, 0.8680, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3075, d5fgfG_, 0.8680, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3076, d5fgaG_, 0.8680, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3077, d5bxlU_, 0.8680, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3078, p4ya7U_, 0.8680, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3079, p4ya7G_, 0.8680, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3080, p4y8sU_, 0.8680, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3081, p4y8kA_, 0.8680, 1.45, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3082, p4y8gU_, 0.8680, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3083, d4qz6U_, 0.8680, 2.12, 0.238, 241, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3084, d4qwuU_, 0.8680, 2.13, 0.238, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3085, d4qwuG_, 0.8680, 2.13, 0.238, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3086, d4qv1U_, 0.8680, 2.13, 0.242, 241, 231, YCP BETA5-M45A MUTANT
3087, d4qv1G_, 0.8680, 2.13, 0.242, 241, 231, YCP BETA5-M45A MUTANT
3088, d3h4pG_, 0.8680, 2.08, 0.430, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3089, d5l6aU_, 0.8679, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3090, d5l6aG_, 0.8679, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3091, d5bxnU_, 0.8679, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3092, p4y8sG_, 0.8679, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3093, p4y8pU_, 0.8679, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3094, p4y8pG_, 0.8679, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3095, p4y8gG_, 0.8679, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3096, d4qz6G_, 0.8679, 2.12, 0.238, 241, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3097, d4qv4U_, 0.8679, 2.13, 0.242, 241, 231, YCP BETA5-M45T MUTANT
3098, d4qv4G_, 0.8679, 2.13, 0.242, 241, 231, YCP BETA5-M45T MUTANT
3099, d4qluU_, 0.8679, 2.13, 0.238, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3100, p5vfuX_, 0.8678, 2.43, 0.343, 240, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3101, p5vftM_, 0.8678, 2.43, 0.343, 240, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3102, d5d0zU_, 0.8678, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3103, d5d0zG_, 0.8678, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3104, d5cz9U_, 0.8678, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3105, d5bxnG_, 0.8678, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3106, p4y8kU_, 0.8678, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3107, p4y8kG_, 0.8678, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3108, d4qz0U_, 0.8678, 2.12, 0.238, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3109, d4qz0G_, 0.8678, 2.12, 0.238, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3110, d4qv8U_, 0.8678, 2.13, 0.238, 241, 231, YCP BETA5-C52F MUTANT
3111, d4qv0U_, 0.8678, 2.13, 0.238, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3112, d4qluG_, 0.8678, 2.13, 0.238, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3113, p6gopU_, 0.8677, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3114, p5vfoM_, 0.8677, 2.38, 0.332, 240, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3115, d5cz9G_, 0.8677, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3116, d4r00U_, 0.8677, 2.13, 0.238, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3117, d4qzzU_, 0.8677, 2.13, 0.238, 241, 231, YCP IN COMPLEX WITH OMURALIDE
3118, d4qzzG_, 0.8677, 2.13, 0.238, 241, 231, YCP IN COMPLEX WITH OMURALIDE
3119, d4qvnU_, 0.8677, 2.13, 0.242, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3120, d4qvnG_, 0.8677, 2.13, 0.242, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3121, d4qv8G_, 0.8677, 2.13, 0.242, 241, 231, YCP BETA5-C52F MUTANT
3122, d4qv0G_, 0.8677, 2.13, 0.242, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3123, p5nifO_, 0.8676, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3124, d5fhsU_, 0.8676, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3125, d5fhsG_, 0.8676, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3126, d4z1lU_, 0.8676, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3127, d4z1lG_, 0.8676, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3128, d4y8mU_, 0.8676, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3129, d4y8mG_, 0.8676, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3130, d4r17U_, 0.8676, 2.14, 0.242, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3131, d4r17G_, 0.8676, 2.14, 0.242, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3132, d4r00G_, 0.8676, 2.13, 0.238, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3133, d4no6U_, 0.8676, 2.13, 0.238, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3134, d4no6G_, 0.8676, 2.13, 0.238, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3135, p6gopG_, 0.8675, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3136, p4y9zU_, 0.8675, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3137, p4y9zG_, 0.8675, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3138, d4y9yU_, 0.8675, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3139, d4y9yG_, 0.8675, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3140, p4y74A_, 0.8675, 1.45, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3141, d4qltU_, 0.8675, 2.13, 0.238, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3142, d4qlsU_, 0.8675, 2.14, 0.238, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3143, d4qlsG_, 0.8675, 2.14, 0.238, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3144, d4g4sF_, 0.8675, 1.63, 0.341, 234, 223, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3145, p5vfqG_, 0.8674, 2.37, 0.336, 240, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3146, d5lttU_, 0.8674, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3147, d5fg9U_, 0.8674, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3148, d5fg9G_, 0.8674, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3149, d5d0vU_, 0.8674, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3150, p4zzgO_, 0.8674, 2.14, 0.242, 242, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3151, p4y75U_, 0.8674, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3152, d4r02U_, 0.8674, 2.13, 0.242, 241, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3153, d4qz3U_, 0.8674, 2.13, 0.238, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3154, d4qz3G_, 0.8674, 2.13, 0.238, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3155, d4qltG_, 0.8674, 2.14, 0.238, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3156, d4nnwU_, 0.8674, 2.13, 0.238, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3157, p3jcoJA_, 0.8674, 2.17, 0.237, 243, 232, 
3158, d5lttG_, 0.8673, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3159, d5jhsU_, 0.8673, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3160, d5jhsG_, 0.8673, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3161, d5d0vG_, 0.8673, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3162, d5cz8U_, 0.8673, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3163, d5cz8G_, 0.8673, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3164, p4ya9U_, 0.8673, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3165, p4ya9G_, 0.8673, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3166, p4y82A_, 0.8673, 1.46, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3167, p4y75G_, 0.8673, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3168, d4qw7U_, 0.8673, 2.13, 0.238, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3169, d4qw7G_, 0.8673, 2.13, 0.238, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3170, d4qw6U_, 0.8673, 2.13, 0.238, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3171, d4qw5U_, 0.8673, 2.13, 0.238, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3172, d4qw5G_, 0.8673, 2.13, 0.238, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3173, d4qv6U_, 0.8673, 2.13, 0.238, 241, 231, YCP BETA5-A49V MUTANT
3174, d4qv6G_, 0.8673, 2.14, 0.238, 241, 231, YCP BETA5-A49V MUTANT
3175, d4nnwG_, 0.8673, 2.14, 0.238, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3176, p3jcoJ_, 0.8673, 2.17, 0.237, 243, 232, 
3177, p5vfpG_, 0.8672, 2.37, 0.332, 240, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3178, d5l6bU_, 0.8672, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3179, d5l6bG_, 0.8672, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3180, d5l5hU_, 0.8672, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3181, d5l5hG_, 0.8672, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3182, d5l5aU_, 0.8672, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3183, d5l5aG_, 0.8672, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3184, d5fgeU_, 0.8672, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3185, d5fgeG_, 0.8672, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3186, p5cghU_, 0.8672, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3187, p5cghG_, 0.8672, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3188, d4qz5U_, 0.8672, 2.13, 0.238, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3189, d4qz5G_, 0.8672, 2.13, 0.238, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3190, d4qw6G_, 0.8672, 2.13, 0.238, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3191, d4intE_, 0.8672, 1.61, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3192, d5l67U_, 0.8671, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3193, d5l5oU_, 0.8671, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3194, d5l5oG_, 0.8671, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3195, d5l54U_, 0.8671, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3196, d5l54G_, 0.8671, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3197, d5cz7U_, 0.8671, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3198, d5cz7G_, 0.8671, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3199, p4y8lU_, 0.8671, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3200, p4y8lG_, 0.8671, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3201, p4y77U_, 0.8671, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3202, p4y77G_, 0.8671, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3203, d4qz7U_, 0.8671, 2.14, 0.238, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3204, d4qvpU_, 0.8671, 2.14, 0.242, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3205, p5mpaf_, 0.8670, 1.60, 0.341, 231, 223, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3206, d5l67G_, 0.8670, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3207, d5l63U_, 0.8670, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3208, d5l63G_, 0.8670, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3209, d5l61U_, 0.8670, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3210, d5l5dU_, 0.8670, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3211, p5dsvH_, 0.8670, 2.26, 0.348, 239, 230, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3212, p4y8qA_, 0.8670, 1.46, 0.336, 228, 220, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3213, p4y7xA_, 0.8670, 1.46, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3214, p4y6zA_, 0.8670, 1.46, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3215, p4y6aA_, 0.8670, 1.46, 0.336, 228, 220, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3216, p4x6zO_, 0.8670, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3217, d4qzwU_, 0.8670, 2.13, 0.238, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3218, d4qzwG_, 0.8670, 2.13, 0.238, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3219, d4qz7G_, 0.8670, 2.14, 0.238, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3220, d4qz4U_, 0.8670, 2.14, 0.238, 241, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3221, d4qwrU_, 0.8670, 2.14, 0.238, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3222, d4qwrG_, 0.8670, 2.14, 0.238, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3223, d4qw1U_, 0.8670, 2.14, 0.242, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3224, d4qw1G_, 0.8670, 2.14, 0.242, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3225, d4qvyU_, 0.8670, 2.15, 0.242, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3226, d4qvpG_, 0.8670, 2.14, 0.242, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3227, d4qvlU_, 0.8670, 2.14, 0.242, 241, 231, YCP IN COMPLEX WITH BORTEZOMIB
3228, d4qvlG_, 0.8670, 2.14, 0.242, 241, 231, YCP IN COMPLEX WITH BORTEZOMIB
3229, d4intS_, 0.8670, 1.61, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3230, p5vfpEA_, 0.8669, 2.48, 0.330, 240, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3231, p5mp9F_, 0.8669, 1.60, 0.345, 233, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3232, d5l64U_, 0.8669, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3233, d5l64G_, 0.8669, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3234, d5l61G_, 0.8669, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3235, d5l5pU_, 0.8669, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3236, d5l5dG_, 0.8669, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3237, d5cz6U_, 0.8669, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3238, d5cz6G_, 0.8669, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3239, p5cgiU_, 0.8669, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3240, p4y84U_, 0.8669, 2.15, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3241, p4y81A_, 0.8669, 1.46, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3242, p4y80A_, 0.8669, 1.46, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3243, p4y7wU_, 0.8669, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3244, p4y70U_, 0.8669, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3245, p4y70G_, 0.8669, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3246, d4r18U_, 0.8669, 2.14, 0.242, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3247, d4r18G_, 0.8669, 2.15, 0.242, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3248, d4qz4G_, 0.8669, 2.14, 0.238, 241, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3249, d4qvyG_, 0.8669, 2.15, 0.242, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3250, d4quxU_, 0.8669, 2.15, 0.242, 241, 231, YCP BETA5-A49T-MUTANT
3251, d4quxG_, 0.8669, 2.15, 0.242, 241, 231, YCP BETA5-A49T-MUTANT
3252, p4qbyU_, 0.8669, 2.15, 0.242, 241, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3253, p4qbyG_, 0.8669, 2.15, 0.242, 241, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3254, d3un8S_, 0.8669, 1.62, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3255, d5lajU_, 0.8668, 2.15, 0.242, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3256, d5l6cU_, 0.8668, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3257, d5l6cG_, 0.8668, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3258, d5l66U_, 0.8668, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3259, d5l66G_, 0.8668, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3260, d5l65U_, 0.8668, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3261, d5l65G_, 0.8668, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3262, d5l62U_, 0.8668, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3263, d5l5wU_, 0.8668, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3264, d5l5pG_, 0.8668, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3265, d5l5fU_, 0.8668, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3266, d5l5fG_, 0.8668, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3267, p5cgiG_, 0.8668, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3268, p4y8uU_, 0.8668, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3269, p4y8qU_, 0.8668, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3270, p4y8qG_, 0.8668, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3271, p4y84G_, 0.8668, 2.15, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3272, p4y7yU_, 0.8668, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3273, p4y7yG_, 0.8668, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3274, p4y7wG_, 0.8668, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3275, d4qzxU_, 0.8668, 2.13, 0.238, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3276, d4qzxG_, 0.8668, 2.13, 0.238, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3277, d4cr2D_, 0.8668, 2.31, 0.339, 242, 233, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3278, d3un8E_, 0.8668, 1.62, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3279, d5lajG_, 0.8667, 2.15, 0.242, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3280, d5l62G_, 0.8667, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3281, d5l5wG_, 0.8667, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3282, p4y8uG_, 0.8667, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3283, p4y82U_, 0.8667, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3284, p4y82G_, 0.8667, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3285, d4qlqU_, 0.8667, 2.15, 0.238, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3286, d4qlqG_, 0.8667, 2.15, 0.238, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3287, p5vfsG_, 0.8666, 2.59, 0.333, 240, 234, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3288, p5vfrM_, 0.8666, 2.38, 0.336, 240, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3289, d5l5qU_, 0.8666, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3290, d5l5eU_, 0.8666, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3291, d5fgiU_, 0.8666, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3292, d5fgiG_, 0.8666, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3293, p4y8jU_, 0.8666, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3294, p4y8jG_, 0.8666, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3295, p4y74U_, 0.8666, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3296, p4y74G_, 0.8666, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3297, d4qvwU_, 0.8666, 2.15, 0.242, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3298, d4g4sA_, 0.8666, 2.25, 0.250, 241, 232, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3299, d5m2bU_, 0.8665, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3300, d5m2bG_, 0.8665, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3301, d5l5xU_, 0.8665, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3302, d5l5xG_, 0.8665, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3303, d5l5tU_, 0.8665, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3304, d5l5qG_, 0.8665, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3305, d5l5eG_, 0.8665, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3306, d5cz5U_, 0.8665, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3307, d5cz5G_, 0.8665, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3308, p4y80U_, 0.8665, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3309, p4y80G_, 0.8665, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3310, p4y7xU_, 0.8665, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3311, p4y7xG_, 0.8665, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3312, p4y6aU_, 0.8665, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3313, p4y6aG_, 0.8665, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3314, d4qz2U_, 0.8665, 2.14, 0.238, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3315, d4qz2G_, 0.8665, 2.14, 0.238, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3316, d4qwxU_, 0.8665, 2.14, 0.238, 241, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3317, d4qwxG_, 0.8665, 2.14, 0.238, 241, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3318, d4qwjU_, 0.8665, 2.14, 0.238, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3319, d4qwjG_, 0.8665, 2.14, 0.238, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3320, d4qvwG_, 0.8665, 2.15, 0.242, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3321, d4eu2O_, 0.8665, 2.08, 0.243, 241, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3322, d3mg8T_, 0.8665, 2.33, 0.336, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3323, p5vfqFA_, 0.8664, 2.39, 0.332, 240, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3324, d5l5vU_, 0.8664, 2.15, 0.242, 241, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3325, d5l5vG_, 0.8664, 2.15, 0.242, 241, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3326, d5l5tG_, 0.8664, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3327, d5fgdU_, 0.8664, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3328, d5fgdG_, 0.8664, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3329, d5d0tU_, 0.8664, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3330, p4zzgT_, 0.8664, 1.62, 0.345, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3331, p4y78A_, 0.8664, 1.47, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3332, d4qwiU_, 0.8664, 2.14, 0.238, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3333, d4qlvU_, 0.8664, 2.15, 0.238, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3334, d4qlvG_, 0.8664, 2.15, 0.238, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3335, d5l5sU_, 0.8663, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3336, d5l5sG_, 0.8663, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3337, d5d0tG_, 0.8663, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3338, p4y6vU_, 0.8663, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3339, p4y6vG_, 0.8663, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3340, d4qwiG_, 0.8663, 2.14, 0.238, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3341, d4qwfU_, 0.8663, 2.14, 0.242, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3342, d4qwfG_, 0.8663, 2.14, 0.242, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3343, d4inrS_, 0.8663, 1.62, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3344, d4inrE_, 0.8663, 1.62, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3345, d4cr2G_, 0.8663, 2.31, 0.329, 245, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3346, d1z7qO1, 0.8663, 2.10, 0.237, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3347, d1z7qA1, 0.8663, 2.10, 0.237, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3348, d5l5zU_, 0.8662, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3349, p4y69U_, 0.8662, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3350, p4y69G_, 0.8662, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3351, d4qvqU_, 0.8662, 2.15, 0.242, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3352, d4qvqG_, 0.8662, 2.15, 0.242, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3353, d4jsqS_, 0.8662, 1.63, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3354, d4jsqE_, 0.8662, 1.63, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3355, p4cr4D_, 0.8662, 2.27, 0.335, 242, 233, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3356, p5nifT_, 0.8661, 1.63, 0.345, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3357, d5l5zG_, 0.8661, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3358, d5l5jU_, 0.8661, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3359, p4y6zU_, 0.8661, 2.15, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3360, d4hrdE_, 0.8661, 1.64, 0.341, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3361, d3oevT_, 0.8661, 2.33, 0.336, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3362, d3oeuT_, 0.8661, 2.34, 0.336, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3363, d3mg6T_, 0.8661, 2.34, 0.336, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3364, d3dy3E_, 0.8661, 1.62, 0.345, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3365, d3bdmS_, 0.8661, 1.62, 0.341, 233, 223, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3366, d3bdmE_, 0.8661, 1.62, 0.341, 233, 223, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3367, d5l68U_, 0.8660, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3368, d5l68G_, 0.8660, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3369, d5l5jG_, 0.8660, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3370, d5l5iU_, 0.8660, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3371, d5l5iG_, 0.8660, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3372, d5bouU_, 0.8660, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3373, d5bouG_, 0.8660, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3374, p4y8nU_, 0.8660, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3375, p4y8nG_, 0.8660, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3376, p4y6zG_, 0.8660, 2.15, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3377, d4qwkU_, 0.8660, 2.14, 0.238, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3378, d4qwkG_, 0.8660, 2.14, 0.238, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3379, d4hnpE_, 0.8660, 1.63, 0.341, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3380, d3mg7T_, 0.8660, 2.33, 0.336, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3381, d3dy3S_, 0.8660, 1.62, 0.345, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3382, p5m32T_, 0.8659, 2.47, 0.341, 240, 232, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3383, d5dkjU_, 0.8659, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3384, d5dkjG_, 0.8659, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3385, d4rurU_, 0.8659, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3386, d4qw0U_, 0.8659, 2.16, 0.242, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3387, d1z7qT1, 0.8659, 1.64, 0.345, 233, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3388, d1z7qF1, 0.8659, 1.64, 0.345, 233, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3389, p5vfuIA_, 0.8658, 2.24, 0.343, 239, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3390, p5vftj_, 0.8658, 2.24, 0.343, 239, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3391, p4ya5U_, 0.8658, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3392, p4y78U_, 0.8658, 2.15, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3393, p4y78G_, 0.8658, 2.15, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3394, d4rurG_, 0.8658, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3395, d4qw0G_, 0.8658, 2.16, 0.242, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3396, d4inuE_, 0.8658, 1.63, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3397, d4hrdS_, 0.8658, 1.63, 0.341, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3398, d4eu2F_, 0.8658, 1.63, 0.341, 232, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3399, p5t0iK_, 0.8657, 1.76, 0.608, 228, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3400, d5l5yU_, 0.8657, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3401, p4ya5G_, 0.8657, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3402, p4y8iU_, 0.8657, 2.15, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3403, p4y8iG_, 0.8657, 2.15, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3404, d4qxjU_, 0.8657, 2.15, 0.238, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3405, d4qxjG_, 0.8657, 2.15, 0.238, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3406, d4ltcS_, 0.8657, 1.64, 0.341, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3407, d4inuS_, 0.8657, 1.63, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3408, d4hnpS_, 0.8657, 1.64, 0.341, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3409, d3d29S_, 0.8657, 1.63, 0.341, 233, 223, PROTEASOME INHIBITION BY FELLUTAMIDE B
3410, d3d29E_, 0.8657, 1.63, 0.341, 233, 223, PROTEASOME INHIBITION BY FELLUTAMIDE B
3411, d1rypF_, 0.8657, 1.64, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3412, d5lajS_, 0.8656, 1.64, 0.341, 231, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3413, d5lajE_, 0.8656, 1.64, 0.341, 231, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3414, d5l60U_, 0.8656, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3415, d5l60G_, 0.8656, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3416, d5l5yG_, 0.8656, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3417, d4qw4U_, 0.8656, 2.15, 0.238, 241, 231, YCP IN COMPLEX WITH CARFILZOMIB
3418, d4qw4G_, 0.8656, 2.15, 0.242, 241, 231, YCP IN COMPLEX WITH CARFILZOMIB
3419, d4qvvU_, 0.8656, 2.15, 0.238, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3420, d4ltcE_, 0.8656, 1.64, 0.341, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3421, d3sdkS_, 0.8656, 1.64, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3422, d3nzjS_, 0.8656, 1.64, 0.341, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3423, d3nzjE_, 0.8656, 1.64, 0.341, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3424, d3d29C2, 0.8656, 1.96, 0.345, 234, 226, PROTEASOME INHIBITION BY FELLUTAMIDE B
3425, p5t0cY_, 0.8655, 2.46, 0.339, 240, 233, 
3426, p5t0cEB_, 0.8655, 2.46, 0.339, 240, 233, 
3427, d5d0xU_, 0.8655, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3428, d4qvvG_, 0.8655, 2.16, 0.238, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3429, d3mg7F_, 0.8655, 2.32, 0.336, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3430, d3gpjE_, 0.8655, 1.63, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3431, d3d29Q2, 0.8655, 1.96, 0.345, 234, 226, PROTEASOME INHIBITION BY FELLUTAMIDE B
3432, p6epfB_, 0.8654, 2.00, 0.308, 234, 227, GROUND STATE 26S PROTEASOME (GS1)
3433, d5laiU_, 0.8654, 2.16, 0.242, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3434, d5laiG_, 0.8654, 2.17, 0.242, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3435, d5d0xG_, 0.8654, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3436, d4r18S_, 0.8654, 1.64, 0.341, 231, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3437, d4r18E_, 0.8654, 1.64, 0.341, 231, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3438, p3un4S_, 0.8654, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3439, p3un4E_, 0.8654, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3440, d3sdkE_, 0.8654, 1.64, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3441, d3oevF_, 0.8654, 2.30, 0.336, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3442, d3mg4S_, 0.8654, 1.65, 0.341, 233, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3443, d3mg0S_, 0.8654, 1.64, 0.341, 233, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3444, d3gpjS_, 0.8654, 1.63, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3445, p5mp9a_, 0.8653, 2.15, 0.242, 241, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3446, d5lttS_, 0.8653, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3447, d5lttE_, 0.8653, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3448, d5fg7S_, 0.8653, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3449, d5dkjS_, 0.8653, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3450, d5dkjE_, 0.8653, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3451, d5cz7S_, 0.8653, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3452, d5cz7E_, 0.8653, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3453, p4zzgF_, 0.8653, 1.63, 0.345, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3454, p4ya3U_, 0.8653, 2.17, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3455, p4ya3G_, 0.8653, 2.17, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3456, p4y81U_, 0.8653, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3457, p4y81G_, 0.8653, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3458, d4r02G_, 0.8653, 2.18, 0.242, 241, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3459, d4r00S_, 0.8653, 1.65, 0.341, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3460, d4r00E_, 0.8653, 1.65, 0.341, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3461, d4qzzS_, 0.8653, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH OMURALIDE
3462, d4qzzE_, 0.8653, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH OMURALIDE
3463, d4qv8S_, 0.8653, 1.65, 0.341, 231, 223, YCP BETA5-C52F MUTANT
3464, d4qv8E_, 0.8653, 1.65, 0.341, 231, 223, YCP BETA5-C52F MUTANT
3465, d4qv7S_, 0.8653, 1.65, 0.341, 231, 223, YCP BETA5-A50V MUTANT
3466, d4qv7E_, 0.8653, 1.65, 0.341, 231, 223, YCP BETA5-A50V MUTANT
3467, d4qv3E_, 0.8653, 1.65, 0.341, 231, 223, YCP BETA5-M45V MUTANT
3468, d4fzgS_, 0.8653, 1.64, 0.341, 233, 223, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3469, d4fzgE_, 0.8653, 1.64, 0.341, 233, 223, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3470, d3mg6S_, 0.8653, 1.64, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3471, p1fntF_, 0.8653, 1.64, 0.345, 233, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3472, d5l6cS_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3473, d5l6cE_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3474, d5l69U_, 0.8652, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3475, d5l69G_, 0.8652, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3476, d5l67S_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3477, d5l67E_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3478, d5l62S_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3479, d5l62E_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3480, d5l61S_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3481, d5l61E_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3482, d5l5vS_, 0.8652, 1.65, 0.341, 231, 223,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3483, d5l5vE_, 0.8652, 1.65, 0.341, 231, 223,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3484, d5l5uS_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3485, d5l5uE_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3486, d5l5pS_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3487, d5l5pE_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3488, d5l5bS_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3489, d5l5bE_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3490, d5fgfS_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3491, d5fgfE_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3492, d5fg7E_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3493, d5czaS_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3494, d5czaE_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3495, p5cggS_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3496, p5cggE_, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3497, d4qz1U_, 0.8652, 2.16, 0.238, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3498, d4qwsU_, 0.8652, 2.15, 0.238, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3499, d4qv3S_, 0.8652, 1.65, 0.341, 231, 223, YCP BETA5-M45V MUTANT
3500, d4quyS_, 0.8652, 1.65, 0.341, 231, 223, YCP BETA5-A49S-MUTANT
3501, d4quyE_, 0.8652, 1.65, 0.341, 231, 223, YCP BETA5-A49S-MUTANT
3502, d4q1sE_, 0.8652, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3503, d4jt0S_, 0.8652, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3504, d4jt0E_, 0.8652, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3505, d4fzcS_, 0.8652, 1.64, 0.341, 233, 223, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3506, d4fzcE_, 0.8652, 1.64, 0.341, 233, 223, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3507, d3dy4S_, 0.8652, 1.64, 0.345, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3508, d3dy4E_, 0.8652, 1.64, 0.345, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3509, d2zcyS_, 0.8652, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3510, d2zcyE_, 0.8652, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3511, d2fakE_, 0.8652, 1.64, 0.341, 233, 223, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3512, p1fntT_, 0.8652, 1.64, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3513, p5nifF_, 0.8651, 1.64, 0.345, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3514, d5l6aS_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3515, d5l6aE_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3516, d5l64S_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3517, d5l64E_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3518, d5l5tS_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3519, d5l5tE_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3520, d5l5qS_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3521, d5l5qE_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3522, d5l5oS_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3523, d5l5oE_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3524, d5l5hS_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3525, d5l5hE_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3526, d5fgeS_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3527, d5fgeE_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3528, d5fgaS_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3529, d5fgaE_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3530, d5fg9S_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3531, d5fg9E_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3532, d5cz9S_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3533, d5cz9E_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3534, d5cgfS_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3535, d5cgfE_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3536, d4z1lS_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3537, d4z1lE_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3538, d4ya1S_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3539, d4ya1E_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3540, p4y8kE_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3541, p4y6aS_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3542, p4y6aE_, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3543, p4x6zT_, 0.8651, 1.63, 0.341, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3544, d4qz1G_, 0.8651, 2.16, 0.238, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3545, d4qwsG_, 0.8651, 2.16, 0.238, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3546, d4qvyS_, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3547, d4qvyE_, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3548, d4qvmU_, 0.8651, 2.17, 0.242, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3549, d4qvmG_, 0.8651, 2.17, 0.242, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3550, d4qv9S_, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-C63F MUTANT
3551, d4qv9E_, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-C63F MUTANT
3552, d4qv1S_, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-M45A MUTANT
3553, d4qv0S_, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3554, d4qv0E_, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3555, d4j70S_, 0.8651, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3556, d4j70E_, 0.8651, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3557, d3wxrF_, 0.8651, 1.64, 0.341, 232, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3558, d3sdiE_, 0.8651, 1.64, 0.345, 230, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3559, d3oeuF_, 0.8651, 2.30, 0.336, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3560, d3nzxS_, 0.8651, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3561, d3nzxE_, 0.8651, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3562, d2fakS_, 0.8651, 1.64, 0.341, 233, 223, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3563, d1g65E_, 0.8651, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3564, p5vfoj_, 0.8650, 2.24, 0.343, 239, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3565, p5t0hH_, 0.8650, 1.82, 0.310, 232, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3566, p5mpbD_, 0.8650, 2.14, 0.348, 240, 230, 
3567, d5l6bS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3568, d5l6bE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3569, d5l66S_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3570, d5l66E_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3571, d5l63S_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3572, d5l63E_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3573, d5l5zS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3574, d5l5zE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3575, d5l5xS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3576, d5l5xE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3577, d5l5wS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3578, d5l5wE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3579, d5l5sS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3580, d5l5sE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3581, d5l5rS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3582, d5l5rE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3583, d5l5fS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3584, d5l5fE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3585, d5l5aS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3586, d5l5aE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3587, d5jhsS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3588, d5jhsE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3589, d5fhsS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3590, d5fhsE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3591, d5fgiS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3592, d5fgiE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3593, d5fggS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3594, d5fggE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3595, d5d0zS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3596, d5d0zE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3597, d5d0tS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3598, d5d0tE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3599, d5d0sS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3600, d5d0sE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3601, d5cz4U_, 0.8650, 2.17, 0.242, 241, 231, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3602, d5cz4G_, 0.8650, 2.17, 0.242, 241, 231, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3603, d5bxlS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3604, d5bxlE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3605, d4y9yS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3606, d4y9yE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3607, p4y8uS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3608, p4y8uE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3609, d4y8mS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3610, d4y8mE_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3611, p4y8kS_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3612, p4y69S_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3613, p4y69E_, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3614, p4x6zF_, 0.8650, 1.64, 0.341, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3615, d4qvpS_, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3616, d4qvpE_, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3617, d4qvnE_, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3618, d4qvlS_, 0.8650, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH BORTEZOMIB
3619, d4qvlE_, 0.8650, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH BORTEZOMIB
3620, d4qv4S_, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-M45T MUTANT
3621, d4qv4E_, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-M45T MUTANT
3622, d4qv1E_, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-M45A MUTANT
3623, d4quxS_, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT
3624, d4quxE_, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT
3625, d3tddE_, 0.8650, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3626, d3nzwS_, 0.8650, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3627, d3nzwE_, 0.8650, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3628, d3mg8F_, 0.8650, 2.32, 0.336, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3629, d3mg0E_, 0.8650, 1.65, 0.341, 233, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3630, d3gpwE_, 0.8650, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3631, p5t0gM_, 0.8649, 2.43, 0.343, 240, 233, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3632, p5mp9A_, 0.8649, 2.14, 0.247, 241, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3633, d5m2bS_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3634, p5ln3B_, 0.8649, 1.98, 0.308, 234, 227, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3635, d5l65S_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3636, d5l65E_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3637, d5l60S_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3638, d5l60E_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3639, d5l5jS_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3640, d5l5jE_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3641, d5fgdS_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3642, d5fgdE_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3643, d5d0wS_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3644, d5d0wE_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3645, d5cz6S_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3646, p5cghS_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3647, p5cghE_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3648, d5bxnS_, 0.8649, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3649, d5bxnE_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3650, d4ya4S_, 0.8649, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3651, d4ya4E_, 0.8649, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3652, d4y8rS_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3653, d4y8rE_, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3654, p4y8oU_, 0.8649, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3655, p4y8oG_, 0.8649, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3656, p4r67t_, 0.8649, 2.02, 0.352, 232, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3657, d4qwlE_, 0.8649, 1.65, 0.341, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3658, d4qvnS_, 0.8649, 1.66, 0.341, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3659, d4qv5S_, 0.8649, 1.65, 0.341, 231, 223, YCP BETA5-M45I MUTANT
3660, d4qv5E_, 0.8649, 1.65, 0.341, 231, 223, YCP BETA5-M45I MUTANT
3661, d4no8S_, 0.8649, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3662, d4no8E_, 0.8649, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3663, d4hrcS_, 0.8649, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3664, p4gk7S_, 0.8649, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3665, p4gk7E_, 0.8649, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3666, d4eu2T_, 0.8649, 1.64, 0.341, 232, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3667, d3tddS_, 0.8649, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3668, d3shjS_, 0.8649, 1.64, 0.341, 233, 223, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3669, d3shjE_, 0.8649, 1.64, 0.341, 233, 223, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3670, d3mg8S_, 0.8649, 1.64, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3671, d3mg4E_, 0.8649, 1.65, 0.341, 233, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3672, d3gpwS_, 0.8649, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3673, d3gptS_, 0.8649, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3674, d3gptE_, 0.8649, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3675, d3e47S_, 0.8649, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3676, d3e47E_, 0.8649, 1.64, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3677, d2gplE_, 0.8649, 1.65, 0.341, 233, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3678, p6gopS_, 0.8648, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3679, p6gopE_, 0.8648, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3680, p5wvkU_, 0.8648, 2.46, 0.332, 244, 232, 
3681, p5vfsFA_, 0.8648, 2.61, 0.333, 240, 234, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3682, d5m2bE_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3683, d5l5yS_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3684, d5l5yE_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3685, d5l5iS_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3686, d5l5iE_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3687, d5l5eS_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3688, d5l5eE_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3689, d5l5dS_, 0.8648, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3690, d5l5dE_, 0.8648, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3691, d5l55S_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3692, d5l55E_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3693, d5l52S_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3694, d5l52E_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3695, d5d0xS_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3696, d5d0xE_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3697, d5cz8S_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3698, d5cz8E_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3699, d5cz6E_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3700, d5bouS_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3701, d5bouE_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3702, d5ahjS_, 0.8648, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3703, d5ahjE_, 0.8648, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3704, p4ya5S_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3705, p4ya5E_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3706, p4y8nS_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3707, p4y8nE_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3708, p4y6vS_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3709, p4y6vE_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3710, d4rurS_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3711, d4rurE_, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3712, p4r67f_, 0.8648, 2.02, 0.352, 232, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3713, p4r67D_, 0.8648, 2.02, 0.352, 232, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3714, d4r02S_, 0.8648, 1.67, 0.341, 231, 223, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3715, d4qz7E_, 0.8648, 1.65, 0.341, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3716, d4qwrS_, 0.8648, 1.65, 0.341, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3717, d4qwrE_, 0.8648, 1.65, 0.341, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3718, d4qwlS_, 0.8648, 1.65, 0.341, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3719, d4qw0S_, 0.8648, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3720, d4qw0E_, 0.8648, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3721, d4qvwS_, 0.8648, 1.65, 0.341, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3722, d4qvwE_, 0.8648, 1.65, 0.341, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3723, d4lqiS_, 0.8648, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3724, d4lqiE_, 0.8648, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3725, d4jsuS_, 0.8648, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3726, d4jsuE_, 0.8648, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3727, d2gplS_, 0.8648, 1.65, 0.341, 233, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3728, d2f16S_, 0.8648, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3729, d2f16E_, 0.8648, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3730, d1rypT_, 0.8648, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3731, p6avoN_, 0.8647, 2.01, 0.352, 232, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3732, p5vfrm_, 0.8647, 2.52, 0.330, 240, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3733, d5l69S_, 0.8647, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3734, d5l69E_, 0.8647, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3735, d5l68S_, 0.8647, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3736, d5l68E_, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3737, d5jhrS_, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3738, d5jhrE_, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3739, p5fghU_, 0.8647, 2.17, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3740, p5fghG_, 0.8647, 2.17, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3741, d5d0vS_, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3742, d5d0vE_, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3743, d5cz5S_, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3744, d5cz5E_, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3745, p4y8qE_, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3746, p4r67R_, 0.8647, 2.02, 0.352, 232, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3747, d4qz7S_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3748, d4qz6S_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3749, d4qz6E_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3750, d4qz3S_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3751, d4qz3E_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3752, d4qz0S_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3753, d4qz0E_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3754, d4qwuS_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3755, d4qwuE_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3756, d4qw7S_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3757, d4qw7E_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3758, d4qw6S_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3759, d4qw6E_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3760, d4qw5S_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3761, d4qw5E_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3762, d4qw1S_, 0.8647, 1.66, 0.341, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3763, d4qw1E_, 0.8647, 1.66, 0.341, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3764, d4qvvS_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3765, d4qvvE_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3766, d4qvqS_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3767, d4qvqE_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3768, d4qvmS_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3769, d4qvmE_, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3770, d3okjS_, 0.8647, 1.65, 0.341, 233, 223, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3771, d3okjE_, 0.8647, 1.65, 0.341, 233, 223, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3772, d3mg6F_, 0.8647, 2.33, 0.336, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3773, d3hyeS_, 0.8647, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3774, d3hyeE_, 0.8647, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3775, d2fnyE_, 0.8647, 1.65, 0.341, 233, 223,  
3776, p5fghS_, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3777, p5fghE_, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3778, p5cgiS_, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3779, p5cgiE_, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3780, p4ya0U_, 0.8646, 2.17, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3781, p4ya0G_, 0.8646, 2.17, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3782, p4y8qS_, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3783, p4y8pS_, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3784, p4y8pE_, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3785, p4y8lS_, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3786, p4y8lE_, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3787, d4qzwE_, 0.8646, 1.65, 0.341, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3788, d4qwjS_, 0.8646, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3789, d4qwjE_, 0.8646, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3790, d4qwiS_, 0.8646, 1.65, 0.341, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3791, d4qwiE_, 0.8646, 1.65, 0.341, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3792, d3mg6E_, 0.8646, 1.65, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3793, d2fnyS_, 0.8646, 1.65, 0.341, 233, 223,  
3794, d1g0uE_, 0.8646, 1.65, 0.345, 230, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3795, p6avoI_, 0.8645, 2.02, 0.352, 232, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3796, d5dkiS_, 0.8645, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3797, d5dkiE_, 0.8645, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3798, p4ya7S_, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3799, p4ya7E_, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3800, p4y82S_, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3801, p4y82E_, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3802, p4y80S_, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3803, p4y80E_, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3804, p4y7xS_, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3805, p4y7xE_, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3806, p4y77S_, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3807, p4y77E_, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3808, d4qzwS_, 0.8645, 1.65, 0.341, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3809, d4qz5S_, 0.8645, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3810, d4qz5E_, 0.8645, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3811, d4qz2S_, 0.8645, 1.65, 0.341, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3812, d4qz2E_, 0.8645, 1.65, 0.341, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3813, d4qwfS_, 0.8645, 1.66, 0.341, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3814, d4qw4S_, 0.8645, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH CARFILZOMIB
3815, d4qw4E_, 0.8645, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH CARFILZOMIB
3816, d4nnnS_, 0.8645, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH MG132
3817, d4nnnE_, 0.8645, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH MG132
3818, d3oevE_, 0.8645, 1.66, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3819, d3mg8E_, 0.8645, 1.65, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3820, d3mg7E_, 0.8645, 1.65, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3821, p5vfuLA_, 0.8644, 2.59, 0.329, 240, 234, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3822, p5vftm_, 0.8644, 2.59, 0.329, 240, 234, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3823, d5cz4S_, 0.8644, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3824, d5cz4E_, 0.8644, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3825, p4ya9S_, 0.8644, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3826, p4ya9E_, 0.8644, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3827, p4ya3S_, 0.8644, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3828, p4ya3E_, 0.8644, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3829, p4y9zS_, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3830, p4y9zE_, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3831, p4y8jS_, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3832, p4y8jE_, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3833, p4y7yS_, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3834, p4y7yE_, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3835, p4y7wS_, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3836, p4y7wE_, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3837, p4y75S_, 0.8644, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3838, p4y75E_, 0.8644, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3839, d4r02E_, 0.8644, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3840, d4qzxS_, 0.8644, 1.65, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3841, d4qzxE_, 0.8644, 1.65, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3842, d4qwxS_, 0.8644, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3843, d4qwxE_, 0.8644, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3844, d4qwkS_, 0.8644, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3845, d4qwkE_, 0.8644, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3846, d4qwfE_, 0.8644, 1.66, 0.341, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3847, d4eu2A_, 0.8644, 2.13, 0.243, 241, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3848, p6epcF_, 0.8643, 2.06, 0.311, 238, 228, GROUND STATE 26S PROTEASOME (GS2)
3849, p4y8iS_, 0.8643, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3850, p4y8iE_, 0.8643, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3851, p4y81S_, 0.8643, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3852, p4y81E_, 0.8643, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3853, p4y78S_, 0.8643, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3854, p4y74S_, 0.8643, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3855, p4y74E_, 0.8643, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3856, p4y70S_, 0.8643, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3857, p4y70E_, 0.8643, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3858, p4y6zS_, 0.8643, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3859, p4y6zE_, 0.8643, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3860, d4r17E_, 0.8643, 1.66, 0.341, 231, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3861, d4qz4S_, 0.8643, 1.66, 0.341, 231, 223, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3862, d4qz4E_, 0.8643, 1.66, 0.341, 231, 223, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3863, d4qw3S_, 0.8643, 1.66, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3864, d4qw3E_, 0.8643, 1.66, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3865, d4qv6S_, 0.8643, 1.66, 0.341, 231, 223, YCP BETA5-A49V MUTANT
3866, d4qv6E_, 0.8643, 1.66, 0.341, 231, 223, YCP BETA5-A49V MUTANT
3867, d4hrcE_, 0.8643, 1.65, 0.341, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3868, p5m32F_, 0.8642, 1.87, 0.350, 232, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3869, p4ya0S_, 0.8642, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3870, p4ya0E_, 0.8642, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3871, p4y8sS_, 0.8642, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3872, p4y8sE_, 0.8642, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3873, p4y8hS_, 0.8642, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3874, p4y8hE_, 0.8642, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3875, p4y78E_, 0.8642, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3876, d4r17S_, 0.8642, 1.66, 0.341, 231, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3877, d4qz1S_, 0.8642, 1.65, 0.341, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3878, d4qz1E_, 0.8642, 1.66, 0.341, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3879, d4qxjS_, 0.8642, 1.66, 0.341, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3880, d4qxjE_, 0.8642, 1.66, 0.341, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3881, d4qw3U_, 0.8642, 2.18, 0.242, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3882, d4qw3G_, 0.8642, 2.18, 0.242, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3883, d4qlsS_, 0.8642, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3884, d4qlsE_, 0.8642, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3885, d3mg7S_, 0.8642, 1.66, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3886, p3jcoPA_, 0.8642, 2.38, 0.323, 244, 232, 
3887, d1g65S_, 0.8642, 1.67, 0.341, 233, 223, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3888, d5laiS_, 0.8641, 1.66, 0.341, 231, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3889, d5laiE_, 0.8641, 1.66, 0.341, 231, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3890, p4y8oS_, 0.8641, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3891, p4y8oE_, 0.8641, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3892, d4qwsS_, 0.8641, 1.66, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3893, d4qwsE_, 0.8641, 1.66, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3894, d4qlqS_, 0.8641, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3895, d4qlqE_, 0.8641, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3896, d4no1S_, 0.8641, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3897, d4no1E_, 0.8641, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3898, d3oeuE_, 0.8641, 1.66, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3899, p3jcpOA_, 0.8641, 1.67, 0.341, 233, 223, 
3900, p3jcpO_, 0.8641, 1.67, 0.341, 233, 223, 
3901, p3jcoP_, 0.8641, 2.38, 0.323, 244, 232, 
3902, p5dsvJ_, 0.8640, 2.34, 0.352, 239, 230, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3903, p4y8gS_, 0.8640, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3904, p4y8gE_, 0.8640, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3905, d4q1sS_, 0.8640, 1.66, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3906, d4nnwS_, 0.8640, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3907, d4nnwE_, 0.8640, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3908, d3wxrT_, 0.8640, 1.65, 0.341, 232, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3909, d3oevS_, 0.8640, 1.66, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3910, p5mpbU_, 0.8639, 2.33, 0.328, 243, 232, 
3911, d5l54S_, 0.8639, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3912, d5l54E_, 0.8639, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3913, p4y84S_, 0.8639, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3914, p4y84E_, 0.8639, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3915, d4qwgS_, 0.8639, 1.66, 0.341, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3916, d4qwgE_, 0.8639, 1.66, 0.341, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3917, d5dkiU_, 0.8638, 2.18, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3918, d5dkiG_, 0.8638, 2.18, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3919, p4y8tS_, 0.8638, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3920, p4y8tE_, 0.8638, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3921, d4qwgU_, 0.8638, 2.17, 0.242, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3922, d4qluE_, 0.8638, 1.67, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3923, d3sdiS_, 0.8638, 1.66, 0.345, 230, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3924, d3oeuS_, 0.8638, 1.66, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3925, p4ya2S_, 0.8637, 1.67, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3926, p4ya2E_, 0.8637, 1.67, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3927, d4qwgG_, 0.8637, 2.17, 0.242, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3928, d4qluS_, 0.8637, 1.67, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3929, d4no9S_, 0.8637, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3930, d4no9E_, 0.8637, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3931, d4no6S_, 0.8637, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3932, d4no6E_, 0.8637, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3933, d4qltE_, 0.8636, 1.67, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3934, p5vfqD_, 0.8635, 2.25, 0.346, 239, 234, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3935, d4qltS_, 0.8635, 1.67, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3936, d4qlvS_, 0.8634, 1.67, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3937, d4qlvE_, 0.8634, 1.67, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3938, p4qbyS_, 0.8634, 1.67, 0.341, 231, 223, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3939, p4qbyE_, 0.8634, 1.67, 0.341, 231, 223, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3940, d3sdkT_, 0.8634, 2.32, 0.338, 236, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3941, d1jd2E_, 0.8634, 1.67, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3942, p6epfF_, 0.8633, 2.03, 0.311, 238, 228, GROUND STATE 26S PROTEASOME (GS1)
3943, p5mp9f_, 0.8633, 1.64, 0.341, 231, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3944, p5a0qS_, 0.8632, 1.01, 0.609, 215, 215, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3945, p5a0qE_, 0.8632, 1.01, 0.609, 215, 215, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3946, d1g0uS_, 0.8632, 1.68, 0.345, 230, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3947, p5vfoJ_, 0.8631, 2.27, 0.342, 239, 234, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3948, p4cr4G_, 0.8630, 2.45, 0.328, 245, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3949, p5l4gR_, 0.8629, 2.06, 0.352, 232, 227, 
3950, p5vfqCA_, 0.8626, 2.26, 0.343, 239, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3951, p5t0gJ_, 0.8625, 2.27, 0.343, 239, 233, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3952, p5mpcR_, 0.8625, 2.17, 0.342, 240, 231, 
3953, p4v7oT_, 0.8625, 1.69, 0.341, 234, 223, 
3954, d3l5qW_, 0.8625, 1.69, 0.341, 234, 223,  
3955, p5wvkT_, 0.8624, 1.65, 0.341, 233, 223, 
3956, p5mpbG_, 0.8624, 2.46, 0.336, 243, 232, 
3957, p4v7oF_, 0.8624, 1.69, 0.341, 234, 223, 
3958, d3l5qK_, 0.8624, 1.69, 0.341, 234, 223,  
3959, p5a5bG_, 0.8623, 2.47, 0.328, 245, 232, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3960, p4v7oNA_, 0.8623, 1.69, 0.341, 234, 223, 
3961, p4v7oBB_, 0.8623, 1.69, 0.341, 234, 223, 
3962, p4cr3G_, 0.8623, 2.47, 0.328, 245, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3963, d1vsyT_, 0.8623, 1.69, 0.341, 234, 223,  
3964, d1vsyF_, 0.8623, 1.69, 0.341, 234, 223,  
3965, p5gjrV_, 0.8622, 2.00, 0.350, 231, 226, 
3966, p5gjrJA_, 0.8622, 2.00, 0.350, 231, 226, 
3967, d4cr2A_, 0.8622, 2.18, 0.246, 243, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3968, p1fntO_, 0.8622, 2.06, 0.222, 238, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3969, p5vfuHA_, 0.8621, 2.19, 0.330, 240, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3970, p5vfti_, 0.8621, 2.19, 0.330, 240, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3971, d3sdkF_, 0.8621, 2.30, 0.338, 236, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3972, p4r3oR_, 0.8620, 2.00, 0.350, 231, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
3973, d1jd2Z_, 0.8620, 1.68, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3974, p1fntA_, 0.8620, 2.06, 0.222, 238, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3975, p4r3oD_, 0.8619, 2.00, 0.350, 231, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
3976, d1ya7F_, 0.8618, 1.73, 0.404, 227, 223, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3977, p6epeC_, 0.8617, 2.42, 0.323, 249, 235, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3978, p5vfpBA_, 0.8616, 2.27, 0.343, 239, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3979, p5m32G_, 0.8616, 2.16, 0.258, 233, 229, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3980, p5gjqE_, 0.8615, 2.02, 0.350, 231, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3981, p5vfrJ_, 0.8612, 2.27, 0.342, 239, 234, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3982, d1ya7C_, 0.8611, 1.73, 0.408, 227, 223, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3983, p5l4gD_, 0.8609, 2.03, 0.354, 231, 226, 
3984, p5vfrj_, 0.8608, 2.28, 0.343, 239, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3985, p5mpcU_, 0.8608, 2.41, 0.336, 243, 232, 
3986, d5lexG_, 0.8608, 2.03, 0.264, 241, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3987, p6epdE_, 0.8607, 2.23, 0.578, 233, 232, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
3988, d1ya7G_, 0.8606, 1.74, 0.404, 227, 223, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3989, d5lf3G_, 0.8605, 2.04, 0.264, 241, 227, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3990, p3j9iU_, 0.8603, 1.73, 0.396, 224, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3991, p3j9iT_, 0.8603, 1.73, 0.396, 224, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3992, p3j9iS_, 0.8603, 1.73, 0.396, 224, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3993, p3j9iR_, 0.8603, 1.73, 0.396, 224, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3994, p3j9iQ_, 0.8603, 1.73, 0.396, 224, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3995, p3j9iP_, 0.8603, 1.73, 0.396, 224, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3996, p3j9iO_, 0.8603, 1.73, 0.396, 224, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3997, p3j9iG_, 0.8603, 1.73, 0.396, 224, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3998, p3j9iF_, 0.8603, 1.73, 0.396, 224, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3999, p3j9iE_, 0.8603, 1.73, 0.396, 224, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4000, p3j9iD_, 0.8603, 1.73, 0.396, 224, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4001, p3j9iC_, 0.8603, 1.73, 0.396, 224, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4002, p3j9iB_, 0.8603, 1.73, 0.396, 224, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4003, p3j9iA_, 0.8603, 1.73, 0.396, 224, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4004, d1ya7A_, 0.8601, 1.74, 0.408, 227, 223, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4005, p5a5bB_, 0.8600, 1.95, 0.326, 250, 227, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4006, p4cr3B_, 0.8600, 1.95, 0.326, 250, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4007, p5mpbF_, 0.8598, 1.71, 0.341, 231, 223, 
4008, d5le5G_, 0.8598, 2.04, 0.264, 241, 227, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4009, d5lf7G_, 0.8597, 2.05, 0.264, 241, 227, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4010, p5mpaF_, 0.8596, 1.71, 0.345, 233, 223, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4011, p5mpaa_, 0.8595, 2.20, 0.247, 241, 231, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4012, d5lf4G_, 0.8595, 2.05, 0.264, 241, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4013, p5t0hM_, 0.8593, 2.53, 0.343, 240, 233, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4014, d5lf1G_, 0.8593, 2.05, 0.264, 241, 227, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4015, d2ku1F1, 0.8593, 1.77, 0.399, 233, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4016, d3jseF_, 0.8592, 1.75, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4017, d3wxrG1, 0.8591, 2.36, 0.338, 236, 228, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4018, d3jseG_, 0.8591, 1.75, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4019, d3jseE_, 0.8591, 1.75, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4020, d3jseC_, 0.8590, 1.75, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4021, d3jseB_, 0.8590, 1.75, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4022, d3jseA_, 0.8590, 1.75, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4023, p5mpcG_, 0.8589, 2.48, 0.332, 243, 232, 
4024, p5m32B_, 0.8589, 2.02, 0.342, 234, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4025, d3jseD_, 0.8589, 1.75, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4026, d1ya7D_, 0.8589, 1.76, 0.404, 227, 223, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4027, d1ya7B_, 0.8589, 1.76, 0.408, 227, 223, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4028, d3wxrU1, 0.8588, 2.40, 0.338, 236, 228, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4029, p6epfG_, 0.8583, 2.48, 0.346, 245, 231, GROUND STATE 26S PROTEASOME (GS1)
4030, d2ku1G1, 0.8582, 1.78, 0.404, 233, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4031, d2ku1E1, 0.8582, 1.78, 0.404, 233, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4032, d2ku2E1, 0.8579, 1.79, 0.399, 233, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4033, d2ku2D1, 0.8579, 1.79, 0.399, 233, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4034, p4cr4A_, 0.8577, 2.24, 0.237, 243, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4035, d3jrmG_, 0.8577, 1.79, 0.404, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4036, d3jrmC_, 0.8577, 1.79, 0.404, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4037, d3jrmA_, 0.8577, 1.78, 0.404, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4038, d3jrmD_, 0.8576, 1.79, 0.404, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4039, d3jrmB_, 0.8576, 1.79, 0.404, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4040, d3jrmF_, 0.8575, 1.79, 0.404, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4041, d3jrmE_, 0.8575, 1.80, 0.404, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4042, d2ku2F1, 0.8574, 1.81, 0.399, 233, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4043, p6epeA_, 0.8572, 2.22, 0.258, 246, 233, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4044, p5gjqk_, 0.8572, 2.06, 0.354, 231, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4045, p6epeE_, 0.8571, 2.27, 0.591, 233, 232, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4046, d2ku1C1, 0.8571, 1.82, 0.404, 233, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4047, d1ya7E_, 0.8567, 1.82, 0.404, 227, 223, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4048, p3jcoOA_, 0.8564, 1.76, 0.341, 233, 223, 
4049, p3jcoO_, 0.8564, 1.76, 0.341, 233, 223, 
4050, p5t0jM_, 0.8562, 2.65, 0.329, 240, 234, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4051, p5wviX_, 0.8559, 2.32, 0.333, 245, 231, 
4052, d5le5Q_, 0.8558, 2.17, 0.352, 233, 227, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4053, d4cr2F_, 0.8557, 1.73, 0.341, 233, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4054, p5t0hJ_, 0.8556, 2.31, 0.339, 239, 233, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4055, d2ku2G1, 0.8556, 1.86, 0.399, 233, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4056, p6epeF_, 0.8552, 2.12, 0.311, 238, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4057, p3jtlC_, 0.8552, 1.82, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4058, p3jtlA_, 0.8552, 1.82, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4059, p3jtlG_, 0.8551, 1.82, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4060, p3jtlD_, 0.8551, 1.82, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4061, p3jtlB_, 0.8551, 1.82, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4062, d5lexQ_, 0.8550, 2.17, 0.352, 233, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4063, p3jtlF_, 0.8550, 1.83, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4064, p3jtlE_, 0.8550, 1.83, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4065, d2ku1D1, 0.8549, 1.90, 0.404, 233, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4066, p5a5bF_, 0.8543, 1.76, 0.341, 233, 223, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4067, p4cr3F_, 0.8543, 1.76, 0.341, 233, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4068, p5mpbT_, 0.8542, 1.78, 0.341, 233, 223, 
4069, p5ln3G_, 0.8542, 2.42, 0.341, 242, 232, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4070, p5lezQ_, 0.8541, 2.20, 0.352, 234, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4071, d1yauA_, 0.8539, 1.67, 0.405, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4072, p5mpbR_, 0.8534, 2.28, 0.354, 240, 229, 
4073, d1yauF_, 0.8532, 1.67, 0.405, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4074, d2ku2A1, 0.8529, 1.83, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4075, p6epeB_, 0.8528, 2.13, 0.301, 234, 226, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4076, p6epfD_, 0.8526, 2.31, 0.323, 246, 232, GROUND STATE 26S PROTEASOME (GS1)
4077, d1yauG_, 0.8526, 1.69, 0.405, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4078, d1yauC_, 0.8523, 1.69, 0.405, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4079, d2ku2C1, 0.8519, 1.90, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4080, d2ku1A1, 0.8516, 1.86, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4081, d2ku2B1, 0.8514, 1.90, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4082, d2ku1B1, 0.8514, 1.90, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4083, p5mpcO_, 0.8512, 2.25, 0.226, 241, 230, 
4084, d5lexU_, 0.8506, 2.16, 0.267, 235, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4085, d1yauB_, 0.8506, 1.72, 0.405, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4086, d5lf7U_, 0.8502, 2.15, 0.267, 235, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4087, d5lf3U_, 0.8502, 2.15, 0.267, 235, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4088, d1yauE_, 0.8502, 1.74, 0.405, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4089, d5lf1U_, 0.8498, 2.16, 0.267, 235, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4090, d1yauD_, 0.8498, 1.73, 0.405, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4091, d1yarC_, 0.8498, 1.67, 0.406, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4092, d1yarG_, 0.8496, 1.67, 0.406, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4093, p5lf6U_, 0.8495, 2.16, 0.267, 235, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4094, d5lf4U_, 0.8495, 2.16, 0.267, 235, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4095, p4v7oP_, 0.8494, 1.40, 0.321, 231, 215, 
4096, p4v7oB_, 0.8494, 1.40, 0.321, 231, 215, 
4097, d3l5qS_, 0.8494, 1.40, 0.321, 231, 215,  
4098, d3l5qG_, 0.8494, 1.40, 0.321, 231, 215,  
4099, p5mpbA_, 0.8493, 2.33, 0.247, 241, 231, 
4100, p4v7oXA_, 0.8492, 1.41, 0.321, 231, 215, 
4101, p4v7oJA_, 0.8492, 1.41, 0.321, 231, 215, 
4102, d1yarD_, 0.8492, 1.68, 0.406, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4103, d1vsyP_, 0.8492, 1.41, 0.321, 231, 215,  
4104, d1vsyB_, 0.8492, 1.41, 0.321, 231, 215,  
4105, p6epdB_, 0.8489, 2.16, 0.308, 234, 227, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4106, d1yarF_, 0.8489, 1.71, 0.406, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4107, d1yarA_, 0.8489, 1.69, 0.406, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4108, d1yarB_, 0.8482, 1.69, 0.406, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4109, p6epcG_, 0.8481, 2.58, 0.342, 245, 234, GROUND STATE 26S PROTEASOME (GS2)
4110, p6epeG_, 0.8478, 2.36, 0.335, 245, 230, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4111, p5wviH_, 0.8477, 1.15, 1.000, 214, 213, 
4112, p4cr4F_, 0.8477, 1.84, 0.345, 233, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4113, p5mpcF_, 0.8475, 1.87, 0.336, 231, 223, 
4114, p4v7oZA_, 0.8475, 1.94, 0.324, 227, 222, 
4115, p4v7oR_, 0.8475, 1.93, 0.324, 227, 222, 
4116, p4v7oLA_, 0.8475, 1.93, 0.324, 227, 222, 
4117, p4v7oD_, 0.8475, 1.93, 0.324, 227, 222, 
4118, d3l5qU_, 0.8475, 1.93, 0.324, 227, 222,  
4119, d3l5qI_, 0.8475, 1.93, 0.324, 227, 222,  
4120, d1vsyR_, 0.8475, 1.94, 0.324, 227, 222,  
4121, d1vsyD_, 0.8475, 1.93, 0.324, 227, 222,  
4122, p5vfqBA_, 0.8474, 1.89, 0.324, 232, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4123, p5vy3Y_, 0.8472, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4124, p5vy3S_, 0.8472, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4125, p5vy3Q_, 0.8472, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4126, p5vy3O_, 0.8472, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4127, p5vy3M_, 0.8472, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4128, p5vy3K_, 0.8472, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4129, p5vy3C_, 0.8472, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4130, p5vy30_, 0.8472, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4131, p5vfoi_, 0.8472, 1.89, 0.324, 232, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4132, p5vy3W_, 0.8471, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4133, p5vy3U_, 0.8471, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4134, p5vy3I_, 0.8471, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4135, p5vy3G_, 0.8471, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4136, p5vy3E_, 0.8471, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4137, p5vy3A_, 0.8471, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4138, p6bdfY_, 0.8470, 1.73, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4139, p6bdfW_, 0.8470, 1.73, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4140, p6bdfU_, 0.8470, 1.73, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4141, p6bdfS_, 0.8470, 1.73, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4142, p6bdfQ_, 0.8470, 1.73, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4143, p6bdfO_, 0.8470, 1.73, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4144, p6bdfM_, 0.8470, 1.73, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4145, p6bdfK_, 0.8470, 1.73, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4146, p6bdfI_, 0.8470, 1.73, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4147, p6bdfG_, 0.8470, 1.73, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4148, p6bdfE_, 0.8470, 1.73, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4149, p6bdfC_, 0.8470, 1.73, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4150, p6bdfA_, 0.8470, 1.73, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4151, p6bdf0_, 0.8470, 1.73, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4152, p5vfpAA_, 0.8470, 1.89, 0.324, 232, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4153, p5dsvC_, 0.8467, 2.29, 0.356, 234, 225, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4154, d1yarE_, 0.8467, 1.73, 0.406, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4155, p5vy4Y_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4156, p5vy4W_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4157, p5vy4U_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4158, p5vy4S_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4159, p5vy4Q_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4160, p5vy4O_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4161, p5vy4M_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4162, p5vy4K_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4163, p5vy4I_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4164, p5vy4G_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4165, p5vy4E_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4166, p5vy4C_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4167, p5vy4AA_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4168, p5vy4A_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4169, p5vy40_, 0.8463, 1.73, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4170, p5vfri_, 0.8457, 1.90, 0.324, 232, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4171, p5fmgS_, 0.8451, 1.46, 0.509, 217, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4172, p5fmgE_, 0.8451, 1.46, 0.509, 217, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4173, p5fmgQ_, 0.8446, 1.78, 0.404, 220, 218, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4174, p5fmgC_, 0.8446, 1.78, 0.404, 220, 218, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4175, d1pmaO_, 0.8444, 1.76, 0.402, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4176, d1pmaN_, 0.8443, 1.77, 0.402, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4177, d1pmaD_, 0.8443, 1.76, 0.402, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4178, d1pmaL_, 0.8442, 1.77, 0.402, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4179, d1pmaG_, 0.8442, 1.77, 0.402, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4180, d1pmaF_, 0.8442, 1.76, 0.402, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4181, d1pmaH_, 0.8441, 1.76, 0.402, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4182, d1pmaM_, 0.8440, 1.77, 0.402, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4183, d1pmaK_, 0.8440, 1.77, 0.402, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4184, d1pmaJ_, 0.8440, 1.76, 0.402, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4185, d1pmaA_, 0.8440, 1.77, 0.402, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4186, d3c92U1, 0.8439, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4187, d3c92T1, 0.8439, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4188, d3c92S1, 0.8439, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4189, d3c92R1, 0.8439, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4190, d3c92Q1, 0.8439, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4191, d3c92P1, 0.8439, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4192, d3c92O1, 0.8439, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4193, d3c92G1, 0.8439, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4194, d3c92F1, 0.8439, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4195, d3c92E1, 0.8439, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4196, d3c92D1, 0.8439, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4197, d3c92C1, 0.8439, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4198, d3c92B1, 0.8439, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4199, d3c92A1, 0.8439, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4200, d1pmaI_, 0.8439, 1.77, 0.402, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4201, d1pmaE_, 0.8436, 1.77, 0.402, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4202, d1pmaC_, 0.8436, 1.78, 0.402, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4203, d3c91U1, 0.8435, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4204, d3c91T1, 0.8435, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4205, d3c91S1, 0.8435, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4206, d3c91R1, 0.8435, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4207, d3c91Q1, 0.8435, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4208, d3c91P1, 0.8435, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4209, d3c91O1, 0.8435, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4210, d3c91G1, 0.8435, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4211, d3c91F1, 0.8435, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4212, d3c91E1, 0.8435, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4213, d3c91D1, 0.8435, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4214, d3c91C1, 0.8435, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4215, d3c91B1, 0.8435, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4216, d3c91A1, 0.8435, 1.77, 0.402, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4217, d5le5U_, 0.8431, 2.03, 0.270, 232, 222, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4218, p6epcB_, 0.8429, 2.30, 0.301, 234, 226, GROUND STATE 26S PROTEASOME (GS2)
4219, p5wviG_, 0.8429, 1.88, 0.341, 233, 223, 
4220, p5mpcA_, 0.8429, 2.32, 0.218, 241, 229, 
4221, p6epdF_, 0.8420, 2.26, 0.316, 238, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4222, p5t0iM_, 0.8408, 2.74, 0.343, 240, 233, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4223, p5wviZ_, 0.8405, 1.91, 0.341, 233, 223, 
4224, p3ipmF_, 0.8396, 2.04, 0.396, 227, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4225, p3ipmE_, 0.8396, 2.04, 0.396, 227, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4226, p3ipmD_, 0.8396, 2.04, 0.396, 227, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4227, p3ipmA_, 0.8396, 2.04, 0.396, 227, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4228, p3ipmG_, 0.8395, 2.04, 0.396, 227, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4229, p3ipmC_, 0.8395, 2.04, 0.396, 227, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4230, p3ipmB_, 0.8395, 2.04, 0.396, 227, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4231, p5fmgT_, 0.8392, 1.73, 0.350, 219, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4232, p5fmgF_, 0.8392, 1.73, 0.350, 219, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4233, p5a5bC_, 0.8383, 2.04, 0.338, 226, 219, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4234, p4cr3C_, 0.8383, 2.04, 0.338, 226, 219, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4235, p5wvkX_, 0.8382, 1.84, 0.339, 225, 218, 
4236, p5wvkQ_, 0.8327, 1.94, 0.339, 225, 218, 
4237, p5a5bA_, 0.8324, 2.49, 0.225, 243, 231, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4238, p4cr3A_, 0.8324, 2.49, 0.225, 243, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4239, p5gjrGA_, 0.8315, 1.90, 0.249, 221, 217, 
4240, p5l4gO_, 0.8314, 1.91, 0.244, 221, 217, 
4241, p5l4gA_, 0.8312, 1.91, 0.244, 221, 217, 
4242, d4g4sD_, 0.8312, 1.76, 0.344, 220, 215, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
4243, p5gjqh_, 0.8309, 1.91, 0.244, 221, 217, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4244, p5gjrS_, 0.8308, 1.92, 0.244, 221, 217, 
4245, p5gjqB_, 0.8301, 1.93, 0.244, 221, 217, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4246, p5wviI_, 0.8283, 2.17, 0.351, 231, 222, 
4247, p6epcD_, 0.8282, 2.63, 0.316, 246, 231, GROUND STATE 26S PROTEASOME (GS2)
4248, p6epdG_, 0.8281, 2.77, 0.338, 245, 231, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4249, p5ln3D_, 0.8275, 2.39, 0.329, 232, 225, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4250, p5t0jH_, 0.8254, 2.50, 0.301, 232, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4251, p3unhU_, 0.8250, 1.94, 0.245, 220, 216, MOUSE 20S IMMUNOPROTEASOME
4252, p3unhG_, 0.8250, 1.94, 0.245, 220, 216, MOUSE 20S IMMUNOPROTEASOME
4253, p5a0qP_, 0.8242, 1.60, 0.322, 214, 211, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4254, p5a0qB_, 0.8242, 1.60, 0.322, 214, 211, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4255, p5t0iL_, 0.8227, 1.99, 0.310, 221, 216, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4256, p5wviAA_, 0.8224, 2.18, 0.348, 231, 221, 
4257, p5t0jK_, 0.8207, 1.50, 0.578, 212, 211, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4258, p6avoR_, 0.8195, 2.06, 0.242, 217, 215, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4259, p5vfoG_, 0.8193, 2.00, 0.245, 220, 216, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4260, p5m32S_, 0.8192, 1.90, 0.305, 218, 213, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4261, p5vfrG_, 0.8189, 2.00, 0.245, 220, 216, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4262, p6avoK_, 0.8186, 2.07, 0.242, 217, 215, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4263, p5vfog_, 0.8182, 2.02, 0.245, 220, 216, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4264, p5mpcD_, 0.8182, 2.19, 0.338, 224, 219, 
4265, p5vfqA_, 0.8180, 2.01, 0.241, 220, 216, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4266, p5vfsA_, 0.8178, 2.06, 0.245, 220, 216, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4267, p5ln3C_, 0.8178, 2.10, 0.311, 225, 219, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4268, p5vfrg_, 0.8177, 2.02, 0.245, 220, 216, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4269, p5fmgO_, 0.8174, 2.04, 0.245, 219, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4270, p5fmgA_, 0.8174, 2.04, 0.245, 219, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4271, p5vfsZ_, 0.8173, 2.07, 0.245, 220, 216, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4272, p5vfpA_, 0.8173, 2.03, 0.241, 220, 216, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4273, p5vfqZ_, 0.8171, 2.03, 0.241, 220, 216, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4274, p5a0qR_, 0.8170, 1.94, 0.360, 214, 214, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4275, p5a0qD_, 0.8170, 1.94, 0.360, 214, 214, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4276, p5vfpY_, 0.8167, 2.05, 0.245, 220, 216, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4277, p5vfuR_, 0.8161, 2.09, 0.245, 220, 216, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4278, p5vftG_, 0.8161, 2.09, 0.245, 220, 216, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4279, p5t0cYA_, 0.8159, 2.05, 0.250, 220, 216, 
4280, p5t0cS_, 0.8159, 2.05, 0.250, 220, 216, 
4281, p5vfuFA_, 0.8120, 2.09, 0.245, 220, 216, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4282, p5vftg_, 0.8120, 2.09, 0.245, 220, 216, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4283, p5fmgP_, 0.8117, 1.79, 0.314, 212, 210, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4284, p5fmgB_, 0.8117, 1.79, 0.314, 212, 210, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4285, p5mpbO_, 0.8113, 2.10, 0.226, 225, 217, 
4286, p5t0gG_, 0.8111, 2.13, 0.245, 220, 216, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4287, p5mpaA_, 0.8111, 2.06, 0.218, 224, 216, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4288, p5m32U_, 0.8101, 1.95, 0.239, 218, 213, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4289, p5t0jG_, 0.8084, 2.11, 0.245, 220, 216, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4290, p5fmgR_, 0.8083, 2.14, 0.308, 215, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4291, p5fmgD_, 0.8083, 2.14, 0.308, 215, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4292, p5wviNA_, 0.8073, 2.16, 0.330, 222, 215, 
4293, p5lf0G_, 0.8064, 1.99, 0.245, 218, 212, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4294, p5lezG_, 0.8063, 1.98, 0.245, 218, 212, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4295, p5leyG_, 0.8062, 1.99, 0.245, 218, 212, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4296, p5fmgU_, 0.8060, 2.16, 0.255, 219, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4297, p5fmgG_, 0.8060, 2.16, 0.255, 219, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4298, p5lf6G_, 0.8051, 2.01, 0.245, 218, 212, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4299, p6epfA_, 0.8035, 2.32, 0.239, 222, 218, GROUND STATE 26S PROTEASOME (GS1)
4300, p5wviY_, 0.8030, 2.17, 0.212, 225, 217, 
4301, p5t0hG_, 0.8003, 2.24, 0.241, 220, 216, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4302, p5t0jJ_, 0.7998, 2.32, 0.320, 222, 219, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4303, p6epdD_, 0.7995, 3.00, 0.341, 246, 232, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4304, p5mpcT_, 0.7995, 1.72, 0.322, 213, 208, 
4305, p5t0iG_, 0.7982, 2.23, 0.250, 220, 216, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4306, p5lf0U_, 0.7968, 2.10, 0.248, 212, 210, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4307, p5vfpD_, 0.7966, 2.27, 0.315, 219, 216, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4308, p5a0qU_, 0.7963, 1.84, 0.353, 209, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4309, p5a0qG_, 0.7963, 1.84, 0.353, 209, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4310, p5lezU_, 0.7962, 2.10, 0.248, 212, 210, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4311, p5leyU_, 0.7962, 2.11, 0.248, 212, 210, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4312, p6epcA_, 0.7958, 2.26, 0.220, 219, 214, GROUND STATE 26S PROTEASOME (GS2)
4313, p6epdA_, 0.7933, 2.44, 0.243, 223, 218, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4314, p5ln3F_, 0.7925, 1.87, 0.308, 212, 208, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4315, p5wvkAA_, 0.7920, 1.66, 0.312, 210, 205, 
4316, d5ts0G_, 0.7920, 2.23, 0.160, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4317, d5trgP_, 0.7916, 2.17, 0.161, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4318, p6epeD_, 0.7914, 2.60, 0.326, 229, 218, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4319, p5wviD_, 0.7914, 2.17, 0.201, 222, 214, 
4320, d3mkaA_, 0.7911, 2.31, 0.164, 222, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4321, d3mkaF_, 0.7895, 2.34, 0.164, 221, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4322, d3mi0F_, 0.7895, 2.28, 0.165, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4323, p5t0iJ_, 0.7886, 2.42, 0.320, 222, 219, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4324, d5trsA_, 0.7885, 2.20, 0.161, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4325, p5ln3A_, 0.7883, 2.30, 0.237, 219, 215, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4326, p2fhgW_, 0.7882, 2.25, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4327, p2fhgM_, 0.7882, 2.25, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4328, p2fhgD_, 0.7882, 2.25, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4329, p2fhgB_, 0.7882, 2.25, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4330, p2fhgA_, 0.7882, 2.25, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4331, p5wviF_, 0.7881, 2.39, 0.305, 223, 213, 
4332, p2fhgU_, 0.7881, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4333, p2fhgS_, 0.7881, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4334, p2fhgQ_, 0.7881, 2.25, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4335, p2fhgK_, 0.7881, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4336, p2fhgI_, 0.7881, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4337, p2fhg1_, 0.7881, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4338, p2fhgO_, 0.7880, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4339, d5thoS_, 0.7876, 2.24, 0.160, 221, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4340, d2fhhW_, 0.7871, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4341, d2fhhO_, 0.7870, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4342, d2fhhM_, 0.7870, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4343, d2fhhD_, 0.7870, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4344, d2fhhA_, 0.7870, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4345, d5trrA_, 0.7869, 2.16, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4346, d2fhhU_, 0.7869, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4347, d2fhhF_, 0.7869, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4348, d5thoG_, 0.7868, 2.20, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4349, d2fhhY_, 0.7868, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4350, d2fhhS_, 0.7868, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4351, d2fhhQ_, 0.7868, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4352, d2fhhK_, 0.7868, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4353, d2fhhI_, 0.7868, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4354, d2fhhB_, 0.7868, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4355, d5trgA_, 0.7867, 2.17, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4356, d3mkaK_, 0.7866, 2.30, 0.160, 221, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4357, d2fhh1_, 0.7866, 2.29, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4358, d5thoA_, 0.7864, 2.18, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4359, d5tryA_, 0.7863, 2.18, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4360, d5ts0A_, 0.7859, 2.19, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4361, d3h6iQ_, 0.7857, 2.18, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4362, d5trsP_, 0.7854, 2.15, 0.162, 219, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4363, d2h6jB1, 0.7852, 2.20, 0.161, 219, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4364, d5ts0T_, 0.7848, 2.23, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4365, d3mkaQ_, 0.7848, 2.35, 0.156, 222, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4366, d3mkaU_, 0.7846, 2.40, 0.165, 221, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4367, d3mfeI_, 0.7846, 2.12, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4368, d2h6jG1, 0.7846, 2.21, 0.156, 219, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4369, d2h6jF1, 0.7846, 2.21, 0.161, 219, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4370, d2h6jA1, 0.7846, 2.21, 0.156, 219, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4371, d5trsD_, 0.7845, 2.22, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4372, d2h6jD1, 0.7845, 2.21, 0.156, 219, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4373, d5tryS_, 0.7844, 2.29, 0.161, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4374, d2h6jE1, 0.7844, 2.21, 0.156, 219, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4375, d2h6jC1, 0.7843, 2.21, 0.161, 219, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4376, d5trsC_, 0.7841, 2.25, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4377, d5thoO_, 0.7841, 2.24, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4378, d5thoE_, 0.7840, 2.24, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4379, d3mka1_, 0.7839, 2.32, 0.166, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4380, d5tryF_, 0.7838, 2.22, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4381, d5ts0U_, 0.7836, 2.18, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4382, d5ts0Q_, 0.7836, 2.25, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4383, d5tryQ_, 0.7836, 2.26, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4384, d5trrP_, 0.7835, 2.18, 0.162, 219, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4385, d1q5rF_, 0.7835, 2.22, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4386, d1q5rD_, 0.7835, 2.22, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4387, d1q5rB_, 0.7835, 2.22, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4388, d1q5rG_, 0.7834, 2.22, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4389, d1q5rE_, 0.7834, 2.22, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4390, d1q5rC_, 0.7834, 2.22, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4391, d1q5rA_, 0.7834, 2.22, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4392, d1q5qF_, 0.7833, 2.28, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME
4393, d1q5qE_, 0.7833, 2.28, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME
4394, d1q5qD_, 0.7833, 2.28, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME
4395, d1q5qC_, 0.7833, 2.28, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME
4396, d1q5qA_, 0.7833, 2.28, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME
4397, d1q5qG_, 0.7832, 2.28, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME
4398, d1q5qB_, 0.7832, 2.28, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME
4399, d5trrT_, 0.7828, 2.18, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4400, d5trgS_, 0.7828, 2.26, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4401, d5trgO_, 0.7828, 2.26, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4402, d5trgE_, 0.7828, 2.25, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4403, d5ts0E_, 0.7827, 2.26, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4404, d3mkaY_, 0.7825, 2.41, 0.160, 224, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4405, d3mkaB_, 0.7825, 2.37, 0.161, 220, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4406, d5trrE_, 0.7824, 2.21, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4407, d5thoT_, 0.7824, 2.20, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4408, d3mkaM_, 0.7824, 2.42, 0.165, 224, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4409, d3h6iF_, 0.7822, 2.18, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4410, d5ts0P_, 0.7821, 2.14, 0.163, 218, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4411, d5trrS_, 0.7821, 2.26, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4412, d3mfeK_, 0.7821, 2.12, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4413, d5ts0B_, 0.7820, 2.16, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4414, d3mfeB_, 0.7820, 2.13, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4415, d5tryP_, 0.7819, 2.10, 0.163, 217, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4416, d3h6fQ_, 0.7817, 2.18, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4417, d5ts0C_, 0.7816, 2.22, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4418, d5trrC_, 0.7816, 2.19, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4419, d5trsS_, 0.7815, 2.28, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4420, d5trsE_, 0.7815, 2.22, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4421, d5trrU_, 0.7815, 2.14, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4422, d5trgT_, 0.7815, 2.23, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4423, d5thoC_, 0.7813, 2.23, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4424, d3mkaD_, 0.7812, 2.38, 0.166, 222, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4425, d5trsU_, 0.7811, 2.15, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4426, p5lzpD_, 0.7811, 2.20, 0.163, 217, 209, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4427, d5tryE_, 0.7810, 2.23, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4428, d5trgD_, 0.7810, 2.66, 0.155, 223, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4429, d3mkaW_, 0.7810, 2.35, 0.162, 221, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4430, d3mkaS_, 0.7810, 2.26, 0.157, 219, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4431, d3mkaO_, 0.7810, 2.29, 0.157, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4432, d5trsT_, 0.7809, 2.22, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4433, d5trgU_, 0.7809, 2.16, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4434, d5thoR_, 0.7808, 2.24, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4435, d3h6iK_, 0.7807, 2.20, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4436, d5ts0D_, 0.7806, 2.23, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4437, d5thoF_, 0.7806, 2.23, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4438, d5tryR_, 0.7805, 2.24, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4439, d3h6fW_, 0.7805, 2.20, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4440, d5tryU_, 0.7804, 2.16, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4441, d5thoU_, 0.7803, 2.17, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4442, d5trsB_, 0.7802, 2.18, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4443, d3h6iW_, 0.7802, 2.23, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4444, d5ts0S_, 0.7799, 2.16, 0.163, 218, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4445, d5ts0R_, 0.7799, 2.25, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4446, d5trgQ_, 0.7799, 2.26, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4447, d5tryD_, 0.7794, 2.25, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4448, d5tryC_, 0.7794, 2.16, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4449, d3h6iA_, 0.7794, 2.16, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4450, d5trrO_, 0.7792, 2.24, 0.158, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4451, d3h6fF_, 0.7792, 2.16, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4452, d3hfaB_, 0.7791, 2.07, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4453, d5trsO_, 0.7787, 2.25, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4454, d5thoP_, 0.7787, 2.13, 0.163, 217, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4455, d5trrD_, 0.7786, 2.21, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4456, d5trrG_, 0.7785, 2.19, 0.159, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4457, d3mi0K_, 0.7785, 2.20, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4458, d5trgG_, 0.7784, 2.21, 0.159, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4459, d5trgB_, 0.7784, 2.14, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4460, d5trsG_, 0.7780, 2.20, 0.159, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4461, d5thoQ_, 0.7780, 2.23, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4462, d5tryT_, 0.7779, 2.20, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4463, d5trsQ_, 0.7779, 2.23, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4464, d3mi0S_, 0.7778, 2.21, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4465, d5ts0O_, 0.7775, 2.23, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4466, d5tryG_, 0.7775, 2.20, 0.159, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4467, d3krdF_, 0.7775, 2.19, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4468, d3h6fK_, 0.7775, 2.11, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4469, d5thoB_, 0.7772, 2.16, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4470, d5trrB_, 0.7770, 2.17, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4471, d3h6iM_, 0.7770, 2.21, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4472, d3h6iI_, 0.7770, 2.13, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4473, d3h6i1_, 0.7770, 2.13, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4474, d5thoD_, 0.7769, 2.23, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4475, d3mi0Y_, 0.7769, 2.22, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4476, d3mi0O_, 0.7769, 2.24, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4477, d3mfeS_, 0.7768, 2.15, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4478, d3h6f1_, 0.7767, 2.13, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4479, d3mi0I_, 0.7766, 2.24, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4480, d3h6fA_, 0.7766, 2.13, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4481, d3mi0U_, 0.7765, 2.23, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4482, d3krdY_, 0.7765, 2.21, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4483, d5tryB_, 0.7763, 2.17, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4484, d3h6iU_, 0.7763, 2.15, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4485, d3mi0M_, 0.7760, 2.25, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4486, d5trsR_, 0.7758, 2.26, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4487, d5trgF_, 0.7755, 2.20, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4488, d3mi01_, 0.7755, 2.19, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4489, d5trsF_, 0.7754, 2.24, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4490, d5trgC_, 0.7754, 2.26, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4491, d3h6fS_, 0.7754, 2.16, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4492, d3krdI_, 0.7751, 2.20, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4493, d3h6fO_, 0.7750, 2.17, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4494, d3h6iO_, 0.7749, 2.17, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4495, d3mkaI_, 0.7748, 2.33, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4496, d3hfaA_, 0.7748, 2.14, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4497, d5trrQ_, 0.7747, 2.22, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4498, d3h6iS_, 0.7746, 2.18, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4499, d3mi0Q_, 0.7745, 2.21, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4500, p5lzpH_, 0.7744, 2.19, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4501, p5lzp2_, 0.7743, 2.20, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4502, p5lzp4_, 0.7742, 2.20, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4503, p5lzp0_, 0.7742, 2.20, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4504, d3hfaM_, 0.7742, 2.15, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4505, d3h6fI_, 0.7742, 2.11, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4506, d3hfaW_, 0.7741, 2.15, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4507, p5lzp6_, 0.7740, 2.20, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4508, p5lzpY_, 0.7739, 2.20, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4509, p5lzp8_, 0.7739, 2.20, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4510, p5lzpW_, 0.7738, 2.20, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4511, d3hfaQ_, 0.7738, 2.16, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4512, d3hfaK_, 0.7737, 2.16, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4513, d3mi0W_, 0.7736, 2.35, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4514, d3hfaS_, 0.7736, 2.17, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4515, d3hfaO_, 0.7736, 2.16, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4516, p5lzpJ_, 0.7735, 2.22, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4517, d3hfaI_, 0.7735, 2.17, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4518, d5ts0F_, 0.7734, 2.22, 0.159, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4519, d5tryO_, 0.7734, 2.27, 0.159, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4520, d3hfaF_, 0.7734, 2.17, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4521, d3hfa1_, 0.7734, 2.18, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4522, d3krdS_, 0.7731, 2.22, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4523, d3h6fM_, 0.7731, 2.22, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4524, d5trrR_, 0.7729, 2.24, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4525, p5lzpS_, 0.7729, 2.21, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4526, d3krd1_, 0.7729, 2.22, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4527, d3mi0A_, 0.7727, 2.22, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4528, d5trgR_, 0.7726, 2.24, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4529, d3mfeA_, 0.7726, 2.14, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4530, d3h6fB_, 0.7726, 2.15, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4531, d3krdW_, 0.7725, 2.23, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4532, d3krdK_, 0.7723, 2.23, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4533, d3hfaY_, 0.7723, 2.20, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4534, d3h6fD_, 0.7723, 2.14, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4535, d5trrF_, 0.7722, 2.22, 0.159, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4536, d3hfaU_, 0.7721, 2.18, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4537, d3h6iB_, 0.7717, 2.16, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4538, d3mi0D_, 0.7714, 2.19, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4539, d3h6iD_, 0.7713, 2.10, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4540, d3h6fU_, 0.7713, 2.17, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4541, d3mfeY_, 0.7712, 2.07, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4542, d3krdQ_, 0.7709, 2.20, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4543, d3krdO_, 0.7707, 2.21, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4544, d3hfaD_, 0.7705, 2.15, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4545, p5lzpM_, 0.7701, 2.20, 0.160, 214, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4546, p5lzpB_, 0.7701, 2.20, 0.160, 214, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4547, p5lzpQ_, 0.7700, 2.21, 0.160, 214, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4548, d3h6fY_, 0.7699, 2.12, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4549, d3krdA_, 0.7692, 2.22, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4550, p2z5cF_, 0.7690, 0.74, 1.000, 189, 189, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4551, p2z5cC_, 0.7690, 0.74, 1.000, 189, 189, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4552, d3mfeO_, 0.7688, 2.17, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4553, d3krdU_, 0.7682, 2.23, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4554, d3hf9I_, 0.7680, 2.09, 0.162, 212, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4555, d3mfe1_, 0.7679, 2.08, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4556, p6bgoI_, 0.7674, 2.26, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4557, p6bgoH_, 0.7674, 2.26, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4558, p6bgoG_, 0.7674, 2.26, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4559, p6bgoF_, 0.7674, 2.26, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4560, p6bgoE_, 0.7674, 2.26, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4561, p6bgoD_, 0.7674, 2.26, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4562, p6bgoC_, 0.7674, 2.26, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4563, p6bglO_, 0.7674, 2.26, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4564, p6bglN_, 0.7674, 2.26, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4565, p6bglM_, 0.7674, 2.26, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4566, p6bglL_, 0.7674, 2.26, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4567, p6bglK_, 0.7674, 2.26, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4568, p6bglJ_, 0.7674, 2.26, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4569, p6bglI_, 0.7674, 2.26, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4570, p6bglH_, 0.7674, 2.26, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4571, p6bglG_, 0.7674, 2.26, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4572, p6bglF_, 0.7674, 2.26, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4573, p6bglE_, 0.7674, 2.26, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4574, p6bglD_, 0.7674, 2.26, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4575, p6bglC_, 0.7674, 2.26, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4576, p6bglA_, 0.7674, 2.26, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4577, d3mfeD_, 0.7672, 2.18, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4578, d3krdM_, 0.7671, 2.25, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4579, d3mfeQ_, 0.7666, 2.18, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4580, d3mi0B_, 0.7665, 2.20, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4581, d3krdD_, 0.7662, 2.22, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4582, d3krdB_, 0.7659, 2.21, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4583, d3h6iY_, 0.7657, 2.20, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4584, p3hf9y_, 0.7656, 2.07, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4585, p3hf9s_, 0.7646, 2.13, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4586, d3hf9B_, 0.7646, 2.04, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4587, p3hf9d_, 0.7643, 2.08, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4588, p3hf9i_, 0.7642, 2.09, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4589, p3hf9b_, 0.7639, 2.05, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4590, p3hf9f_, 0.7638, 2.12, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4591, d3hf9S_, 0.7637, 2.11, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4592, p3hf9w_, 0.7636, 2.08, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4593, d3hf9K_, 0.7636, 2.07, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4594, d3hf91_, 0.7636, 2.10, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4595, p3hf9u_, 0.7635, 2.11, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4596, p3hf9k_, 0.7634, 2.12, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4597, d3hf9A_, 0.7633, 2.11, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4598, p3hf9a_, 0.7632, 2.10, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4599, d3hf9O_, 0.7629, 2.10, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4600, p3hf9o_, 0.7628, 2.10, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4601, d3hf9U_, 0.7625, 2.13, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4602, d3mfeU_, 0.7624, 2.21, 0.162, 212, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4603, p3hf9q_, 0.7621, 2.11, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4604, d3hf9Q_, 0.7619, 2.08, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4605, d3hf9Y_, 0.7605, 2.09, 0.163, 210, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4606, d3hf93_, 0.7602, 2.04, 0.163, 210, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4607, d3mfeW_, 0.7585, 1.99, 0.164, 209, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4608, d3hf9D_, 0.7566, 2.16, 0.163, 210, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4609, p2fhgF_, 0.7560, 2.04, 0.159, 209, 201, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4610, p2fhgY_, 0.7559, 2.04, 0.159, 209, 201, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4611, p5a0qT_, 0.7550, 1.69, 0.330, 195, 194, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4612, p5a0qF_, 0.7545, 1.70, 0.330, 195, 194, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4613, p3hf9m_, 0.7527, 2.10, 0.160, 208, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4614, p5a0qO_, 0.7490, 1.75, 0.290, 195, 193, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4615, p5a0qA_, 0.7490, 1.75, 0.290, 195, 193, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4616, p6bgoA_, 0.7489, 1.98, 0.171, 207, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4617, p6bgoN_, 0.7488, 1.98, 0.171, 207, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4618, p6bgoM_, 0.7488, 1.98, 0.171, 207, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4619, p6bgoL_, 0.7488, 1.98, 0.171, 207, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4620, p6bgoK_, 0.7488, 1.98, 0.171, 207, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4621, p6bgoJ_, 0.7488, 1.98, 0.171, 207, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4622, d3hf9M_, 0.7458, 1.95, 0.162, 205, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4623, p6bgoO_, 0.7453, 1.98, 0.172, 206, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4624, p3h4pf_, 0.7363, 2.23, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4625, d3h4pl_, 0.7360, 2.22, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4626, p3h4pe_, 0.7360, 2.25, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4627, d3h4pj_, 0.7359, 2.23, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4628, p3h4pc_, 0.7359, 2.23, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4629, p3h4pa_, 0.7359, 2.23, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4630, p3j9iZ_, 0.7358, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4631, p3j9iY_, 0.7358, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4632, p3j9iX_, 0.7358, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4633, p3j9iW_, 0.7358, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4634, p3j9iV_, 0.7358, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4635, p3j9iN_, 0.7358, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4636, p3j9iM_, 0.7358, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4637, p3j9iL_, 0.7358, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4638, p3j9iK_, 0.7358, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4639, p3j9iJ_, 0.7358, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4640, p3j9iI_, 0.7358, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4641, p3j9iH_, 0.7358, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4642, p3j9i2_, 0.7358, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4643, p3j9i1_, 0.7358, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4644, d3h4pn_, 0.7358, 2.23, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4645, p5vy3Z_, 0.7357, 2.19, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4646, p5vy3X_, 0.7357, 2.19, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4647, p5vy3V_, 0.7357, 2.19, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4648, p5vy3T_, 0.7357, 2.19, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4649, p5vy3R_, 0.7357, 2.19, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4650, p5vy3P_, 0.7357, 2.19, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4651, p5vy3N_, 0.7357, 2.19, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4652, p5vy3L_, 0.7357, 2.19, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4653, p5vy3J_, 0.7357, 2.19, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4654, p5vy3H_, 0.7357, 2.19, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4655, p5vy3F_, 0.7357, 2.19, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4656, p5vy3D_, 0.7357, 2.19, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4657, p5vy3B_, 0.7357, 2.19, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4658, p5vy31_, 0.7357, 2.19, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4659, p3h4pg_, 0.7357, 2.22, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4660, d3h4pk_, 0.7356, 2.24, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4661, p3h4pb_, 0.7355, 2.23, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4662, p5vy4Z_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4663, p5vy4X_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4664, p5vy4V_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4665, p5vy4T_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4666, p5vy4R_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4667, p5vy4P_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4668, p5vy4N_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4669, p5vy4L_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4670, p5vy4J_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4671, p5vy4H_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4672, p5vy4F_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4673, p5vy4D_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4674, p5vy4BA_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4675, p5vy4B_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4676, p5vy41_, 0.7354, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4677, p3h4pd_, 0.7354, 2.23, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4678, d3h4ph_, 0.7353, 2.24, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4679, d3h4pi_, 0.7352, 2.25, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4680, p6bdfZ_, 0.7351, 2.19, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4681, p6bdfX_, 0.7351, 2.19, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4682, p6bdfV_, 0.7351, 2.19, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4683, p6bdfT_, 0.7351, 2.19, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4684, p6bdfR_, 0.7351, 2.19, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4685, p6bdfP_, 0.7351, 2.19, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4686, p6bdfN_, 0.7351, 2.19, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4687, p6bdfL_, 0.7351, 2.19, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4688, p6bdfJ_, 0.7351, 2.19, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4689, p6bdfH_, 0.7351, 2.19, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4690, p6bdfF_, 0.7351, 2.19, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4691, p6bdfD_, 0.7351, 2.19, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4692, p6bdfB_, 0.7351, 2.19, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4693, p6bdf1_, 0.7351, 2.19, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4694, d3h4pm_, 0.7345, 2.25, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4695, d1yauM_, 0.7345, 2.22, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4696, d1yarM_, 0.7341, 2.23, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4697, d1ya7M_, 0.7337, 2.23, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4698, d3jseM_, 0.7332, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4699, d3jrmM_, 0.7332, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4700, d1yauJ_, 0.7332, 2.24, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4701, d1pmaX_, 0.7331, 2.24, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4702, d3jrmK_, 0.7330, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4703, d3jrmJ_, 0.7330, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4704, d3jrmI_, 0.7330, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4705, d3jseK_, 0.7329, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4706, d3jrmL_, 0.7329, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4707, d3jrmH_, 0.7329, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4708, d3c92X1, 0.7329, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4709, d3c92J1, 0.7329, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4710, d3c91X1, 0.7329, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4711, d3c91J1, 0.7329, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4712, d1ya7K_, 0.7329, 2.24, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4713, d1ya7J_, 0.7329, 2.24, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4714, d1pmaY_, 0.7329, 2.24, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4715, d1pmaQ_, 0.7329, 2.24, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4716, d3c92W1, 0.7328, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4717, d3c92N1, 0.7328, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4718, d3c92M1, 0.7328, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4719, d3c92I1, 0.7328, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4720, d3c9221, 0.7328, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4721, d3c9211, 0.7328, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4722, d3c91W1, 0.7328, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4723, d3c91N1, 0.7328, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4724, d3c91M1, 0.7328, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4725, d3c91I1, 0.7328, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4726, d3c9121, 0.7328, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4727, d3c9111, 0.7328, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4728, d1pmaU_, 0.7328, 2.24, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4729, d1pmaP_, 0.7328, 2.24, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4730, d3jseL_, 0.7327, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4731, d3jseJ_, 0.7327, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4732, d3jseI_, 0.7327, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4733, d1ya7I_, 0.7327, 2.24, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4734, d1pmaT_, 0.7327, 2.24, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4735, d1pma1_, 0.7327, 2.25, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4736, d3jseN_, 0.7326, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4737, d3jseH_, 0.7326, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4738, d1pmaV_, 0.7326, 2.24, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4739, d1pma2_, 0.7326, 2.24, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4740, d1yauK_, 0.7325, 2.25, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4741, d1yauI_, 0.7325, 2.25, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4742, p3jtlM_, 0.7324, 2.26, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4743, d2h6jN1, 0.7324, 2.55, 0.199, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4744, d2h6jK1, 0.7324, 2.55, 0.199, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4745, d1yarK_, 0.7324, 2.25, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4746, d1ya7L_, 0.7324, 2.25, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4747, d1pmaZ_, 0.7324, 2.25, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4748, p3jtlK_, 0.7323, 2.26, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4749, p3jtlI_, 0.7323, 2.26, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4750, d3c92Z1, 0.7323, 2.25, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4751, d3c92L1, 0.7323, 2.25, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4752, d3c91Z1, 0.7323, 2.25, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4753, d3c91L1, 0.7323, 2.25, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4754, d1yauH_, 0.7323, 2.26, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4755, d1pmaS_, 0.7323, 2.25, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4756, p3jtlN_, 0.7322, 2.26, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4757, p3jtlL_, 0.7322, 2.26, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4758, p3jtlJ_, 0.7322, 2.26, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4759, p3jtlH_, 0.7322, 2.26, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4760, d3c92V1, 0.7322, 2.25, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4761, d3c92H1, 0.7322, 2.25, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4762, d3c91V1, 0.7322, 2.25, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4763, d3c91H1, 0.7322, 2.25, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4764, d2h6jJ1, 0.7322, 2.55, 0.199, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4765, d1yarJ_, 0.7322, 2.25, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4766, d1ya7H_, 0.7322, 2.26, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4767, d1pmaB_, 0.7322, 2.25, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4768, d2h6jI1, 0.7321, 2.55, 0.199, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4769, d1yauL_, 0.7321, 2.25, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4770, d1yarL_, 0.7321, 2.25, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4771, d1yarI_, 0.7321, 2.26, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4772, d1pmaW_, 0.7321, 2.25, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4773, d3jrmN_, 0.7320, 2.32, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4774, d1ya7N_, 0.7320, 2.26, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4775, d3c92Y1, 0.7319, 2.25, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4776, d3c92K1, 0.7319, 2.25, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4777, d3c91Y1, 0.7319, 2.25, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4778, d3c91K1, 0.7319, 2.25, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4779, d2h6jH1, 0.7319, 2.56, 0.199, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4780, d1pmaR_, 0.7319, 2.25, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4781, d2h6jM1, 0.7318, 2.62, 0.198, 225, 202, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4782, d1yarN_, 0.7316, 2.27, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4783, d1yarH_, 0.7316, 2.27, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4784, d2h6jL1, 0.7310, 2.43, 0.195, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4785, d1yauN_, 0.7306, 2.35, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4786, d1q5rN_, 0.7302, 2.71, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4787, d1q5rM_, 0.7301, 2.71, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4788, d1q5rL_, 0.7301, 2.71, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4789, d1q5rK_, 0.7301, 2.71, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4790, d1q5rJ_, 0.7301, 2.71, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4791, d1q5rI_, 0.7301, 2.71, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4792, d1q5rH_, 0.7301, 2.71, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4793, d5fgdY_, 0.7277, 2.99, 0.216, 216, 204, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4794, d5fgeY_, 0.7276, 2.97, 0.206, 218, 204, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4795, d5fgeK_, 0.7274, 2.97, 0.206, 218, 204, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4796, d1j2qN_, 0.7267, 2.34, 0.231, 202, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4797, d1j2qJ_, 0.7267, 2.34, 0.231, 202, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4798, d3hfaV_, 0.7266, 2.71, 0.152, 226, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4799, d1j2qL_, 0.7266, 2.34, 0.231, 202, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4800, d1j2qK_, 0.7265, 2.34, 0.231, 202, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4801, d1j2qI_, 0.7265, 2.48, 0.230, 202, 196, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4802, d5fgdK_, 0.7264, 2.91, 0.217, 215, 203, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4803, d1j2qM_, 0.7264, 2.47, 0.230, 202, 196, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4804, d1j2qH_, 0.7264, 2.47, 0.230, 202, 196, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4805, d5cz7Y_, 0.7263, 3.06, 0.206, 217, 204, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4806, d5cz7K_, 0.7263, 3.07, 0.206, 217, 204, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4807, d5ts0K_, 0.7258, 2.75, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4808, d1q5qM_, 0.7255, 2.78, 0.186, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
4809, d1q5qN_, 0.7254, 2.78, 0.186, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
4810, d1q5qL_, 0.7254, 2.78, 0.186, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
4811, d1q5qK_, 0.7254, 2.78, 0.186, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
4812, d1q5qH_, 0.7254, 2.78, 0.186, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
4813, d3mkaL_, 0.7253, 3.07, 0.150, 251, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4814, d1q5qJ_, 0.7253, 2.78, 0.186, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
4815, d1q5qI_, 0.7253, 2.78, 0.186, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
4816, p3ipmM_, 0.7252, 2.44, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4817, p3ipmL_, 0.7252, 2.44, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4818, p3ipmK_, 0.7252, 2.44, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4819, p3ipmJ_, 0.7252, 2.44, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4820, d5trgK_, 0.7251, 2.75, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4821, d3mi0L_, 0.7251, 2.75, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4822, p3ipmI_, 0.7251, 2.44, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4823, p3ipmH_, 0.7251, 2.44, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4824, d5trsK_, 0.7250, 2.77, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4825, d5fgfK_, 0.7250, 2.86, 0.208, 214, 202, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4826, p3ipmN_, 0.7250, 2.44, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4827, d3hfaZ_, 0.7250, 2.77, 0.152, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4828, d5trgL_, 0.7248, 2.75, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4829, d5thoL_, 0.7247, 2.74, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4830, d5fgfY_, 0.7247, 2.86, 0.208, 214, 202, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4831, d3hfaX_, 0.7247, 2.81, 0.147, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4832, d5trrL_, 0.7245, 2.68, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4833, d5trsL_, 0.7243, 2.75, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4834, d3mka2_, 0.7242, 3.00, 0.151, 246, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4835, p5lzpI_, 0.7241, 2.71, 0.153, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4836, d3hfaT_, 0.7241, 2.78, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4837, d5trgY_, 0.7240, 2.76, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4838, d5trgV_, 0.7240, 2.76, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4839, d3mkaV_, 0.7240, 2.95, 0.155, 249, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4840, d5tryK_, 0.7239, 2.77, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4841, d5trrW_, 0.7239, 2.77, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4842, d3mkaN_, 0.7239, 2.94, 0.155, 252, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4843, d3mkaC_, 0.7239, 2.99, 0.151, 250, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4844, d3hfaH_, 0.7239, 2.77, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4845, d3mkaT_, 0.7238, 3.00, 0.151, 250, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4846, d3hfaE_, 0.7238, 2.74, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4847, p5trrb_, 0.7237, 2.78, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4848, d5trrY_, 0.7236, 2.75, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4849, d3mi0V1, 0.7236, 2.79, 0.157, 234, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4850, d5trrV_, 0.7235, 2.77, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4851, d5trrK_, 0.7235, 2.79, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4852, d5trrI_, 0.7235, 2.70, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4853, d5thoK_, 0.7235, 2.72, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4854, d3mkaR_, 0.7235, 2.87, 0.157, 246, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4855, d3mkaG_, 0.7235, 2.90, 0.152, 251, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4856, d5trsY_, 0.7234, 2.81, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4857, p5trra_, 0.7234, 2.73, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4858, d3mi0R1, 0.7234, 2.79, 0.157, 234, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4859, d5thoW_, 0.7233, 2.78, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4860, d5thoV_, 0.7233, 2.78, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4861, d3mkaP_, 0.7233, 2.88, 0.157, 250, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4862, d3mkaE_, 0.7233, 3.08, 0.150, 248, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4863, d5ts0L_, 0.7231, 2.77, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4864, d3mkaJ_, 0.7231, 2.94, 0.156, 252, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4865, d5ts0W_, 0.7230, 2.78, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4866, d3mkaH_, 0.7230, 2.90, 0.152, 249, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4867, d3mi0X_, 0.7230, 2.79, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4868, d3hfaG_, 0.7230, 2.71, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4869, d5trsW_, 0.7229, 2.79, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4870, d5trsV_, 0.7229, 2.78, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4871, d3hfaC_, 0.7229, 2.73, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4872, d5tryL_, 0.7228, 2.76, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4873, d5trgI_, 0.7228, 2.70, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4874, d5thoY_, 0.7228, 2.78, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4875, d3mi0T_, 0.7228, 2.72, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4876, d3hfa2_, 0.7228, 2.73, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4877, p5trya_, 0.7227, 2.80, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4878, d3hfaR_, 0.7227, 2.73, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4879, d3hfaP_, 0.7227, 2.73, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4880, d3hfaL_, 0.7227, 2.72, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4881, p5thoa_, 0.7226, 2.79, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4882, d3mi0J_, 0.7226, 2.71, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4883, d3hfaN_, 0.7226, 2.72, 0.153, 223, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4884, d3hfaJ_, 0.7226, 2.72, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4885, d5tryW_, 0.7225, 2.80, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4886, p5tryb_, 0.7225, 2.80, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4887, d5thoI_, 0.7225, 2.72, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4888, d5tryV_, 0.7224, 2.79, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4889, p5lzpG_, 0.7224, 2.66, 0.154, 222, 201, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4890, p5lzpC_, 0.7223, 2.69, 0.153, 223, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4891, p5trsa_, 0.7222, 2.81, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4892, d5trrZ_, 0.7222, 2.71, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4893, d5trgX_, 0.7222, 2.73, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4894, d3mi0N_, 0.7222, 2.71, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4895, p5thob_, 0.7221, 2.81, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4896, p5lzpU_, 0.7221, 2.64, 0.154, 223, 201, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4897, p5lzpK_, 0.7221, 2.72, 0.153, 222, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4898, p5ts0a_, 0.7220, 2.82, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4899, d3mi0E_, 0.7220, 2.70, 0.153, 223, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4900, d5ts0I_, 0.7219, 2.73, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4901, p5lzpO_, 0.7219, 2.72, 0.149, 223, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4902, d5tryY_, 0.7218, 2.80, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4903, p5trga_, 0.7218, 2.88, 0.152, 223, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4904, p5lzpR_, 0.7218, 2.69, 0.153, 223, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4905, d3mi02_, 0.7218, 2.89, 0.152, 223, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4906, d5ts0V_, 0.7217, 2.80, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4907, p5lzpE_, 0.7217, 2.72, 0.153, 222, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4908, d3mi0Z_, 0.7217, 2.81, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4909, d5trsN_, 0.7216, 2.80, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4910, p5trsb_, 0.7216, 2.82, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4911, d3mi0G_, 0.7216, 2.72, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4912, p5ts0b_, 0.7215, 2.81, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4913, p5lzpT_, 0.7215, 2.70, 0.153, 223, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4914, d5tryI_, 0.7214, 2.73, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4915, d5trsI_, 0.7213, 2.74, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4916, d5ts0Y_, 0.7212, 2.80, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4917, d5thoZ_, 0.7212, 2.73, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4918, d5trrN_, 0.7211, 2.81, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4919, d5trgN_, 0.7211, 2.80, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4920, d5thoM_, 0.7209, 2.86, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4921, d3mi0C_, 0.7209, 2.74, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4922, d5d0vK_, 0.7208, 2.96, 0.208, 218, 202, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4923, d5tryZ_, 0.7207, 2.73, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4924, d5thoJ_, 0.7207, 2.75, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4925, d3krdL_, 0.7207, 2.70, 0.154, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4926, d5trgZ_, 0.7206, 2.73, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4927, p5trgb_, 0.7206, 2.83, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4928, p5lzpF_, 0.7206, 2.59, 0.150, 222, 200, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4929, p6bgoZ_, 0.7205, 2.59, 0.150, 222, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4930, p6bgoY_, 0.7205, 2.59, 0.150, 222, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4931, p6bgoX_, 0.7205, 2.59, 0.150, 222, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4932, p6bgoW_, 0.7205, 2.59, 0.150, 222, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4933, p6bgoV_, 0.7205, 2.59, 0.150, 222, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4934, p6bgoU_, 0.7205, 2.59, 0.150, 222, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4935, p6bgoT_, 0.7205, 2.59, 0.150, 222, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4936, p6bgoS_, 0.7205, 2.59, 0.150, 222, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4937, p6bgoR_, 0.7205, 2.59, 0.150, 222, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4938, p6bgoQ_, 0.7205, 2.59, 0.150, 222, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4939, p6bgoP_, 0.7205, 2.59, 0.150, 222, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4940, p6bgoc_, 0.7205, 2.59, 0.150, 222, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4941, p6bgob_, 0.7205, 2.59, 0.150, 222, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4942, p6bgoa_, 0.7205, 2.59, 0.150, 222, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4943, p6bglZ_, 0.7205, 2.59, 0.150, 222, 200, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4944, p6bglY_, 0.7205, 2.59, 0.150, 222, 200, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4945, p6bglX_, 0.7205, 2.59, 0.150, 222, 200, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4946, p6bglW_, 0.7205, 2.59, 0.150, 222, 200, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4947, p6bglV_, 0.7205, 2.59, 0.150, 222, 200, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4948, p6bglU_, 0.7205, 2.59, 0.150, 222, 200, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4949, p6bglT_, 0.7205, 2.59, 0.150, 222, 200, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4950, p6bglS_, 0.7205, 2.59, 0.150, 222, 200, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4951, p6bglR_, 0.7205, 2.59, 0.150, 222, 200, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4952, p6bglQ_, 0.7205, 2.59, 0.150, 222, 200, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4953, p6bglP_, 0.7205, 2.59, 0.150, 222, 200, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4954, p6bglc_, 0.7205, 2.59, 0.150, 222, 200, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4955, p6bglb_, 0.7205, 2.59, 0.150, 222, 200, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4956, p6bgla_, 0.7205, 2.59, 0.150, 222, 200, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4957, d5trrM_, 0.7205, 2.76, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4958, d5trgH_, 0.7205, 2.74, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4959, d5thoH_, 0.7205, 2.74, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4960, p5lzpN_, 0.7205, 2.62, 0.154, 221, 201, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4961, d5ts0N_, 0.7204, 2.82, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4962, d5trsH_, 0.7204, 2.75, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4963, d5trgW_, 0.7204, 2.72, 0.153, 223, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4964, p5lzpP_, 0.7204, 2.58, 0.155, 221, 200, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4965, p5lzpL_, 0.7204, 2.59, 0.150, 222, 200, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4966, d5trsZ_, 0.7203, 2.74, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4967, d5trrH_, 0.7203, 2.74, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4968, d5thoN_, 0.7203, 2.74, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4969, p5lzpA_, 0.7203, 2.65, 0.149, 222, 201, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4970, d3mi0H_, 0.7202, 2.64, 0.154, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4971, d5ts0Z_, 0.7201, 2.74, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4972, d5tryH_, 0.7201, 2.74, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4973, d5trrJ_, 0.7201, 2.75, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4974, d3mi0P_, 0.7201, 2.64, 0.154, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4975, d3krdR_, 0.7201, 2.86, 0.157, 229, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4976, d5tryN_, 0.7200, 2.84, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4977, d3krdV_, 0.7200, 2.86, 0.157, 229, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4978, d5trgM_, 0.7197, 2.76, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4979, d5ts0M_, 0.7195, 2.71, 0.154, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4980, d5trsJ_, 0.7195, 2.77, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4981, d5ts0H_, 0.7194, 2.76, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4982, d5trsM_, 0.7194, 2.78, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4983, d5l5rK_, 0.7193, 2.81, 0.216, 211, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4984, d5l5rY_, 0.7192, 2.81, 0.216, 211, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4985, d4z1lK_, 0.7192, 2.84, 0.205, 212, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4986, d5l5bY_, 0.7191, 2.82, 0.216, 211, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4987, d4z1lY_, 0.7191, 2.84, 0.205, 212, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4988, d5tryM_, 0.7190, 2.78, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4989, d5trgJ_, 0.7190, 2.76, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4990, d5l5bK_, 0.7190, 2.82, 0.216, 211, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4991, d5trrX_, 0.7189, 2.78, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4992, d4q1sK_, 0.7189, 2.83, 0.205, 212, 200, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4993, d4j70K_, 0.7189, 2.83, 0.205, 212, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4994, d5cgfK_, 0.7188, 2.84, 0.205, 212, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4995, d5bouY_, 0.7188, 2.84, 0.205, 212, 200, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4996, d5bouK_, 0.7188, 2.84, 0.205, 212, 200, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4997, d4j70Y_, 0.7188, 2.83, 0.205, 212, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4998, d5cgfY_, 0.7187, 2.84, 0.205, 212, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4999, d4qv3Y_, 0.7187, 2.84, 0.200, 212, 200, YCP BETA5-M45V MUTANT
5000, d4qv3K_, 0.7187, 2.84, 0.200, 212, 200, YCP BETA5-M45V MUTANT
